"#",Jurisdiction,Kind,Display Key,Lens ID,Publication Date,Publication Year,Application Number,Application Date,Priority Numbers,Earliest Priority Date,Title,Abstract,Applicants,Inventors,Owners,URL,Document Type,Has Full Text,Cites Patent Count,Cited by Patent Count,Simple Family Size,Extended Family Size,Sequence Count,CPC Classifications,IPCR Classifications,US Classifications,NPL Citation Count,NPL Resolved Citation Count,NPL Resolved Lens ID(s),NPL Resolved External ID(s),NPL Citations,Legal Status
1,EP,A1,EP 2351853 A1,021-865-062-741-758,2011-08-03,2011,EP 10182843 A,2001-06-01,EP 10182843 A;;US 58956000 A,2000-06-06,Method and devices for multiplexing amplification reactions,"The present invention pertains to methods, reagents, compositions, kits and instruments for use in simultaneously amplifying multiple targets. In particular, this invention is based on the discovery of a two-step multiplex amplification reaction wherein the first step truncates the standard initial multiplex amplification round to ""boost"" the sample copy number by only a 100 - 1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid.
",LIFE TECHNOLOGIES CORP,MARMARO JEFFREY M;;GERDES JOHN C,,https://lens.org/021-865-062-741-758,Patent Application,yes,26,0,1,14,84,C12Q1/6844;;C12Q1/689;;C12Q2600/16,C12Q1/68;;G01N33/53;;C12N15/09;;C12Q1/06;;C12Q1/10;;C12Q1/48;;G01N33/566,,23,19,070-656-465-248-593;;032-597-682-620-712;;079-074-030-459-68X;;017-515-593-292-125;;068-917-929-803-50X;;045-081-326-747-615;;005-540-691-594-134;;078-302-340-811-20X;;001-560-891-833-008;;041-417-339-486-865;;003-784-819-011-670;;023-050-451-230-180;;113-237-014-874-941;;078-302-340-811-20X;;041-417-339-486-865;;066-697-166-954-718;;085-112-370-064-707;;069-142-568-607-17X;;168-857-875-253-832,8637917;;pmc39840;;10.1073/pnas.93.6.2582;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;10.1016/s0890-8508(95)90125-6;;7477021;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;10.1016/0890-8508(90)90026-v;;2280781;;10.1101/gr.3.4.s65;;8173510;;10794932;;10.1016/s0732-8893(00)00116-4;;9298224;;10.2144/97233rr01;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;10.1021/ac970642d;;9463271;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;10.1101/gr.3.4.s65;;8173510;;9298224;;10.2144/97233rr01;;10.1101/gr.5.5.488;;8808470;;pmc148576;;10.1093/nar/27.17.e15;;10446258;;2466663;;10.1002/elps.1150090803;;10.2144/000114018;;23599926,"LIN Z ET AL: ""Multiplex genotype determination at a large number of gene loci"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US, vol. 93, no. 6, 19 March 1996 (1996-03-19), pages 2582 - 2587, XP002142667, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.6.2582;;SAIKI R K ED - ERLICH H A: ""THE DESIGN AND OPTIMIZATION OF THE PCR"", PCR TECHNOLOGY. PRINCIPLES AND APPLICATIONS FOR DNA AMPLIFICATION, NEW YORK, STOCKTON PRESS, US, 1 January 1989 (1989-01-01), pages 7 - 16, XP002223319;;RUANO G ET AL: ""BOOSTER PCR: A BIPHASIC PARADIGM FOR AMPLIFICATION OF A FEW MOLECULES OF TARGET"", AMPLIFICATIONS: A FORUM FOR PCR USERS, PERKIN-ELMER CO., NORWALK, CT, US, 1 September 1989 (1989-09-01), pages 12 - 13, XP000567442;;RUANO G ET AL: ""BIPHASIC AMPLIFICATION OF VERY DILUTE DNA SAMPLES VIA 'BOOSTER' PCR"", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 17, no. 13, 11 July 1989 (1989-07-11), pages 5407, XP000371657, ISSN: 0305-1048;;BORG K L ET AL: ""Detection of cytomegalovirus using 'boosted' nested PCR."", MOLECULAR AND CELLULAR PROBES. ENGLAND AUG 1995, vol. 9, no. 4, August 1995 (1995-08-01), pages 251 - 257, XP009003162, ISSN: 0890-8508;;PICARD C ET AL: ""DETECTION AND ENUMERATION OF BACTERIA IN SOIL BY DIRECT DNA EXTRACTION AND POLYMERASE CHAIN REACTION"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 58, no. 9, September 1992 (1992-09-01), pages 2717 - 2722, XP000946427, ISSN: 0099-2240;;SAULNIER P ET AL: ""DETECTON OF GENES IN FECES BY BOOSTER POLYMERASE CHAIN REACTION"", JOURNAL OF CLINICAL MICROBIOLOGY, WASHINGTON, DC, US, vol. 30, no. 8, August 1992 (1992-08-01), pages 2080 - 2083, XP001084737, ISSN: 0095-1137;;BEJ A K ET AL: ""DETECTION OF COLIFORM BACTERIA AND ESCHERICHIA COLI BY MULTIPLEX POLYMERASE CHAIN REACTION: COMPARISON WITH DEFINED SUBSTRATE AND PLATING METHODS FOR WATER QUALITY MONITORING"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 57, no. 8, August 1991 (1991-08-01), pages 2429 - 2432, XP001004829, ISSN: 0099-2240;;ASIM K BEJ ET AL: ""MULTIPLEX PCR AMPLIFICATION AND IMMOBILIZED CAPTURE PROBES FOR DETECTION OF BACTERIAL PATHOGENES AND INDICATORS IN WATER"", MOLECULAR AND CELLULAR PROBES, ACADEMIC PRESS, LONDON, GB, vol. 4, 1990, pages 353 - 365, XP000578307, ISSN: 0890-8508;;EDWARDS M C ET AL: ""Multiplex PCR: advantages, development, and applications."", PCR METHODS AND APPLICATIONS. UNITED STATES FEB 1994, vol. 3, no. 4, February 1994 (1994-02-01), pages S65 - S75, XP009003160, ISSN: 1054-9803;;GONIN P ET AL: ""Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory."", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. UNITED STATES MAY 2000, vol. 37, no. 1, May 2000 (2000-05-01), pages 1 - 4, XP002225665, ISSN: 0732-8893;;HENEGARIU O ET AL: ""MULTIPLEX PCR: CRITICAL PARAMETERS AND STEP-BY-STEP PROTOCOL"", BIOTECHNIQUES, EATON PUBLISHING, NATICK, US, vol. 23, no. 3, 1 September 1997 (1997-09-01), pages 504 - 511, XP000703350, ISSN: 0736-6205;;SONG Y ET AL: ""Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA."", FEMS MICROBIOLOGY LETTERS. NETHERLANDS 15 JUN 2000, vol. 187, no. 2, 15 June 2000 (2000-06-15), pages 167 - 173, XP002225666, ISSN: 0378-1097;;WATERS L C ET AL: ""MICROCHIP DEVICE FOR CELL LYSIS, MULTIPLEX PCR AMPLIFICATION, AND ELECTROPHORETIC SIZING"", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 70, no. 1, 1998, pages 158 - 162, XP000733220, ISSN: 0003-2700;;CHAMBERLAIN, NUCLEIC ACID RESEARCH, vol. 16, 1988, pages 11141 - 11156;;EDWARDS; GIBBS, PCR METHODS APPLIC., vol. 3, 1994, pages S65 - S75;;HENEGARIU ET AL., BLOTECHNIQUE, vol. 23, 1997, pages 504 - 511;;SHUBER ET AL., GENOME RESEARCH, vol. 5, 1995, pages 488 - 493;;VAN DEURSEN, NUCLEIC ACID RESEARCH, vol. 27, 1999, pages E15;;MANIATIS ET AL.: ""Molecular Cloning; A Laboratory Manual"", CSHL PRESS;;DYKES, ELECTROPHORESIS, vol. 9, 1989, pages 359 - 368;;WALSH ET AL., BIOTECHNIQUES, vol. 10, 1991, pages 506 - 513;;VOGELSTEIN; GILLESPIE, PROC. NAF. ACAD. SCI. USA, vol. 76, 1979, pages 616 - 619",DISCONTINUED
2,EP,B1,EP 2949757 B1,131-788-039-294-373,2019-11-13,2019,EP 14164752 A,2001-06-01,US 58956000 A;;EP 10179067 A;;EP 01939852 A;;US 0117901 W,2000-06-06,Method for multiplexing amplification reactions,,LIFE TECHNOLOGIES CORP,MARMARO JEFFREY M;;GERDES JOHN C,LIFE TECHNOLOGIES CORPORATION (2016-11-23),https://lens.org/131-788-039-294-373,Granted Patent,yes,3,0,13,14,0,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,C12Q1/6844;;C12N15/09;;G01N33/53;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,15,0,,,"LIN Z ET AL: ""Multiplex genotype determination at a large number of gene loci"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 93, no. 6, 19 March 1996 (1996-03-19) , pages 2582-2587, XP002142667, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.6.2582;;SAIKI R K ED - ERLICH H A: ""THE DESIGN AND OPTIMIZATION OF THE PCR"", 1 January 1989 (1989-01-01), PCR TECHNOLOGY. PRINCIPLES AND APPLICATIONS FOR DNA AMPLIFICATION, NEW YORK, STOCKTON PRESS, US, PAGE(S) 7 - 16, XP002223319, * the whole document *;;LUND BORG K ET AL: ""DETECTION OF CYTOMEGALOVIRUS USING 'BOOSTED' NESTED PCR"", MOLECULAR AND CELLULAR PROBES, ACADEMIC PRESS, LONDON, GB, vol. 9, no. 4, 1 August 1995 (1995-08-01), pages 251-257, XP009003162, ISSN: 0890-8508, DOI: 10.1016/S0890-8508(95)90125-6;;RUANO G ET AL: ""BIPHASIC AMPLIFICATION OF VERY DILUTE DNA SAMPLES VIA 'BOOSTER' PCR"", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, vol. 17, no. 13, 11 July 1989 (1989-07-11) , page 5407, XP000371657, ISSN: 0305-1048;;RUANO G ET AL: ""BOOSTER PCR: A BIPHASIC PARADIGM FOR AMPLIFICATION OF A FEW MOLECULES OF TARGET"", AMPLIFICATIONS: A FORUM FOR PCR USERS, PERKIN-ELMER CO., NORWALK, CT, US, 1 September 1989 (1989-09-01), page 12/13, XP000567442,;;PICARD C ET AL: ""DETECTION AND ENUMERATION OF BACTERIA IN SOIL BY DIRECT DNA EXTRACTION AND POLYMERASE CHAIN REACTION"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 58, no. 9, 1 September 1992 (1992-09-01), pages 2717-2722, XP000946427, ISSN: 0099-2240;;SAULNIER P ET AL: ""DETECTON OF GENES IN FECES BY BOOSTER POLYMERASE CHAIN REACTION"", JOURNAL OF CLINICAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 30, no. 8, 1 August 1992 (1992-08-01) , pages 2080-2083, XP001084737, ISSN: 0095-1137;;BEJ A K ET AL: ""DETECTION OF COLIFORM BACTERIA AND ESCHERICHIA COLI BY MULTIPLEX POLYMERASE CHAIN REACTION: COMPARISON WITH DEFINED SUBSTRATE AND PLATING METHODS FOR WATER QUALITY MONITORING"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 57, no. 8, 1 August 1991 (1991-08-01) , pages 2429-2432, XP001004829, ISSN: 0099-2240;;BEJ A K ET AL: ""Multiplex PCR amplification and immobilized capture probes for detection of bacterial pathogens and indicators in water"", MOLECULAR AND CELLULAR PROBES, ACADEMIC PRESS, LONDON, GB, vol. 4, no. 5, 1 October 1990 (1990-10-01) , pages 353-365, XP024865848, ISSN: 0890-8508, DOI: 10.1016/0890-8508(90)90026-V [retrieved on 1990-10-01];;EDWARDS M C ET AL: ""MULTIPLEX PCR: ADVANTAGES, DEVELOPMENT AND APPLICATIONS"", PCR METHODS & APPLICATIONS, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 3, no. 4, 1 February 1994 (1994-02-01), pages S65-S75, XP009003160, ISSN: 1054-9803;;GONIN P ET AL: ""Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory"", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES, ELSEVIER SCIENCE PUBLISHING CO., AMSTERDAM, NL, vol. 37, no. 1, 1 May 2000 (2000-05-01), pages 1-4, XP002225665, ISSN: 0732-8893, DOI: 10.1016/S0732-8893(00)00116-4;;HENEGARIU O ET AL: ""MULTIPLEX PCR: CRITICAL PARAMETERS AND STEP-BY-STEP PROTOCOL"", BIOTECHNIQUES, INFORMA HEALTHCARE, US, vol. 23, no. 3, 1 September 1997 (1997-09-01), pages 504-511, XP000703350, ISSN: 0736-6205;;WATERS L C ET AL: ""MICROCHIP DEVICE FOR CELL LYSIS, MULTIPLEX PCR AMPLIFICATION, AND ELECTROPHORETIC SIZING"", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 70, no. 1, 1 January 1998 (1998-01-01), pages 158-162, XP000733220, ISSN: 0003-2700, DOI: 10.1021/AC970642D;;I. I. WISTUBA ET AL: ""Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects"", JAMA, vol. 279, no. 19, 20 May 1998 (1998-05-20) , pages 1554-1559, XP055064067, ISSN: 0098-7484, DOI: 10.1001/jama.279.19.1554;;SONG Y-L ET AL: ""Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA"", FEMS MICROBIOLOGY LETTERS, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 187, no. 2, 15 June 2000 (2000-06-15) , pages 167-173, XP002225666, ISSN: 0378-1097, DOI: 10.1016/S0378-1097(00)00196-8",EXPIRED
3,WO,A2,WO 2001/094634 A2,190-764-921-974-10X,2001-12-13,2001,US 0117901 W,2001-06-01,US 58956000 A,2000-06-06,METHODS AND DEVICES FOR MULTIPLEXING AMPLIFICATION REACTIONS,"The present invention pertains to methods, reagents, compositions, kits and instruments for use in simultaneously amplifying multiple targets. In particular, this invention is based on the discovery of a two-step multiplex amplification reaction wherein the first step truncates the standard initial multiplex amplification roud to 'boost' the sample copy number by only a 100 - 1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid.",BIOPOOL INT INC,MARMARO JEFFREY M;;GERDES JOHN C,,https://lens.org/190-764-921-974-10X,Patent Application,yes,21,60,13,14,84,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,C12N15/09;;C12Q1/06;;G01N33/53;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,11,9,113-237-014-874-941;;078-302-340-811-20X;;041-417-339-486-865;;066-697-166-954-718;;085-112-370-064-707;;070-656-465-248-593;;069-142-568-607-17X;;168-857-875-253-832;;024-179-957-960-272,pmc339001;;10.1093/nar/16.23.11141;;3205741;;10.1101/gr.3.4.s65;;8173510;;9298224;;10.2144/97233rr01;;10.1101/gr.5.5.488;;8808470;;pmc148576;;10.1093/nar/27.17.e15;;10446258;;8637917;;pmc39840;;10.1073/pnas.93.6.2582;;2466663;;10.1002/elps.1150090803;;10.2144/000114018;;23599926;;284385;;10.1073/pnas.76.2.615;;pmc382999,"CHAMBERLAIN, NUCLEIC ACID RESEARCH, vol. 16, 1988, pages 11141 - 11156;;EDWARDS; GIBBS, PCR METHODS APPLIC., vol. 3, 1994, pages S65 - S75;;HENEGARIU ET AL., BIOTECHNIQUES, vol. 23, 1997, pages 504 - 511;;SHUBER ET AL., GENOME RESEARCH, vol. 5, 1995, pages 488 - 493;;VAN DEURSEN ET AL., NUCLEIC ACID RESEARCH, vol. 27, 1999, pages E15;;R K SAIKI AND H A ERLICH: ""PCR technology. Principles and applications for DNA amplification"", 1989, STOCKTON PRESS, article ""The Design And Optimization Of The PCR"", pages: 7 - 16;;LIN ET AL., PNAS, vol. 93, no. 6, pages 2582 - 2587;;MANIATIS ET AL., MOLECULAR CLONING; A LABORATORY MANUAL;;DYKES, ELECTROPHORESIS, vol. 9, 1989, pages 359 - 368;;WALSH ET AL., BIOTECHNIQUES, vol. 1 0, 1991, pages 506 - 513;;VOGELSTEIN; GILLESPIE, PROC. NAT. ACAD. SCI. USA, vol. 76, 1979, pages 615 - 619",PATENTED
4,US,B1,US 6258543 B1,016-723-556-159-827,2001-07-10,2001,US 39853999 A,1999-09-17,US 39853999 A;;US 85061397 A;;US 1671096 P,1996-05-02,Quantitation of RNA transcripts using genomic DNA as the internal amplification competitor,"This invention is directed to methods for the quantitative measurement of specific gene expression levels in biological samples. In one embodiment, methods for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript are provided. The former involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction and intron sequences for the mRNA and DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are also present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. In another embodiment, methods for the quantitative monitoring of gene expression involving determining the ratio of genomic material to expressed mRNA without nucleic acid amplification and/or primer binding are described. This method includes the independent and direct detection of the genomic material and mRNA by complementary probe binding without prior amplification. Additional methods for quantitative measurement of gene expression rates without RNA transcription region introns are described. The invention is useful in gene expression determination in research and commercial applications.",XTRANA INC,GERDES JOHN C;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2000-06-07),https://lens.org/016-723-556-159-827,Granted Patent,yes,2,9,5,5,17,C12Q1/6851;;C12Q1/6851,C12Q1/68,435/6;;435/91.2;;435/91.21;;435/91.51;;536/24.33,2,2,010-783-358-274-089;;121-841-451-868-823,7589776;;10.1016/0303-7207(95)03576-s;;7535986;;10.1006/abio.1995.1049,"Gotteland et al. Molecular and Cellular Endocrinology, 112:1-13, 1995.;;Zenilman et al. Analytical Biochemistry. 224:339-346, 1995.*",EXPIRED
5,EP,A1,EP 1224330 A1,075-813-834-720-557,2002-07-24,2002,EP 00971978 A,2000-09-15,US 0025401 W;;US 39853999 A,1999-09-17,QUANTITATION OF RNA TRANSCRIPTS USING GENOMIC DNA AS THE INTERNAL AMPLIFICATION COMPETITOR,,XTRANA INC,GERDES JOHN C;;MARMARO JEFFREY M,APPLERA CORPORATION (2004-08-25),https://lens.org/075-813-834-720-557,Patent Application,yes,0,0,5,5,0,C12Q1/6851;;C12Q1/6851,C12Q1/68,,0,0,,,,DISCONTINUED
6,AU,A,AU 1997/031169 A,004-561-035-235-973,1997-11-19,1997,AU 1997/031169 A,1997-05-02,US 1671096 P;;US 9707386 W,1996-05-02,Quantitation of rna transcripts using genomic dna as the internal amplification competitor,"A method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. The invention may be used, for example, in the determination of gene expression in both research and commercial applications.",IMMUNOLOGICAL ASS OF DENVER,GERDES JOHN C;;MARMARO JEFFREY M,,https://lens.org/004-561-035-235-973,Patent Application,no,0,1,9,9,0,C12Q1/6851;;C12Q2600/158;;C12Q1/6851;;C12Q2600/158,C12Q1/68;;C12Q1/6851,,0,0,,,,PENDING
7,EP,B1,EP 1352087 B1,089-691-348-100-665,2013-05-29,2013,EP 01939852 A,2001-06-01,US 0117901 W;;US 58956000 A,2000-06-06,METHODS FOR MULTIPLEXING AMPLIFICATION REACTIONS,,LIFE TECHNOLOGIES CORP,MARMARO JEFFREY M;;GERDES JOHN C,APPLERA CORPORATION (2004-08-25);;LIFE TECHNOLOGIES CORPORATION (2010-05-26),https://lens.org/089-691-348-100-665,Granted Patent,yes,0,3,13,14,0,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,C12Q1/68;;C12N15/09;;G01N33/53;;C12Q1/06;;C12Q1/10;;C12Q1/48;;G01N33/566,,2,1,070-656-465-248-593,8637917;;pmc39840;;10.1073/pnas.93.6.2582,"LIN Z ET AL: ""Multiplex genotype determination at a large number of gene loci"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, WASHINGTON, DC; US, vol. 93, no. 6, 19 March 1996 (1996-03-19), pages 2582 - 2587, XP002142667, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.6.2582;;SAIKI R K ED - ERLICH H A: ""THE DESIGN AND OPTIMIZATION OF THE PCR"", PCR TECHNOLOGY. PRINCIPLES AND APPLICATIONS FOR DNA AMPLIFICATION, NEW YORK, STOCKTON PRESS, US, 1 January 1989 (1989-01-01), pages 7 - 16, XP002223319",EXPIRED
8,US,A,US 6063568 A,030-001-031-343-034,2000-05-16,2000,US 85061397 A,1997-05-02,US 85061397 A;;US 1671096 P,1996-05-02,Quantitation of RNA transcripts using genomic DNA as the internal amplification competitor,"A method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. The invention may be used, for example, in the determination of gene expression in both research and commercial applications.",MOLECULAR INNOVATIONS INC,GERDES JOHN C;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2000-01-31);;IMMUNOLOGICAL ASSOCIATES OF DENVER (1999-03-30),https://lens.org/030-001-031-343-034,Granted Patent,yes,4,12,9,9,14,C12Q1/6851;;C12Q2600/158;;C12Q1/6851;;C12Q2600/158,C12Q1/68;;C12Q1/6851,435/6;;435/91.2;;435/91.21;;435/91.51;;536/24.33,1,1,121-841-451-868-823,7535986;;10.1006/abio.1995.1049,"Zenilman et al. Analytical Biochemistry. 224: 339 346, 1995.",EXPIRED
9,EP,A2,EP 1352087 A2,032-679-406-184-802,2003-10-15,2003,EP 01939852 A,2001-06-01,US 0117901 W;;US 58956000 A,2000-06-06,METHODS FOR MULTIPLEXING AMPLIFICATION REACTIONS,,XTRANA INC,MARMARO JEFFREY M;;GERDES JOHN C,APPLERA CORPORATION (2004-08-25);;LIFE TECHNOLOGIES CORPORATION (2010-05-26),https://lens.org/032-679-406-184-802,Patent Application,yes,0,0,13,14,0,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,C12N15/09;;G01N33/53;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,0,0,,,,EXPIRED
10,EP,A1,EP 0910666 A1,169-853-829-853-448,1999-04-28,1999,EP 97926396 A,1997-05-02,US 9707386 W;;US 1671096 P,1996-05-02,QUANTITATION OF RNA TRANSCRIPTS USING GENOMIC DNA AS THE INTERNAL AMPLIFICATION COMPETITOR,"A method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. The invention may be used, for example, in the determination of gene expression in both research and commercial applications.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;MARMARO JEFFREY M,APPLERA CORPORATION (2004-10-06),https://lens.org/169-853-829-853-448,Patent Application,yes,0,1,9,9,0,C12Q1/6851;;C12Q2600/158;;C12Q1/6851;;C12Q2600/158,C12Q1/68;;C12Q1/6851,,0,0,,,,EXPIRED
11,AT,T1,AT E335843 T1,038-946-484-910-699,2006-09-15,2006,AT 97926396 T,1997-05-02,US 1671096 P,1996-05-02,QUANTIFIZIERUNG VON RNA-TRANSKRIPTEN MITTELS GENOMISCHER DNA ALS INTERNEN STANDARD DER AMPLIFIZIERUNGSREAKTION,"A method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. The invention may be used, for example, in the determination of gene expression in both research and commercial applications.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M,,https://lens.org/038-946-484-910-699,Granted Patent,no,0,0,9,9,0,C12Q1/6851;;C12Q2600/158;;C12Q1/6851;;C12Q2600/158,C12Q1/68;;C12Q1/6851,,0,0,,,,EXPIRED
12,EP,B1,EP 0910666 B1,122-876-384-696-166,2006-08-09,2006,EP 97926396 A,1997-05-02,US 9707386 W;;US 1671096 P,1996-05-02,QUANTITATION OF RNA TRANSCRIPTS USING GENOMIC DNA AS THE INTERNAL AMPLIFICATION COMPETITOR,"A method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. The invention may be used, for example, in the determination of gene expression in both research and commercial applications.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M,APPLERA CORPORATION (2004-10-06),https://lens.org/122-876-384-696-166,Granted Patent,yes,6,1,9,9,0,C12Q1/6851;;C12Q2600/158;;C12Q1/6851;;C12Q2600/158,C12Q1/68;;C12P19/34;;C12Q1/6851,,5,0,,,"ZENILMAN M E ET AL: ""COMPETITIVE REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION WITHOUTAN ARTIFICIAL INTERNAL STANDARD"" ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 224, no. 1, 1995, pages 339-346, XP000486748 ISSN: 0003-2697;;LIVAK ET AL: ""Towards fully automated genome-wide polymorphism screening"" NATURE GENETICS, NEW YORK, NY, US, vol. 9, no. 4, April 1995 (1995-04), pages 341-342, XP002113150 ISSN: 1061-4036;;GIBSON U E M ET AL: ""A NOVEL METHOD FOR REAL TIME QUANTITATIVE RT-PCR"" GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 6, no. 10, 1 October 1996 (1996-10-01), pages 995-1001, XP000642796 ISSN: 1088-9051;;ANALYTICAL BIOCHEMISTRY, January 1995, Vol. 224, No. 1, ZENILMAN et al., ""Competitive Reverse-Transcriptase Polymerase Chain Reaction Without an Artificial Internal Standard"", pages 339-346.;;JONES et al., ""RNA Isolation and Analysis"", OXFORD: BIOS. SCIENTIFIC PUBLISHERS LTD., 1994, pages 15-93 and 129-143.",EXPIRED
13,WO,A1,WO 2001/020041 A1,054-645-556-794-123,2001-03-22,2001,US 0025401 W,2000-09-15,US 39853999 A,1999-09-17,QUANTITATION OF RNA TRANSCRIPTS USING GENOMIC DNA AS THE INTERNAL AMPLIFICATION COMPETITOR,"This invention is directed to methods for the quantitative measurement of specific gene expression levels in biological samples. More specifically, methods for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided and involving the rationing of genomic material to expressed mRNA without nucleic acid amplification and/or primer binding are described.",XTRANA INC;;GERDES JOHN C;;MARMARO JEFFREY M,GERDES JOHN C;;MARMARO JEFFREY M,,https://lens.org/054-645-556-794-123,Patent Application,yes,3,4,5,5,0,C12Q1/6851;;C12Q1/6851,C12Q1/68,,3,2,010-783-358-274-089;;121-841-451-868-823,7589776;;10.1016/0303-7207(95)03576-s;;7535986;;10.1006/abio.1995.1049,"GOTTELAND ET AL.: ""Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues"", MOLECULAR AND CELLULAR ENDOCRINOLOGY, vol. 112, 1995, pages 1 - 13, XP002935019;;ZENILMAN ET AL.: ""Competitive reverse-transcriptase polymerase chain reaction without an artificial internal standard"", ANALYTICAL BIOCHEMISTRY, vol. 224, 1995, pages 339 - 346, XP002935018;;See also references of EP 1224330A4",PENDING
14,AU,A,AU 2001/010705 A,143-532-982-292-471,2001-04-17,2001,AU 2001/010705 A,2000-09-15,US 39853999 A;;US 0025401 W,1999-09-17,Quantitation of rna transcripts using genomic dna as the internal amplification competitor,,XTRANA INC,GERDES JOHN C;;MARMARO JEFFREY M,,https://lens.org/143-532-982-292-471,Patent Application,no,0,0,5,5,0,C12Q1/6851;;C12Q1/6851,C12Q1/68,,0,0,,,,DISCONTINUED
15,CA,A1,CA 2410281 A1,068-474-691-064-128,2001-12-13,2001,CA 2410281 A,2001-06-01,US 58956000 A;;US 0117901 W,2000-06-06,METHODS AND DEVICES FOR MULTIPLEXING AMPLIFICATION REACTIONS,,XTRANA INC,MARMARO JEFFREY M;;GERDES JOHN C,,https://lens.org/068-474-691-064-128,Patent Application,no,0,0,13,14,84,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,G01N33/53;;C12N15/09;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,0,0,,,,DISCONTINUED
16,EP,A1,EP 2949757 A1,082-469-866-267-818,2015-12-02,2015,EP 14164752 A,2001-06-01,US 58956000 A;;EP 10179067 A;;EP 01939852 A;;US 0117901 W,2000-06-06,Method for multiplexing amplification reactions,"The present invention pertains to methods, reagents, compositions, kits and instruments for use in simultaneously amplifying multiple targets. In particular, this invention is based on the discovery of a two-step multiplex amplification reaction wherein the first step truncates the standard initial multiplex amplification round to ""boost"" the sample copy number by only a 100- 1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid.
",LIFE TECHNOLOGIES CORP,MARMARO JEFFREY M;;GERDES JOHN C,LIFE TECHNOLOGIES CORPORATION (2016-11-23),https://lens.org/082-469-866-267-818,Patent Application,yes,25,0,13,14,84,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,C12Q1/6844;;C12N15/09;;G01N33/53;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,24,20,070-656-465-248-593;;079-074-030-459-68X;;032-597-682-620-712;;017-515-593-292-125;;068-917-929-803-50X;;045-081-326-747-615;;005-540-691-594-134;;078-302-340-811-20X;;001-560-891-833-008;;041-417-339-486-865;;023-050-451-230-180;;021-605-881-544-255;;003-784-819-011-670;;113-237-014-874-941;;078-302-340-811-20X;;066-697-166-954-718;;085-112-370-064-707;;069-142-568-607-17X;;168-857-875-253-832;;024-179-957-960-272,8637917;;pmc39840;;10.1073/pnas.93.6.2582;;10.1016/s0890-8508(95)90125-6;;7477021;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;10.1016/0890-8508(90)90026-v;;2280781;;10.1101/gr.3.4.s65;;8173510;;10794932;;10.1016/s0732-8893(00)00116-4;;9298224;;10.2144/97233rr01;;10.1021/ac970642d;;9463271;;10.1001/jama.279.19.1554;;9605900;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;10.1101/gr.3.4.s65;;8173510;;10.1101/gr.5.5.488;;8808470;;pmc148576;;10.1093/nar/27.17.e15;;10446258;;2466663;;10.1002/elps.1150090803;;10.2144/000114018;;23599926;;284385;;10.1073/pnas.76.2.615;;pmc382999,"LIN Z ET AL: ""Multiplex genotype determination at a large number of gene loci"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 93, no. 6, 19 March 1996 (1996-03-19), pages 2582 - 2587, XP002142667, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.6.2582;;SAIKI R K ED - ERLICH H A: ""THE DESIGN AND OPTIMIZATION OF THE PCR"", 1 January 1989, PCR TECHNOLOGY. PRINCIPLES AND APPLICATIONS FOR DNA AMPLIFICATION, NEW YORK, STOCKTON PRESS, US, PAGE(S) 7 - 16, XP002223319;;LUND BORG K ET AL: ""DETECTION OF CYTOMEGALOVIRUS USING 'BOOSTED' NESTED PCR"", MOLECULAR AND CELLULAR PROBES, ACADEMIC PRESS, LONDON, GB, vol. 9, no. 4, 1 August 1995 (1995-08-01), pages 251 - 257, XP009003162, ISSN: 0890-8508, DOI: 10.1016/S0890-8508(95)90125-6;;RUANO G ET AL: ""BIPHASIC AMPLIFICATION OF VERY DILUTE DNA SAMPLES VIA 'BOOSTER' PCR"", NUCLEIC ACIDS RESEARCH, INFORMATION RETRIEVAL LTD, vol. 17, no. 13, 11 July 1989 (1989-07-11), pages 5407, XP000371657, ISSN: 0305-1048;;RUANO G ET AL: ""BOOSTER PCR: A BIPHASIC PARADIGM FOR AMPLIFICATION OF A FEW MOLECULES OF TARGET"", AMPLIFICATIONS: A FORUM FOR PCR USERS, PERKIN-ELMER CO., NORWALK, CT, US, 1 September 1989 (1989-09-01), pages 12/13, XP000567442;;PICARD C ET AL: ""DETECTION AND ENUMERATION OF BACTERIA IN SOIL BY DIRECT DNA EXTRACTION AND POLYMERASE CHAIN REACTION"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 58, no. 9, 1 September 1992 (1992-09-01), pages 2717 - 2722, XP000946427, ISSN: 0099-2240;;SAULNIER P ET AL: ""DETECTON OF GENES IN FECES BY BOOSTER POLYMERASE CHAIN REACTION"", JOURNAL OF CLINICAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 30, no. 8, 1 August 1992 (1992-08-01), pages 2080 - 2083, XP001084737, ISSN: 0095-1137;;BEJ A K ET AL: ""DETECTION OF COLIFORM BACTERIA AND ESCHERICHIA COLI BY MULTIPLEX POLYMERASE CHAIN REACTION: COMPARISON WITH DEFINED SUBSTRATE AND PLATING METHODS FOR WATER QUALITY MONITORING"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 57, no. 8, 1 August 1991 (1991-08-01), pages 2429 - 2432, XP001004829, ISSN: 0099-2240;;BEJ A K ET AL: ""Multiplex PCR amplification and immobilized capture probes for detection of bacterial pathogens and indicators in water"", MOLECULAR AND CELLULAR PROBES, ACADEMIC PRESS, LONDON, GB, vol. 4, no. 5, 1 October 1990 (1990-10-01), pages 353 - 365, XP024865848, ISSN: 0890-8508, [retrieved on 19901001], DOI: 10.1016/0890-8508(90)90026-V;;EDWARDS M C ET AL: ""MULTIPLEX PCR: ADVANTAGES, DEVELOPMENT AND APPLICATIONS"", PCR METHODS & APPLICATIONS, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 3, no. 4, 1 February 1994 (1994-02-01), pages S65 - S75, XP009003160, ISSN: 1054-9803;;GONIN P ET AL: ""Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory"", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASES, ELSEVIER SCIENCE PUBLISHING CO., AMSTERDAM, NL, vol. 37, no. 1, 1 May 2000 (2000-05-01), pages 1 - 4, XP002225665, ISSN: 0732-8893, DOI: 10.1016/S0732-8893(00)00116-4;;HENEGARIU O ET AL: ""MULTIPLEX PCR: CRITICAL PARAMETERS AND STEP-BY-STEP PROTOCOL"", BIOTECHNIQUES, INFORMA HEALTHCARE, US, vol. 23, no. 3, 1 September 1997 (1997-09-01), pages 504 - 511, XP000703350, ISSN: 0736-6205;;WATERS L C ET AL: ""MICROCHIP DEVICE FOR CELL LYSIS, MULTIPLEX PCR AMPLIFICATION, AND ELECTROPHORETIC SIZING"", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 70, no. 1, 1 January 1998 (1998-01-01), pages 158 - 162, XP000733220, ISSN: 0003-2700, DOI: 10.1021/AC970642D;;I. I. WISTUBA ET AL: ""Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects"", JAMA, vol. 279, no. 19, 20 May 1998 (1998-05-20), pages 1554 - 1559, XP055064067, ISSN: 0098-7484, DOI: 10.1001/jama.279.19.1554;;SONG Y-L ET AL: ""Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA"", FEMS MICROBIOLOGY LETTERS, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 187, no. 2, 15 June 2000 (2000-06-15), pages 167 - 173, XP002225666, ISSN: 0378-1097, DOI: 10.1016/S0378-1097(00)00196-8;;CHAMBERLAIN, NUCLEIC ACID RESEARCH, vol. 16, 1988, pages 11141 - 11156;;EDWARDS; GIBBS, PCR METHODS APPLIC., vol. 3, 1994, pages S65 - S75;;HENEGARIU ET AL., BIOTEEHNJQUAS, vol. 23, 1997, pages 504 - 51;;SHUBER ET AL., GENOME RESEARCH, vol. 5, 1995, pages 488 - 493;;VAN DEURSEN, NUCLEIC ACID RESEARCH, vol. 27, 1999, pages E15;;MANIATIS ET AL.: ""Molecular Cloning; A Laboratory Manual high Salt precipitation"";;DYKES, ELECTROPHORESIS, vol. 9, 1989, pages 359 - 368;;WALSH ET AL., BIOTECHNIQUES, vol. 10, 1991, pages 506 - 513;;VOGELSTEIN; GILLESPIE, PROC. NAF. ACAD. SCI. USA, vol. 76, 1979, pages 615 - 619",EXPIRED
17,EP,A4,EP 1224330 A4,076-391-909-970-219,2004-09-15,2004,EP 00971978 A,2000-09-15,US 0025401 W;;US 39853999 A,1999-09-17,QUANTITATION OF RNA TRANSCRIPTS USING GENOMIC DNA AS THE INTERNAL AMPLIFICATION COMPETITOR,,APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M,APPLERA CORPORATION (2004-08-25),https://lens.org/076-391-909-970-219,Search Report,no,2,0,5,5,0,C12Q1/6851;;C12Q1/6851,C12Q1/68,,9,8,090-497-342-025-867;;005-618-441-290-952;;035-555-391-941-931;;067-592-095-085-118;;046-044-728-292-565;;054-021-320-014-578;;061-011-328-207-483;;050-119-434-651-268,9028384;;10.3109/07357909709018911;;10322428;;10.1016/s0968-0004(99)01382-1;;10.1038/12640;;10471496;;10.1002/bies.950180513;;8639166;;8828038;;10.1101/gr.6.6.492;;10.1006/geno.1995.1233;;8530073;;8891204;;10.2144/96214bm04;;10.1385/1-59259-283-x:093;;12325528,"ZENILMAN M E ET AL: ""Insulin-like growth factor I receptor messenger RNA in the colon is unchanged during neoplasia."", CANCER INVESTIGATION. UNITED STATES 1997, vol. 15, no. 1, 1997, pages 1 - 7, XP009032637, ISSN: 0735-7907;;GERHOLD D ET AL: ""DNA chips: promising toys have become powerful tools"", TIBS TRENDS IN BIOCHEMICAL SCIENCES, ELSEVIER PUBLICATION, CAMBRIDGE, EN, vol. 24, no. 5, 1 May 1999 (1999-05-01), pages 168 - 173, XP004167912, ISSN: 0968-0004;;POLLACK J R ET AL: ""Genome-wide analysis of DNA copy-number changes using cDNA microarrays"", NATURE GENETICS, NATURE AMERICA, NEW YORK, US, vol. 23, no. 1, September 1999 (1999-09-01), pages 41 - 46, XP002221379, ISSN: 1061-4036;;SCHENA M: ""GENOME ANALYSIS WITH GENE EXPRESSION MICROARRAYS"", BIOESSAYS, CAMBRIDGE, GB, vol. 18, no. 5, 1996, pages 427 - 431, XP002916033, ISSN: 0265-9247;;PIETU G ET AL: ""NOVEL GENE TRANSCRIPTS PREFERENTIALLY EXPRESSED IN HUMAN MUSCLES REVEALED BY QUANTITATIVE HYBRIDIZATION OF A HIGH DENSITY CDNA ARRAY"", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 6, no. 6, 1 June 1996 (1996-06-01), pages 492 - 503, XP000597086, ISSN: 1088-9051;;NGUYEN C ET AL: ""DIFFERENTIAL GENE EXPRESSION IN THE MURINE THYMUS ASSAYED BY QUANTITATIVE HYBRIDIZATION OF ARRAYED CDNA CLONES"", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 29, 1995, pages 207 - 216, XP002914394, ISSN: 0888-7543;;ZHU KUN YAN ET AL: ""ADDITION OF A COMPETITIVE PRIMER CAN DRAMATICALLY IMPROVE THE SPECIFICITY OF PCR AMPLIFICATION OF SPECIFIC ALLELES"", BIOTECHNIQUES, EATON PUBLISHING, NATICK, US, vol. 21, no. 4, October 1996 (1996-10-01), pages 586 - 590, XP008027025, ISSN: 0736-6205;;O'CONNELL J ET AL: ""RAPID DEVELOPMENT OF A QUANTITATIVE-COMPETITIVE (QC) RT-PCR ASSAY USING A COMPOSITE PRIMER APPROACH"", METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS INC., CLIFTON, NJ, US, vol. 193, 2002, pages 93 - 102, XP001127461;;See also references of WO 0120041A1",DISCONTINUED
18,AU,A,AU 2001/065327 A,073-125-455-953-13X,2001-12-17,2001,AU 2001/065327 A,2001-06-01,US 58956000 A;;US 0117901 W,2000-06-06,Methods and devices for multiplexing amplification reactions,,BIOPOOL INT INC,MARMARO JEFFREY M;;GERDES JOHN C,,https://lens.org/073-125-455-953-13X,Patent Application,no,0,0,13,14,0,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,G01N33/53;;C12N15/09;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,0,0,,,,PENDING
19,WO,A3,WO 2001/094634 A3,058-585-068-498-433,2003-07-31,2003,US 0117901 W,2001-06-01,US 58956000 A,2000-06-06,METHODS AND DEVICES FOR MULTIPLEXING AMPLIFICATION REACTIONS,"The present invention pertains to methods, reagents, compositions, kits and instruments for use in simultaneously amplifying multiple targets. In particular, this invention is based on the discovery of a two-step multiplex amplification reaction wherein the first step truncates the standard initial multiplex amplification roud to 'boost' the sample copy number by only a 100 - 1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid.",XTRANA INC,MARMARO JEFFREY M;;GERDES JOHN C,,https://lens.org/058-585-068-498-433,Search Report,yes,2,0,13,14,0,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,C12N15/09;;G01N33/53;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,12,11,045-081-326-747-615;;005-540-691-594-134;;078-302-340-811-20X;;001-560-891-833-008;;079-074-030-459-68X;;032-597-682-620-712;;017-515-593-292-125;;068-917-929-803-50X;;041-417-339-486-865;;003-784-819-011-670;;023-050-451-230-180,1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;10.1016/0890-8508(90)90026-v;;2280781;;10.1101/gr.3.4.s65;;8173510;;10794932;;10.1016/s0732-8893(00)00116-4;;10.1016/s0890-8508(95)90125-6;;7477021;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;9298224;;10.2144/97233rr01;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;10.1021/ac970642d;;9463271,"BEJ A K ET AL: ""DETECTION OF COLIFORM BACTERIA AND ESCHERICHIA COLI BY MULTIPLEX POLYMERASE CHAIN REACTION: COMPARISON WITH DEFINED SUBSTRATE AND PLATING METHODS FOR WATER QUALITY MONITORING"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 57, no. 8, August 1991 (1991-08-01), pages 2429 - 2432, XP001004829, ISSN: 0099-2240;;ASIM K BEJ ET AL: ""MULTIPLEX PCR AMPLIFICATION AND IMMOBILIZED CAPTURE PROBES FOR DETECTION OF BACTERIAL PATHOGENES AND INDICATORS IN WATER"", MOLECULAR AND CELLULAR PROBES, ACADEMIC PRESS, LONDON, GB, vol. 4, 1990, pages 353 - 365, XP000578307, ISSN: 0890-8508;;EDWARDS M C ET AL: ""Multiplex PCR: advantages, development, and applications."", PCR METHODS AND APPLICATIONS. UNITED STATES FEB 1994, vol. 3, no. 4, February 1994 (1994-02-01), pages S65 - S75, XP009003160, ISSN: 1054-9803;;GONIN P ET AL: ""Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory."", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. UNITED STATES MAY 2000, vol. 37, no. 1, May 2000 (2000-05-01), pages 1 - 4, XP002225665, ISSN: 0732-8893;;BORG K L ET AL: ""Detection of cytomegalovirus using 'boosted' nested PCR."", MOLECULAR AND CELLULAR PROBES. ENGLAND AUG 1995, vol. 9, no. 4, August 1995 (1995-08-01), pages 251 - 257, XP009003162, ISSN: 0890-8508;;RUANO G ET AL: ""BIPHASIC AMPLIFICATION OF VERY DILUTE DNA SAMPLES VIA 'BOOSTER' PCR"", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 17, no. 13, 11 July 1989 (1989-07-11), pages 5407, XP000371657, ISSN: 0305-1048;;RUANO G ET AL: ""BOOSTER PCR: A BIPHASIC PARADIGM FOR AMPLIFICATION OF A FEW MOLECULES OF TARGET"", AMPLIFICATIONS: A FORUM FOR PCR USERS, PERKIN-ELMER CO., NORWALK, CT, US, 1 September 1989 (1989-09-01), pages 12 - 13, XP000567442;;PICARD C ET AL: ""DETECTION AND ENUMERATION OF BACTERIA IN SOIL BY DIRECT DNA EXTRACTION AND POLYMERASE CHAIN REACTION"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 58, no. 9, September 1992 (1992-09-01), pages 2717 - 2722, XP000946427, ISSN: 0099-2240;;SAULNIER P ET AL: ""DETECTON OF GENES IN FECES BY BOOSTER POLYMERASE CHAIN REACTION"", JOURNAL OF CLINICAL MICROBIOLOGY, WASHINGTON, DC, US, vol. 30, no. 8, August 1992 (1992-08-01), pages 2080 - 2083, XP001084737, ISSN: 0095-1137;;HENEGARIU O ET AL: ""MULTIPLEX PCR: CRITICAL PARAMETERS AND STEP-BY-STEP PROTOCOL"", BIOTECHNIQUES, EATON PUBLISHING, NATICK, US, vol. 23, no. 3, 1 September 1997 (1997-09-01), pages 504 - 511, XP000703350, ISSN: 0736-6205;;SONG Y ET AL: ""Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA."", FEMS MICROBIOLOGY LETTERS. NETHERLANDS 15 JUN 2000, vol. 187, no. 2, 15 June 2000 (2000-06-15), pages 167 - 173, XP002225666, ISSN: 0378-1097;;WATERS L C ET AL: ""MICROCHIP DEVICE FOR CELL LYSIS, MULTIPLEX PCR AMPLIFICATION, AND ELECTROPHORETIC SIZING"", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 70, no. 1, 1998, pages 158 - 162, XP000733220, ISSN: 0003-2700",PATENTED
20,EP,A4,EP 0910666 A4,019-137-025-895-398,2002-11-06,2002,EP 97926396 A,1997-05-02,US 9707386 W;;US 1671096 P,1996-05-02,QUANTITATION OF RNA TRANSCRIPTS USING GENOMIC DNA AS THE INTERNAL AMPLIFICATION COMPETITOR,"A method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript is provided. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA respectively. By their use, any suitable nucleic acid amplification technology yields mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers are present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, allowing the quantitation of mRNA in a sample which is normalized to the number of copies of genomic DNA since the genomic DNA acts as the internal quantitation standard, and in effect yields the amount of mRNA per cell. Any detection methodology which can detect amplimers of different lengths or sequences can be used for post amplification quantitation. This strategy may be employed for any gene system in which the mRNA sequence differs from the original genomic DNA sequence. The invention may be used, for example, in the determination of gene expression in both research and commercial applications.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;MARMARO JEFFREY M,APPLERA CORPORATION (2004-10-06),https://lens.org/019-137-025-895-398,Search Report,no,5,0,9,9,0,C12Q1/6851;;C12Q2600/158;;C12Q1/6851;;C12Q2600/158,C12Q1/68;;C12Q1/6851,,3,3,121-841-451-868-823;;018-406-958-772-273;;018-213-954-971-063,7535986;;10.1006/abio.1995.1049;;7795635;;10.1038/ng0495-341;;10.1101/gr.6.10.995;;8908519,"ZENILMAN M E ET AL: ""COMPETITIVE REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION WITHOUTAN ARTIFICIAL INTERNAL STANDARD"", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 224, no. 1, 1995, pages 339 - 346, XP000486748, ISSN: 0003-2697;;LIVAK ET AL: ""Towards fully automated genome-wide polymorphism screening"", NATURE GENETICS, NEW YORK, NY, US, vol. 9, no. 4, April 1995 (1995-04-01), pages 341 - 342, XP002113150, ISSN: 1061-4036;;GIBSON U E M ET AL: ""A NOVEL METHOD FOR REAL TIME QUANTITATIVE RT-PCR"", GENOME RESEARCH, COLD SPRING HARBOR LABORATORY PRESS, US, vol. 6, no. 10, 1 October 1996 (1996-10-01), pages 995 - 1001, XP000642796, ISSN: 1088-9051",EXPIRED
21,WO,A1,WO 1997/041261 A1,038-738-707-402-602,1997-11-06,1997,US 9707386 W,1997-05-02,US 1671096 P,1996-05-02,QUANTITATION OF RNA TRANSCRIPTS USING GENOMIC DNA AS THE INTERNAL AMPLIFICATION COMPETITOR,"This invention describes a method for the quantitative monitoring of gene expression without either co-amplification of an added template or use of an endogenous constitutive transcript. The process involves a duplex amplification reaction in which a single set of primers is used to amplify both genomic DNA and expressed mRNA from the same gene sequence. These primers are targeted for sequences flanking the splice junction/intron sequences for the mRNA/DNA, as shown in the figure. Use of these primers with any suitable nucleic acid amplification technology will yield mRNA and DNA amplimers which are distinguishable by length and sequence heterogeneity. These amplimers will also be present in the final amplification reaction in ratios which are dependent upon the ratios of the expressed mRNA to the DNA in the sample, thus allowing thequantitation of mRNA in a sample.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;MARMARO JEFFREY M,,https://lens.org/038-738-707-402-602,Patent Application,yes,2,10,9,9,0,C12Q1/6851;;C12Q2600/158;;C12Q1/6851;;C12Q2600/158,C12Q1/68;;C12Q1/6851,,2,1,121-841-451-868-823,7535986;;10.1006/abio.1995.1049,"ANALYTICAL BIOCHEMISTRY, January 1995, Vol. 224, No. 1, ZENILMAN et al., ""Competitive Reverse-Transcriptase Polymerase Chain Reaction Without an Artificial Internal Standard"", pages 339-346.;;JONES et al., ""RNA Isolation and Analysis"", OXFORD: BIOS. SCIENTIFIC PUBLISHERS LTD., 1994, pages 15-93 and 129-143.",PATENTED
22,EP,A1,EP 2295603 A1,149-483-315-778-97X,2011-03-16,2011,EP 10179067 A,2001-06-01,EP 01939852 A;;US 58956000 A,2000-06-06,Method and devices for multiplexing amplification reactions,"The present invention pertains to methods, reagents, compositions, kits and instruments for use in simultaneously amplifying multiple targets. In particular, this invention is based on the discovery of a two-step multiplex amplification reaction wherein the first step truncates the standard initial multiplex amplification round to ""boost"" the sample copy number by only a 100 - 1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid.
",LIFE TECHNOLOGIES CORP,MARMARO JEFFREY M;;GERDES JOHN C,,https://lens.org/149-483-315-778-97X,Patent Application,yes,26,3,13,14,0,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,C12Q1/68;;G01N33/53;;C12N15/09;;C12Q1/06;;C12Q1/10;;C12Q1/48;;G01N33/566,,23,18,070-656-465-248-593;;079-074-030-459-68X;;032-597-682-620-712;;017-515-593-292-125;;068-917-929-803-50X;;045-081-326-747-615;;005-540-691-594-134;;078-302-340-811-20X;;001-560-891-833-008;;041-417-339-486-865;;003-784-819-011-670;;023-050-451-230-180;;113-237-014-874-941;;041-417-339-486-865;;066-697-166-954-718;;085-112-370-064-707;;069-142-568-607-17X;;021-605-881-544-255,8637917;;pmc39840;;10.1073/pnas.93.6.2582;;10.1016/s0890-8508(95)90125-6;;7477021;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;10.1016/0890-8508(90)90026-v;;2280781;;10.1101/gr.3.4.s65;;8173510;;10794932;;10.1016/s0732-8893(00)00116-4;;9298224;;10.2144/97233rr01;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;10.1021/ac970642d;;9463271;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;9298224;;10.2144/97233rr01;;10.1101/gr.5.5.488;;8808470;;pmc148576;;10.1093/nar/27.17.e15;;10446258;;2466663;;10.1002/elps.1150090803;;10.1001/jama.279.19.1554;;9605900,"LIN Z ET AL: ""Multiplex genotype determination at a large number of gene loci"", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US, vol. 93, no. 6, 19 March 1996 (1996-03-19), pages 2582 - 2587, XP002142667, ISSN: 0027-8424, DOI: 10.1073/PNAS.93.6.2582;;SAIKI R K ED - ERLICH H A: ""THE DESIGN AND OPTIMIZATION OF THE PCR"", PCR TECHNOLOGY. PRINCIPLES AND APPLICATIONS FOR DNA AMPLIFICATION, NEW YORK, STOCKTON PRESS, US, 1 January 1989 (1989-01-01), pages 7 - 16, XP002223319;;BORG K L ET AL: ""Detection of cytomegalovirus using 'boosted' nested PCR."", MOLECULAR AND CELLULAR PROBES. ENGLAND AUG 1995, vol. 9, no. 4, August 1995 (1995-08-01), pages 251 - 257, XP009003162, ISSN: 0890-8508;;RUANO G ET AL: ""BIPHASIC AMPLIFICATION OF VERY DILUTE DNA SAMPLES VIA 'BOOSTER' PCR"", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 17, no. 13, 11 July 1989 (1989-07-11), pages 5407, XP000371657, ISSN: 0305-1048;;RUANO G ET AL: ""BOOSTER PCR: A BIPHASIC PARADIGM FOR AMPLIFICATION OF A FEW MOLECULES OF TARGET"", AMPLIFICATIONS: A FORUM FOR PCR USERS, PERKIN-ELMER CO., NORWALK, CT, US, 1 September 1989 (1989-09-01), pages 12 - 13, XP000567442;;PICARD C ET AL: ""DETECTION AND ENUMERATION OF BACTERIA IN SOIL BY DIRECT DNA EXTRACTION AND POLYMERASE CHAIN REACTION"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 58, no. 9, September 1992 (1992-09-01), pages 2717 - 2722, XP000946427, ISSN: 0099-2240;;SAULNIER P ET AL: ""DETECTON OF GENES IN FECES BY BOOSTER POLYMERASE CHAIN REACTION"", JOURNAL OF CLINICAL MICROBIOLOGY, WASHINGTON, DC, US, vol. 30, no. 8, August 1992 (1992-08-01), pages 2080 - 2083, XP001084737, ISSN: 0095-1137;;BEJ A K ET AL: ""DETECTION OF COLIFORM BACTERIA AND ESCHERICHIA COLI BY MULTIPLEX POLYMERASE CHAIN REACTION: COMPARISON WITH DEFINED SUBSTRATE AND PLATING METHODS FOR WATER QUALITY MONITORING"", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 57, no. 8, August 1991 (1991-08-01), pages 2429 - 2432, XP001004829, ISSN: 0099-2240;;ASIM K BEJ ET AL: ""MULTIPLEX PCR AMPLIFICATION AND IMMOBILIZED CAPTURE PROBES FOR DETECTION OF BACTERIAL PATHOGENES AND INDICATORS IN WATER"", MOLECULAR AND CELLULAR PROBES, ACADEMIC PRESS, LONDON, GB, vol. 4, 1990, pages 353 - 365, XP000578307, ISSN: 0890-8508;;EDWARDS M C ET AL: ""Multiplex PCR: advantages, development, and applications."", PCR METHODS AND APPLICATIONS. UNITED STATES FEB 1994, vol. 3, no. 4, February 1994 (1994-02-01), pages S65 - S75, XP009003160, ISSN: 1054-9803;;GONIN P ET AL: ""Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory."", DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. UNITED STATES MAY 2000, vol. 37, no. 1, May 2000 (2000-05-01), pages 1 - 4, XP002225665, ISSN: 0732-8893;;HENEGARIU O ET AL: ""MULTIPLEX PCR: CRITICAL PARAMETERS AND STEP-BY-STEP PROTOCOL"", BIOTECHNIQUES, EATON PUBLISHING, NATICK, US, vol. 23, no. 3, 1 September 1997 (1997-09-01), pages 504 - 511, XP000703350, ISSN: 0736-6205;;SONG Y ET AL: ""Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA."", FEMS MICROBIOLOGY LETTERS. NETHERLANDS 15 JUN 2000, vol. 187, no. 2, 15 June 2000 (2000-06-15), pages 167 - 173, XP002225666, ISSN: 0378-1097;;WATERS L C ET AL: ""MICROCHIP DEVICE FOR CELL LYSIS, MULTIPLEX PCR AMPLIFICATION, AND ELECTROPHORETIC SIZING"", ANALYTICAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, vol. 70, no. 1, 1998, pages 158 - 162, XP000733220, ISSN: 0003-2700;;CHAMBERLAIN, NUCLEIC ACID RESEARCH, vol. 16, 1988, pages 11141 - 11156;;EDWARDS; GIBBS, PCR METHODS APPLIC., vol. 3, 1994, pages 565 - 575;;HENEGARIU ET AL., BLOTECHNIQUES, vol. 23, 1997, pages 504 - 511;;SHUBER ET AL., GENOME RESEARCH, vol. 5, 1995, pages 488 - 493;;VAN DEURSEN, NUCLEIC ACID RESEARCH, vol. 27, 1999, pages E15;;DYKES, ELECTROPHORESIS, vol. 9, 1989, pages 359 - 368;;WALSH ET AL., BIOTECHNIQUES, vol. 19, 1991, pages 506 - 513;;VOGELSTEIN; GILLESPIE, PROC. NAF. ACAD. SCI. USA, vol. 76, 1979, pages 616 - 619;;I. I. WISTUBA ET AL: ""Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects"", JAMA, vol. 279, no. 19, 20 May 1998 (1998-05-20), pages 1554 - 1559, XP055064067, ISSN: 0098-7484, DOI: 10.1001/jama.279.19.1554",DISCONTINUED
23,AU,B2,AU 2001/265327 B2,071-247-148-766-660,2005-10-13,2005,AU 2001/265327 A,2001-06-01,US 58956000 A;;US 0117901 W,2000-06-06,Methods and devices for multiplexing amplification reactions,,APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;MARMARO JEFFREY M,"APPLIED BIOSYSTEMS, LLC. (2010-04-01);;APPLERA CORPORATION (2004-08-19)",https://lens.org/071-247-148-766-660,Granted Patent,no,0,6,13,14,0,C12Q1/6844;;C12Q1/689;;C12Q2600/16;;C12Q1/689;;C12Q1/6844;;C12Q2600/16,G01N33/53;;C12N15/09;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,2,2,045-081-326-747-615;;005-540-691-594-134,1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;10.1016/0890-8508(90)90026-v;;2280781,"Bej, A. K. et al (1991) Applied and Environmental Microbiology, 57(8): 2429-2432;;Bej, A. K. et al (1990) Molecular and Cellular Probes, 4: 353-365",EXPIRED
24,US,B2,US 8815546 B2,108-601-464-705-544,2014-08-26,2014,US 201213619436 A,2012-09-14,US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,Methods for multiplexing amplification reactions,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",GERDES JOHN;;BEST ELAINE;;MARMARO JEFFREY M;;APPLIED BIOSYSTEMS LLC,GERDES JOHN;;BEST ELAINE;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLERA CORPORATION (2004-03-31);;APPLIED BIOSYSTEMS INC (2008-06-30);;XTRANA INC (2013-07-30),https://lens.org/108-601-464-705-544,Granted Patent,yes,70,11,17,17,84,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12P19/34;;G01N33/53;;C12N15/09;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,435/91.2,99,38,007-782-541-984-959;;045-081-326-747-615;;070-660-701-185-769;;005-540-691-594-134;;079-074-030-459-68X;;113-237-014-874-941;;014-353-991-909-225;;045-377-687-919-809;;078-302-340-811-20X;;051-671-860-596-375;;001-560-891-833-008;;014-051-545-273-403;;004-802-768-681-203;;041-417-339-486-865;;055-980-684-558-947;;055-501-408-900-258;;042-810-087-283-347;;070-656-465-248-593;;010-045-471-526-650;;091-616-122-117-431;;054-095-134-696-001;;005-093-091-683-529;;012-315-547-510-664;;080-120-399-411-790;;005-098-521-717-817;;017-515-593-292-125;;008-213-359-148-352;;032-597-682-620-712;;068-917-929-803-50X;;017-391-717-403-017;;066-697-166-954-718;;003-784-819-011-670;;138-426-789-339-83X;;032-781-980-714-725;;025-891-722-731-526;;023-050-451-230-180;;021-605-881-544-255;;030-836-231-181-354,2306085;;10.1128/aem.56.2.307-314.1990;;pmc183336;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;2059028;;10.1128/aem.57.4.1013-1017.1991;;pmc182838;;10.1016/0890-8508(90)90026-v;;2280781;;10.1016/s0890-8508(95)90125-6;;7477021;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;pmc328414;;10.1093/nar/19.13.3749;;1852616;;10.1101/gr.191301;;11544191;;10.1101/gr.3.4.s65;;8173510;;10.1006/mcpr.2002.0433;;12477439;;10794932;;10.1016/s0732-8893(00)00116-4;;10.1016/0167-7012(91)90046-s;;10.1101/gr.6.10.986;;8908518;;9298224;;10.2144/97233rr01;;1571150;;1349899;;pmc265232;;10.1128/jcm.30.5.1098-1104.1992;;10.1093/nar/24.3.538;;pmc145645;;8602371;;8637917;;pmc39840;;10.1073/pnas.93.6.2582;;9863056;;10.2144/98256rr01;;2227421;;10.1016/0378-1119(90)90145-h;;pmc248091;;4914564;;10.1128/jb.103.2.382-386.1970;;pmc84298;;10.1128/jcm.37.2.327-332.1999;;9889212;;11950218;;10.1006/abio.2002.5593;;10.1007/s100380170047;;11501945;;pmc167648;;10.1093/nar/gng073;;12853650;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;10.1073/pnas.88.7.2815;;1672768;;pmc51330;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;9546166;;10.1128/aem.64.4.1313-1318.1998;;pmc106147;;10.1101/gr.5.5.488;;8808470;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;10.1006/geno.1999.6048;;10644449;;10.1093/nar/gng122;;14530455;;pmc219490;;9582121;;10.1126/science.280.5366.1077;;10.1021/ac970642d;;9463271;;10.1001/jama.279.19.1554;;9605900;;10.1006/meth.2001.1265;;11846612,"U.S. Appl. No. 10/441,158; Office Action mailed Mar. 23, 2005.;;U.S. Appl. No. 10/441,158; Response to Mar. 23, 2005 Office Action filed on May 23, 2005.;;U.S. Appl. No. 10/441,158; Office Action mailed Aug. 17, 2005.;;U.S. Appl. No. 10/441,158; Response to Aug. 17, 2005 Office Action filed on Sep. 14, 2005.;;U.S. Appl. No. 10/441,158; Notice of Allowance mailed Dec. 13, 2005.;;U.S. Appl. No. 10/723,520; Office Action mailed Oct. 30, 2006.;;U.S. Appl. No. 10/723,520; Response to Oct. 30, 2006 Office Action filed on Nov. 29, 2006.;;U.S. Appl. No. 10/723,520; Office Action mailed Jan. 19, 2007.;;U.S. Appl. No. 10/723,520; Response to Jan. 19, 2007 Office Action filed on Jul. 19, 2007.;;U.S. Appl. No. 10/723,520; Office Action mailed Aug. 1, 2007.;;U.S. Appl. No. 10/723,520; Response to Aug. 1, 2007 Office Action filed on Feb. 1, 2008.;;U.S. Appl. No. 10/723,520; Office Action mailed Apr. 29, 2008.;;U.S. Appl. No. 10/723,520; Response to Apr. 29, 2008 Office Action filed on Aug. 29, 2008.;;U.S. Appl. No. 10/723,520; Office Action mailed Nov. 7, 2008.;;U.S. Appl. No. 10/723,520; Response to Nov. 7, 2008 Office Action filed Aug. 7, 2009.;;U.S. Appl. No. 10/723,520; Office Action mailed Oct. 13, 2009.;;U.S. Appl. No. 10/723,520; Response to Oct. 13, 2009 Office Action filed Apr. 13, 2010.;;U.S. Appl. No. 10/723,520; Office Action mailed Jul. 6, 2010.;;U.S. Appl. No. 11/176,795; Office Action mailed Jul. 11, 2007.;;U.S. Appl. No. 11/176,795; Response to Jul. 11, 2007 Office Action filed on Jul. 30, 2007.;;U.S. Appl. No. 11/176,795; Office Action mailed Oct. 12, 2007.;;U.S. Appl. No. 11/176,795; Response to Oct. 12, 2007 Office Action filed on Jan. 14, 2008.;;U.S. Appl. No. 11/176,795; Office Action mailed Apr. 1, 2008.;;U.S. Appl. No. 11/176,795; Response to Apr. 1, 2008 Office Action filed on Jul. 30, 2008.;;U.S. Appl. No. 11/176,795; Office Action mailed Sep. 16, 2008.;;U.S. Appl. No. 11/176,795; Response to Sep. 16, 2008 Office Action filed on Oct. 1, 2008.;;U.S. Appl. No. 11/176,795; Notice of Allowance mailed Dec. 30, 2008.;;CA 2,410,281; Notice of Allowance mailed Aug. 24, 2009.;;EP01939852.8; Office Action mailed Apr. 6, 2006.;;EP01939852.8; Response to Apr. 6, 2006 Office Action filed on Oct. 24, 2006.;;EP01939852.8; Office Action mailed Jun. 2, 2009.;;EP01939852.8; Response to Jun. 2, 2009 Office Action filed on Dec. 14, 2009.;;EP03796461.6; Partial European Search Report mailed Apr. 6, 2006.;;EP03796461.6; Supplementary European Search Report mailed Jun. 30, 2006.;;EP03796461.6; Office Action mailed Oct. 13, 2006.;;EP03796461.6; Response to Oct. 13, 2006 Office Action filed on Feb. 19, 2007.;;EP03796461.6; Office Action mailed Mar. 9, 2007.;;EP03796461.6; Response to Mar. 7, 2007 Office Action filed on Apr. 16, 2007.;;EP03796461.6; Office Action mailed Sep. 9, 2008.;;EP08020322.7; EP search report mailed Jan. 29, 2009.;;EP08020322.7; Office Action mailed Sep. 18, 2009.;;EP08020322.7; Response to Sep. 18, 2009 Office Action filed on Mar. 18, 2010.;;EP09016059.9; Extended European Search Report mailed Apr. 29, 2010.;;EP10182843.2; Extended European Search Report mailed Jun. 20, 2011.;;JP2002-502174; English Translation of Office Action mailed Oct. 9, 2008.;;JP2004-557332 ; Office Action mailed Jun. 4, 2009.;;WO2001/094634; PCT International Search Report mailed Jan. 23, 2003.;;WO2001/094634; PCT International Preliminary Examination Report mailed Mar. 4, 2004.;;WO2004/051218; PCT International Search Report mailed Dec. 10, 2004.;;WO2004/104214; PCT International Search Report mailed Jan. 26, 2006.;;WO2004/104214; PCT Written Opinion mailed Mar. 7, 2006.;;WO2004/104214; PCT International Preliminary Report on Patentability mailed Mar. 13, 2006.;;Assays-By-Design Service[Online], [retrieved on May 13, 2003],;;Assays-On-Demand, Gene Expression Products [online], [retrieved on May 13, 2003], .;;Assays-On-Demand, SNP Genotyping Products [online], [retrieved on May 13, 2003], .;;Bej, A K. et al., ""Detection of Coliform Bacteria in Water by Polymerase Chain Reaction and Gene Probes"", Applied and Environmental Microbiology, vol. 56, No. 2, Feb. 1990; pp. 307-314.;;Bej, A. K. et al., ""Detection of Coliform Bacteria and Escherichia Coli by Multiplex Polymerase Chain Reaction: Comparison With Defined Substrate and Plating Methods for Water Quality Monitoring"", Applied and Environmental Microbiology, vol. 57, No. 8, Aug. 1991; pp. 2429-2432.;;Bej, A. K. et al., ""Detection of Escherichia coli and Shigella spp. in Water by Using the Polymerase Chain Reaction and Gene Probes for uid"", Applied and Environmental Microbiology, vol. 57, No. 4, Apr. 1991; pp. 1013-1017.;;Bej, A. K. et al., ""Multiplex PCR Amplification and Immobilized Capture Probes for Detection of Bacterial Pathogenes and Indicators in Water"", Molecular and Cellular Probes, vol. 4, Issue 5, Academic Press, London, GB, Oct. 1990; pp. 353-365.;;Borg, K. L. et al., ""Detection of cytomegalovirus using 'boosted' nested PCR."", Molecular and Cellular Probes, vol. 9, No. 4, England, Aug. 1995; pp. 251-257.;;Chamberlain, Jeffrey et al., ""Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification"", Nucl. Acids Res., vol. 16, No. 23, 1988 ; pp. 11141-11155.;;D'Aquila, Richard T. et al., ""Maximizing sensitivity and specificity of PCR by pre-amplification heating"", Nucleic Acids Research, vol. 19, No. 13, Oxford University Press, Jul. 11, 1991; p. 3749.;;Dolganov, G. , ""A Novel Method of Gene Transcript Profiling in Airway Biopsy Homogenates Reveals Increased Expression of a Na+ -K+-C1- Cotransporter (NKCC1) in Asthmatic Subjects"", Genome Research, vol. 11, 2001; pp. 1473-1483.;;Edwards, M. C. et al., ""Multiplex PCR: Advantages, Development, and Applications"" PCR Methods and Applications, vol. 3, No. 4, Cold Spring Harbor Laboratory Press, US, Feb. 1994: pp. S65-S75.;;Exner, M. et al., ""Sensitivity of multiplex real-time PCR reactions, using the LightCycler and the ABI PRISM 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase"", Mol. Cell Probes, vol. 16, Oct. 2002; pp. 351-357.;;Gonin, P. et al., ""Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory"", Diagnostic Microbiology and Infectious Disease, vol. 37, No. 1, US, May 2000; pp. 1-4.;;Graves, L. M. et al., ""Universal Bacterial DNA Isolation Procedure"", Diagnostic Molecular Microbiology; Principles and Applications, American Society for Microbiology, Washington, D.C., 1993; pp. 617-621.;;Green, D et al., ""Detection of faecal pollution in water by an Escherichia coli uidA gene probe"", Journal of Microbiological Methods, vol. 13, Issue 3, Jul. 1991; pp. 207-214.;;Heid, et al., ""Real Time Quantitative PCR"", Genome Research, vol. 6, No. 10, Cold Spring Harbor Laboratory Press, Woodbury, NY, Oct. 1996; pp. 986-994.;;Henegariu, et al., ""Multiplex PCR: Critical Parameters and Step-by-Step Protocol"", BioTechniques, vol. 23, No. 3, Sep. 1997; pp. 504-511.;;Jayaraman, et al., ""A PCR-mediated Gene Synthesis strategy involving assamply of oligonucleotides resenting only one of the strands"", BioTechniques, vol. 12, No. 3, 1992; pp. 392-398.;;Kaltenboeck, ""Two-Step Polymerase Chain Reactions and Restriction Endonuclease Analyses Detect and Differentiate ompA DNA of Chlamydia spp"", Journal of Clinical Microbiology, vol. 30, No. 5, American Society for Microbiology, May 1992; pp. 1098-1104.;;Kato, K., ""Laboratory Manual PCR- Study and Application to Clinical Diagnosis"", First Edition Takara Shuzo Co. Ltd, 1996; pp. 73-81.;;Li, D. et al., ""Multiplex co-amplification of 24 retinoblastoma gene exons after pre-amplification by long-distance PCR"", Nucleic Acids Research, vol. 24, No. 3, 1996; pp. 538-539.;;Lin, Z et al., ""Multiplex Genotype Determination at a Large Number of Gene Loci"", Proceedings of the National Academy of Sciences of the United State, vol. 93, No. 6, Genetics, USA, Mar. 1996; pp. 2582-2587.;;Liu, Q., ""Subcycling-PCR for Multiplex Long-Distance Amplification of Regions with High and Low GC Content: Application to the Inversion Hotspot in the Factor VIII Gene"", BioTechniques, vol. 25, No. 6, Dec. 1998; pp. 1022-1028.;;Longo, M. et al., ""Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions"", Genevol. 93, 1990; pp. 125-128.;;Lupo, M et al., ""Gene Controlling L-Glutamic Acid Decarboxylase Synthesis in Escherichia coli K-12"", Journal of Bacteriology, vol. 103, No. 2, American Society for Microbiology, USA, Aug. 1970; pp. 382-386.;;Martell, M et al., ""High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA"", Journal of Clinical Microbiology, vol. 37, No. 2, American Society for Microbiology, Feb. 1999; pp. 327-332.;;Min, J. et al., ""Highly Sensitive and Specific Detection of Viable Escherichia coli in Drinking Water"", Analytical Biochemistry, vol. 303, Issue 2, Elsevier Science, USA, Apr. 15, 2002; pp. 186-193.;;Ohnishi, et al., ""A high-throughput SNP typing system for genome-wide association studies"", J. Hum. Genet., vol. 46, 2001; pp. 471-477.;;Peirson, S. N., ""Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis"", Nucleic Acids Res., vol. 31, No. 14 e73, 2003; pp. 1-7.;;Picard, C. et al., ""Detection and Enumeration of Bacteria in Soil by Direct DNA Extraction and Polymerase Chain Reaction"", Applied and Environmental Microbiology, vol. 58, No. 9, Sep. 1992; pp. 2717-2722.;;Rice, et al., ""Detection of Escherichia coli in Water Using a Colorimetric Gene Probe Assay"", Journal of Environmental Science and Health, vol. 30, Issue 5, 1995; pp. 1059-1067.;;Ruano, G. et al., ""coupled amplification and sequencing of genomic DNA"", Proceedings of the National Academy of Sciences of the Untied States of America, vol. 88, 1991; pp. 2815-2519.;;Ruano, G. et al., ""Biphasic Amplification of Very Dilute DNA Samples Via 'Booster' PCR"", Nucleic Acids Research, vol. 17, No. 13, Oxford University Press, Surrey, GB, Jul. 11, 1989; p. 5407.;;Ruano, G. et al., ""Booster PCR: A Biphasic Paradigm for Amplification of a Few Molecules of Target"", Amplifications: A Forum for PCR Users, Perkin-Elmer Co., Norwalk, CT, US, Sep. 1989; pp. 12-13.;;Saiki, R.K., ""The Design and Optimiztion of The PCR"", PCR Technology. Principles and Applications for the DNA Amplification, Stockton Press, New York, US, Jan. 1989; pp. 7-16.;;Saulnier, P. et al., ""Detection of Genes in Feces by Booster Polymerase Chain Reaction"", Journal of Clinical Microbiology, vol. 30, No. 8, American Society for Microbiology, Aug. 1992; pp. 2080-2083.;;Sheridan, G. E. et al., ""Detection of mRNA by Reverse Transcription-PCR as an Indicator of Viability in Escherichia coli Cells"", Applied and Environmental Microbiology, vol. 64, No. 4, American Society for Microbiology, Apr. 1998; pp. 1313-1318.;;Shuber, A. et al., ""A Simplified Procedure for Developing Multiplex PCRs"", Genome Research, vol. 5, 1995; pp. 488-493.;;Song, Y. et al., ""Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA"", FEMS Microbiology Letters, vol. 187, No. 2, Federation of European Microbiological Societies, Elsevier Science B.V., Netherlands, 2000; pp. 167-173.;;Tettelin, et al., ""Optimized Multiplex PCR: Efficiently Closing a Whole-Genome Shotgun Sequencing Project"", Genomics, vol. 62, 1999; pp. 500-507.;;Tichopad, A. et al., ""Standardized determination of real-time PCR efficiency from a single reaction set-up"", Nucleic Acids Res., vol. 31 e122, 2003; pp. 1-6.;;User Bulletin #2:, ""ABI Prism 7700 Sequence Detection System. Subject: Relative Quantitation of Gene Expression, Datasheet"", Applied Biosystems, (updated Oct. 2001), 1997.;;Wang, et al., ""Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome"", Science vol. 280, 1998; pp. 1077-1082.;;Waters, L.C. et al., ""Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing"", Analytical Chemistry, vol. 70, No. 1, American Chemical Society, Columbus, US, 1998; pp. 158-162.;;Witsuba, Ignatio I. et al. Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects, JAMA, vol. 279, No. 19, May 20, 1998; pp. 1554-1559.;;Wittwer, C. et al., ""Real-Time Multiplex PCR Assays"", Methods, vol. 25, Elsevier Science, USA, 2001; pp. 430-442.",EXPIRED
25,US,B2,US 10106845 B2,099-327-408-063-328,2018-10-23,2018,US 201615293387 A,2016-10-14,US 201615293387 A;;US 201414302980 A;;US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,Methods for multiplexing amplification reactions,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLIED BIOSYSTEMS LLC,GERDES JOHN;;BEST ELAINE;;MARMARO JEFFREY M,,https://lens.org/099-327-408-063-328,Granted Patent,yes,78,2,17,17,100,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12P19/34;;G01N33/53;;C12N15/09;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;C12Q1/6806;;C12Q1/6827;;C12Q1/6844;;C12Q1/686;;C12Q1/689;;G01N33/566,,66,43,007-782-541-984-959;;045-081-326-747-615;;070-660-701-185-769;;005-540-691-594-134;;079-074-030-459-68X;;113-237-014-874-941;;014-353-991-909-225;;045-377-687-919-809;;078-302-340-811-20X;;051-671-860-596-375;;001-560-891-833-008;;016-383-594-999-909;;014-051-545-273-403;;004-802-768-681-203;;041-417-339-486-865;;041-417-339-486-865;;055-980-684-558-947;;043-583-305-054-251;;055-501-408-900-258;;042-810-087-283-347;;070-656-465-248-593;;010-045-471-526-650;;091-616-122-117-431;;054-095-134-696-001;;005-093-091-683-529;;012-315-547-510-664;;080-120-399-411-790;;005-098-521-717-817;;017-515-593-292-125;;008-213-359-148-352;;032-597-682-620-712;;030-415-746-440-014;;068-917-929-803-50X;;017-391-717-403-017;;066-697-166-954-718;;003-784-819-011-670;;138-426-789-339-83X;;032-781-980-714-725;;025-891-722-731-526;;023-050-451-230-180;;021-605-881-544-255;;030-836-231-181-354;;050-069-505-989-408,2306085;;10.1128/aem.56.2.307-314.1990;;pmc183336;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;2059028;;10.1128/aem.57.4.1013-1017.1991;;pmc182838;;10.1016/0890-8508(90)90026-v;;2280781;;10.1016/s0890-8508(95)90125-6;;7477021;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;pmc328414;;10.1093/nar/19.13.3749;;1852616;;10.1101/gr.191301;;11544191;;10.1101/gr.3.4.s65;;8173510;;10.1006/mcpr.2002.0433;;12477439;;10794932;;10.1016/s0732-8893(00)00116-4;;10.1006/abio.1998.2771;;9750148;;10.1016/0167-7012(91)90046-s;;10.1101/gr.6.10.986;;8908518;;9298224;;10.2144/97233rr01;;9298224;;10.2144/97233rr01;;1571150;;11072065;;10.1016/s0167-4781(00)00200-1;;1349899;;pmc265232;;10.1128/jcm.30.5.1098-1104.1992;;10.1093/nar/24.3.538;;pmc145645;;8602371;;8637917;;pmc39840;;10.1073/pnas.93.6.2582;;9863056;;10.2144/98256rr01;;2227421;;10.1016/0378-1119(90)90145-h;;pmc248091;;4914564;;10.1128/jb.103.2.382-386.1970;;pmc84298;;10.1128/jcm.37.2.327-332.1999;;9889212;;11950218;;10.1006/abio.2002.5593;;10.1007/s100380170047;;11501945;;pmc167648;;10.1093/nar/gng073;;12853650;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;10.1073/pnas.88.7.2815;;1672768;;pmc51330;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;12771226;;10.1093/nar/gng061;;pmc156739;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;9546166;;10.1128/aem.64.4.1313-1318.1998;;pmc106147;;10.1101/gr.5.5.488;;8808470;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;10.1006/geno.1999.6048;;10644449;;10.1093/nar/gng122;;14530455;;pmc219490;;9582121;;10.1126/science.280.5366.1077;;10.1021/ac970642d;;9463271;;10.1001/jama.279.19.1554;;9605900;;10.1006/meth.2001.1265;;11846612;;8994665;;10.2144/97221pf02,"Assays-by-Design Service [Online], “[retrieved on May 13, 2003], Retrieved from the Applied Biosystems using the Internet”, <URL: http://www.applied biosystems.com/products/productdetail.cfm?prod_id=761.<., May 13, 2005.;;Assays-on-Demand, “Gene Expression Products [online], [retrieved on May 13, 2003], Retrieved from the Applied Biosystems using Internet”, <http://www.applied biosystems.com/products/productdetail.cfm?prod_id=1101>., May 13, 2003.;;Assays-on-Demand, “SNP Genotyping Products [online], [retrieved on May 13, 2003], Retrieved from the Applied Biosystems using Internet”, <http://www.applied biosystems.com/products/productdetail.cfm?prod_id=1141>, May 13, 2003.;;Bej, A K. et al., “Detection of Coliform Bacteria in Water by Polymerase Chain Reaction and Gene Probes”, Applied and Environmental Microbiology, vol. 56, No. 2,, Feb. 1990, 307-314.;;Bej, A. K. et al., “Detection of Coliform Bacteria and Escherichia coli by Multiplex Polymerase Chain Reaction: Comparison With Defined Substrate and Plating Methods for Water Quality Monitoring”, Applied and Environmental Microbiology, vol. 57, No. 8,, Aug. 1991, 2429-2432.;;Bej, A. K. et al., “Detection of Escherichia coli and Shigella spp. in Water by Using the Polymerase Chain Reaction and Gene Probes for uid”, Applied and Environmental Microbiology, vol. 57, No. 4,, Apr. 1991, 1013-1017.;;Bej, A. K. et al., “Multiplex PCR Amplification and Immobilized Capture Probes for Detection of Bacterial Pathogenes and Indicators in Water”, Molecular and Cellular Probes, vol. 4, Issue 5, Academic Press, London, GB,, Oct. 1990, 353-365.;;Borg, K. L. et al., “Detection of cytomegalovirus using ‘boosted’ nested PCR.”, Molecular and Cellular Probes, vol. 9, No. 4, England,, Aug. 1995, 251-257.;;Chamberlain, Jeffrey et al., “Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification”, Nucl. Acids Res., vol. 16, No. 23, 1988, 11141-11155.;;D'Aquila, Richard T. et al., “Maximizing sensitivity and specificity of PCR by pre-amplification heating”, Nucleic Acids Research, vol. 19, No. 13, Oxford University Press,, Jul. 11, 1991, 3749.;;Dolganov, G., “A Novel Method of Gene Transcript Profiling in Airway Biopsy Homogenates Reveals Increased Expression of a Na+—K+—Cl- Cotransporter (NKCC1) in Asthmatic Subjects”, Genome Research, 11, 2001, 1473-1483.;;Edwards, M. C. et al., “Multiplex PCR: Advantages, Development, and Applications”, PCR Methods and Applications, vol. 3, No. 4, Cold Spring Harbor Laboratory Press, US,, Feb. 1994, S65-S75.;;EP 03796461, “Partial European Search Report”, dated Apr. 6, 2006.;;EP 03796461, “Supplementary European Search Report”, dated Jun. 30, 2006.;;EP08020322, “EP search report”, dated Jan. 29, 2009, 7 pages.;;EP09016059, “Search Report”, dated Apr. 29, 2010, 5 pages.;;EP10182843.2, “Extended European Search Report”, dated Jun. 20, 2011, 14 pages.;;EP14164752.9, “Extended European Search Report dated Oct. 12, 2015”, Oct. 12, 2015, 12 Pages.;;EP15177617.6, “Extended European Search Report dated Feb. 26, 2016”, Feb. 26, 2016, 6 pages.;;Exner, M. et al., “Sensitivity of multiplex real-time PCR reactions, using the LightCycler and the ABI Prism 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase”, Mol. Cell Probes, 16:, Oct. 2002, 351-357.;;Gonin, P. et al., “Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory”, Diagnostic Microbiology and Infectious Disease, vol. 37, No. 1, US,, May 2000, 1-4.;;Grace, M. et al., “Degradable dUMP Outer Primers in Merged Tandem (M/T)-Nested PCR: Low- and Single-Copy DNA Target Amplification”, vol. 263, Article No. AB982771, 1998, 85-92.;;Graves, L. M. et al., “Universal Bacterial DNA Isolation Procedure”, Diagnostic Molecular Microbiology; Principles and Applications, American Society for Microbiology, Washington, D.C.,, 1993, 617-621.;;Green, D et al., “Detection of faecal pollution in water by an Escherichia coli uidA gene probe”, Journal of Microbiological Methods, vol. 13, Issue 3,, Jul. 1991, 207-214.;;Heid, et al., “Real Time Quantitative PCR”, Genome Research, Cold Spring Harbor Laboratory Press, Woodbury, NY, vol. 6 (10), Oct. 1996, 986-994.;;Henegariu, et al., “Multiplex PCR: Critical Parameters and Step-by-Step Protocol”, BioTechniques, vol. 23, No. 3, 1997, 504-511.;;Henegariu, et al., “Multiplex PCR: Critical Parameters and Step-By-Step Protocol”, Biotechniques, vol. 23, No. 3, Sep. 1997, 504-511.;;Jayaraman, et al., “A PCR-mediated Gene Synthesis strategy involving assamply of oligonucleotides resenting only one of the strands”, BioTechniques, vol. 12, No. 3, 1992, 392-398.;;Kainz, Peter, “The PCR plateau phase—towards an understanding of its limitations”, Biochimica et Biophysica Acta, vol. 1494, 2000, 23-27.;;Kaltenboeck, “Two-Step Polymerase Chain Reactions and Restriction Endonuclease Analyses Detect and Differentiate ompA DNA of Chlamydia spp”, Journal of Clinical Microbiology, vol. 30, No. 5, American Society for Microbiology,, May 1992, 1098-1104.;;Kato, K., “Laboratory Manual PCR- Study and Application to Clinical Diagnosis”, First Edition Takara Shuzo Co. Ltd, 1996, 73-81.;;Li, D. et al., “Multiplex co-amplification of 24 retinoblastoma gene exons after pre-amplification by long-distance PCR”, Nucleic Acids Research, 24(3), 1996, 538-539.;;Lin, Z et al., “Multiplex Genotype Determination at a Large Number of Gene Loci”, Proceedings of the National Academy of Sciences of the United States, vol. 93, No. 6, Genetics, USA,, Mar. 1996, 2582-2587.;;Liu, Q, “Subcycling-PCR for Multiplex Long-Distance Amplification of Regions with High and Low GC Content: Application to the Inversion Hotspot in the Factor VIII Gene”, BioTechniques, vol. 25, No. 6, Dec. 1998, 1022-1028.;;Longo, M et al., “Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions”, Gene, vol. 93,, 1990, 125-128.;;Lupo, M et al., “Gene Controlling L-Glutamic Acid Decarboxylase Synthesis in Escherichia coli K-12”, Journal of Bacteriology, vol. 103, No. 2, American Society for Microbiology, USA,, Aug. 1970, 382-386.;;Martell, M et al., “High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA”, Journal of Clinical Microbiology, vol. 37, No. 2, American Society for Microbiology, Feb. 1999, 327-332.;;Min, J. et al., “Highly Sensitive and Specific Detection of Viable Escherichia coli in Drinking Water”, Analytical Biochemistry, vol. 303, Issue 2, Elsevier Science, USA,, Apr. 15, 2002, 186-193.;;Ohnishi, et al., “A high-throughput SNP typing system for genome-wide association studies”, J. Hum. Genet., 46:, 2001, 471-477.;;Peirson, S. N., “Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis”, Nucleic Acids Res., 31(14), 2003, e73.;;Picard, C. et al., “Detection and Enumeration of Bacteria in Soil by Direct DNA Extraction and Polymerase Chain Reaction”, Applied and Environmental Microbiology, vol. 58, No. 9,, Sep. 1992, 2717-2722.;;Rice, et al., “Detection of Escherichia coli in Water Using a Colorimetric Gene Probe Assay”, Journal of Environmental Science and Health, vol. 30, Issue 5,, 1995, 1059-1067.;;Roche Diagnostics GmbH, “RealTime ready cDNA Pre-Amp Master”, Roche Applied Science Catalog No. 06 720 455 001, Version 01, Sep. 2012, 16 pages.;;Ruano, G et al., “Coupled amplification and sequencing of genomic DNA”, Proceedings of the National Academy of Sciences of the United States of America, vol. 88,, 1991, 2815-2519.;;Ruano, G. et al., “Biphasic Amplification of Very Dilute DNA Samples via ‘Booster’ PCR”, Nucleic Acids Research, vol. 17, No. 13, Oxford University Press, Surrey, GB,, Jul. 11, 1989, 5407.;;Ruano, G. et al., “Booster PCR: A Biphasic Paradigm for Amplification of a Few Molecules of Target”, Amplifications: A Forum for PCR Users, Perkin-Elmer Co., Norwalk, CT, US,, Sep. 1989, 12-13.;;Rudi, K et al., “A Novel MUltiplex Quantitative DNA Array Based PCR (MQDAPCR)”, Nucleic Acids Research, 2003, vol. 31, No. 11 e62, Jan. 31, 2008, 1-8.;;Saiki, R. K., “The Design and Optimization of the PCR”, PCR Technology, Principles and Applications for DNA Amplification, Stockton Press, New York, US,, Jan. 1989, 7-16.;;Saulnier, P. et al., “Detection of Genes in Feces by Booster Polymerase Chain Reaction”, Journal of Clinical Microbiology, vol. 30, No. 8, American Society for Microbiology, Aug. 1992, 2080-2083.;;Sheridan, G. E. et al., “Detection of mRNA by Reverse Transcription-PCR as an Indicator of Viability in Escherichia coli Cells”, Applied and Environmental Microbiology, vol. 64, No. 4, American Society for Microbiology,, Apr. 1998, 1313-1318.;;Shuber, A. et al., “A Simplified Procedure for Developing Multiplex PCRs”, Genome Research, 5, 1995, 488-493.;;Song, Y. et al., “Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA”, FEMS Microbiology Letters, vol. 187, No. 2, Federation of European Microbiological Societies, Elsevier Science B.V., Netherlands,, 2000, 167-173.;;Tettelin, et al., “Optimized Multiplex PCR: Efficiently Closing a Whole-Genome Shotgun Sequencing Project”, Genomics, vol. 62, 1999, 500-507.;;Tichopad, A et al., “Standardized determination of real-time PCR efficiency from a single reaction set-up”, Nucleic Acids Res., 31, 2003, e122.;;User Bulletin #2, “ABI Prism 7700 Sequence Detection System. Subject: Relative Quantitation of Gene Expression, Datasheet”, Applied Biosystems, (updated Oct. 2001), 1997.;;Wang, et al., “Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome”, Science, 280:, 1998, 1077-1082.;;Waters, L. C. et al., “Microchip Device for Cell Lysis, Multiplex PCR Amplification, and Electrophoretic Sizing”, Analytical Chemistry, vol. 70, No. 1, American Chemical Society, Columbus, US,, 1998, 158-162.;;Wistuba, Ignacio I. et al., “Comparison of Molecular Changes in Lung Cancers in HIV-Positive and HIV-Indeterminate Subjects”, JAMA, vol 279, No. 19, May 20, 1998, pp. 1554-1559.;;Wittwer, C. et al., “Real-Time Multiplex PCR Assays”, Methods, vol. 25,, 2001, 430-442.;;Wittwer, C.T. et al., “The LightCycler™: A Microvolume Multisample Fluorimeter with Rapid Temperature Control”, BioTechniques, vol. 22 (1), Jan. 1997, 176-181.;;WO2001/094634, “PCT International Preliminary Examination Report”, dated Mar. 4, 2004, 8 pages.;;WO2001/094634, “PCT International Search Report”, dated Jan. 23, 2003.;;WO2004/051218, “PCT International Search Report”, dated Dec. 10, 2004.;;WO2004/104214, “PCT International Preliminary Report on Patentability”, dated Mar. 13, 2006.;;WO2004/104214, “PCT International Search Report”, dated Jan. 26, 2006.;;WO2004/104214, “PCT Written Opinion”, dated Mar. 7, 2006.",EXPIRED
26,US,A1,US 2017/0130259 A1,085-942-038-198-028,2017-05-11,2017,US 201615293387 A,2016-10-14,US 201615293387 A;;US 201414302980 A;;US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,METHODS FOR MULTIPLEXING AMPLIFICATION REACTIONS,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLIED BIOSYSTEMS LLC,GERDES JOHN;;BEST ELAINE;;MARMARO JEFFREY M,,https://lens.org/085-942-038-198-028,Patent Application,yes,0,0,17,17,100,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12Q1/68;;G01N33/53;;C12N15/09;;C12P19/34;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;G01N33/566,,0,0,,,,EXPIRED
27,US,A1,US 2019/0078137 A1,066-665-410-047-938,2019-03-14,2019,US 201816137929 A,2018-09-21,US 201816137929 A;;US 201615293387 A;;US 201414302980 A;;US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,METHODS FOR MULTIPLEXING AMPLIFICATION REACTIONS,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,,https://lens.org/066-665-410-047-938,Patent Application,yes,7,0,17,17,100,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12Q1/686;;G01N33/53;;C12N15/09;;C12P19/34;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;C12Q1/6806;;C12Q1/6827;;C12Q1/6844;;C12Q1/689;;G01N33/566,,0,0,,,,DISCONTINUED
28,WO,A3,WO 2004/104214 A3,067-428-978-235-525,2006-03-23,2006,US 2004/0015826 W,2004-05-19,US 44115803 A,2003-05-19,METHODS AND DEVICES FOR MULTIPLEXING AMPLIFICATION REACTIONS,"The present invention provides a two-step multiplex amplification reaction wherein the first step truncates the standard initial multiplex amplification round to 'boost' the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLERA CORP;;GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,,https://lens.org/067-428-978-235-525,Search Report,yes,1,0,17,17,0,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,G01N33/53;;C12N15/09;;C12P19/34;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,0,0,,,,PENDING
29,WO,A2,WO 2004/104214 A2,168-950-706-573-647,2004-12-02,2004,US 2004/0015826 W,2004-05-19,US 44115803 A,2003-05-19,METHODS AND DEVICES FOR MULTIPLEXING AMPLIFICATION REACTIONS,"The present invention provides a two-step multiplex amplification reaction wherein the first step truncates the standard initial multiplex amplification round to 'boost' the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLERA CORP;;GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,,https://lens.org/168-950-706-573-647,Patent Application,yes,0,0,17,17,0,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,G01N33/53;;C12N15/09;;C12P19/34;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,0,0,,,,PENDING
30,US,B2,US 9206475 B2,054-944-968-740-770,2015-12-08,2015,US 201514589864 A,2015-01-05,US 201514589864 A;;US 201414302980 A;;US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,Methods for multiplexing amplification reactions,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLERA CORPORATION (2004-03-31);;APPLIED BIOSYSTEMS INC (2008-06-30);;XTRANA INC (2003-07-31),https://lens.org/054-944-968-740-770,Granted Patent,yes,74,42,17,17,100,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12P19/34;;G01N33/53;;C12N15/09;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,99,37,007-782-541-984-959;;045-081-326-747-615;;070-660-701-185-769;;005-540-691-594-134;;079-074-030-459-68X;;113-237-014-874-941;;014-353-991-909-225;;045-377-687-919-809;;078-302-340-811-20X;;051-671-860-596-375;;001-560-891-833-008;;016-383-594-999-909;;014-051-545-273-403;;004-802-768-681-203;;041-417-339-486-865;;055-980-684-558-947;;043-583-305-054-251;;055-501-408-900-258;;042-810-087-283-347;;070-656-465-248-593;;010-045-471-526-650;;091-616-122-117-431;;054-095-134-696-001;;005-093-091-683-529;;012-315-547-510-664;;080-120-399-411-790;;005-098-521-717-817;;017-515-593-292-125;;008-213-359-148-352;;032-597-682-620-712;;030-415-746-440-014;;068-917-929-803-50X;;017-391-717-403-017;;066-697-166-954-718;;003-784-819-011-670;;138-426-789-339-83X;;032-781-980-714-725,2306085;;10.1128/aem.56.2.307-314.1990;;pmc183336;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;2059028;;10.1128/aem.57.4.1013-1017.1991;;pmc182838;;10.1016/0890-8508(90)90026-v;;2280781;;10.1016/s0890-8508(95)90125-6;;7477021;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;pmc328414;;10.1093/nar/19.13.3749;;1852616;;10.1101/gr.191301;;11544191;;10.1101/gr.3.4.s65;;8173510;;10.1006/mcpr.2002.0433;;12477439;;10794932;;10.1016/s0732-8893(00)00116-4;;10.1006/abio.1998.2771;;9750148;;10.1016/0167-7012(91)90046-s;;10.1101/gr.6.10.986;;8908518;;9298224;;10.2144/97233rr01;;1571150;;11072065;;10.1016/s0167-4781(00)00200-1;;1349899;;pmc265232;;10.1128/jcm.30.5.1098-1104.1992;;10.1093/nar/24.3.538;;pmc145645;;8602371;;8637917;;pmc39840;;10.1073/pnas.93.6.2582;;9863056;;10.2144/98256rr01;;2227421;;10.1016/0378-1119(90)90145-h;;pmc248091;;4914564;;10.1128/jb.103.2.382-386.1970;;pmc84298;;10.1128/jcm.37.2.327-332.1999;;9889212;;11950218;;10.1006/abio.2002.5593;;10.1007/s100380170047;;11501945;;pmc167648;;10.1093/nar/gng073;;12853650;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;10.1073/pnas.88.7.2815;;1672768;;pmc51330;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;12771226;;10.1093/nar/gng061;;pmc156739;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;9546166;;10.1128/aem.64.4.1313-1318.1998;;pmc106147;;10.1101/gr.5.5.488;;8808470;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;10.1006/geno.1999.6048;;10644449;;10.1093/nar/gng122;;14530455;;pmc219490,"U.S. Appl. No. 10/441,158; Office Action mailed Mar. 23, 2005.;;U.S. Appl. No. 10/441,158; Response to Mar. 23, 2005 Office Action filed on May 23, 2005.;;U.S. Appl. No. 10/441,158; Office Action mailed Aug. 17, 2005.;;U.S. Appl. No. 10/441,158; Response to Aug. 17, 2005 Office Action filed on Sep. 14, 2005.;;U.S. Appl. No. 10/441,158; Notice of Allowance mailed Dec. 13, 2005.;;U.S. Appl. No. 10/723,520; Office Action mailed Oct. 30, 2006.;;U.S. Appl. No. 10/723,520; Response to Oct. 30, 2006 Office Action filed on Nov. 29, 2006.;;U.S. Appl. No. 10/723,520; Office Action mailed Jan. 19, 2007.;;U.S. Appl. No. 10/723,520; Response to Jan. 19, 2007 Office Action filed on Jul. 19, 2007.;;U.S. Appl. No. 10/723,520; Office Action mailed Aug. 1, 2007.;;U.S. Appl. No. 10/723,520; Response to Aug. 1, 2007 Office Action filed on Feb. 1, 2008.;;U.S. Appl. No. 10/723,520; Office Action mailed Apr. 29, 2008.;;U.S. Appl. No. 10/723,520; Response to Apr. 29, 2008 Office Action filed on Aug. 29, 2008.;;U.S. Appl. No. 10/723,520; Office Action mailed Nov. 7, 2008.;;U.S. Appl. No. 10/723,520; Response to Nov. 7, 2008 Office Action filed Aug. 7, 2009.;;U.S. Appl. No. 10/723,520; Office Action mailed Oct. 13, 2009.;;U.S. Appl. No. 10/723,520; Response to Oct. 13, 2009 Office Action filed Apr. 13, 2010.;;U.S. Appl. No. 10/723,520; Office Action mailed Jul. 6, 2010.;;U.S. Appl. No. 11/176,795; Office Action mailed Jul. 11, 2007.;;U.S. Appl. No. 11/176,795; Response to Jul. 11, 2007 Office Action filed on Jul. 30, 2007.;;U.S. Appl. No. 11/176,795; Office Action mailed Oct. 12, 2007.;;U.S. Appl. No. 11/176,795; Response to Oct. 12, 2007 Office Action filed on Jan. 14, 2008.;;U.S. Appl. No. 11/176,795, Office Action mailed Apr. 1, 2008.;;U.S. Appl. No. 11/176,795; Response to Apr. 1, 2008 Office Action filed on Jul. 30, 2008.;;U.S. Appl. No. 11/176,795; Office Action mailed Sep. 16, 2008.;;U.S. Appl. No. 11/176,795; Response to Sep. 16, 2008 Office Action filed on Oct. 1, 2008.;;U.S. Appl. No. 11/176,795; Notice of Allowance mailed Dec. 30, 2008.;;CA 2,410,281; Notice of Allowance mailed Aug. 24, 2009.;;EP01939852.8; Office Action mailed Apr. 6, 2006.;;EP01939852.8; Response to Apr. 6, 2006 Office Action filed on Oct. 24, 2006.;;EP01939852.8; Office Action mailed Jun. 2, 2009.;;EP01939852.8; Response to Jun. 2, 2009 Office Action filed on Dec. 14, 2009.;;EP03796461.6, Partial European Search Report mailed Apr. 6, 2006.;;EP03796461.6; Supplementary European Search Report mailed Jun. 30, 2006.;;EP03796461.6; Office Action mailed Oct. 13, 2006.;;EP03796461.6; Response to Oct. 13, 2006 Office Action filed on Feb. 19, 2007.;;EP03796461.6; Office Action mailed Mar. 9, 2007.;;EP03796461.6; Response to Mar. 7, 2007 Office Action filed on Apr. 16, 2007.;;EP03796461.6; Office Action mailed Sep. 9, 2008.;;EP08020322.7; EP search report mailed Jan. 29, 2009.;;EP08020322.7; Office Action mailed Sep. 18, 2009.;;EP08020322.7; Response to Sep. 18, 2009 Office Action filed on Mar. 18, 2010.;;EP09016059.9; Extended European Search Report mailed Apr. 29, 2010.;;EP10162843.2; Extended European Search Report mailed Jun. 20, 2011.;;JP2002-502174; English Translation of Office Action mailed Oct. 9, 2008.;;JP2004-557332 ; Office Action mailed Jun. 4, 2009.;;WO2001/094634; PCT International Search Report mailed Jan. 23, 2003.;;WO2001/094634; PCT International Preliminary Examination Report mailed Mar. 4, 2004.;;WO2004/051218; PCT International Search Report mailed Dec. 10, 2004.;;WO2004/104214; PCT International Search Report mailed Jan. 26, 2006.;;WO2004/104214; PCT Written Opinion mailed Mar. 7, 2006.;;WO2004/104214; PCT International Preliminary Report on Patentability mailed Mar. 13, 2006.;;Assays-By-Design Service[Online], [retrieved on May 13, 2003], .;;Assays-On-Demand, Gene Expression Products [online], [retrieved on May 13, 2003], .;;Assays-On-Demand, SNP Genotyping Products [online], [retrieved on May 13, 20013], .;;Bej. A K. et al., ""Detection of Coliform Bacteria in Water by Polymerase Chain Reaction and Gene Probes"", Applied and Environmental Microbiology, vol. 56, No. 2, Feb. 1990; pp. 307-314.;;Bej. A. K. et al., ""Detection of Coliform Bacteria and Escherichia coli by Multiplex Polymerase Chain Reaction: Comparison With Defined Substrate and Plating Methods for Water Quality Monitoring"", Applied and Environmental Microbiology, vol. 57, No. 8, Aug. 1991; pp. 2429-2432.;;Bej, A. K. et al., ""Detection of Escherichia coli and Shigella spp. In Water by Using the Polymerase Chain Reaction and Gene Probes for uid"", Applied and Environmental Microbiology, vol. 57, No. 4, Apr. 1991; pp. 1013-1017.;;Bej, A. K. et al., ""Multiplex PCR Amplification and Immobilized Capture Probes for Detection of Bacterial Pathogens and Indicators in Water"", Molecular and Cellular Probes, vol. 4, Issue 5, Academic Press, London, GB, Oct. 1990; pp. 353-365.;;Borg, K. L. et al., ""Detection of cytomegalovirus using 'boosted'nested PCR"", Molecular and Cellular Probes, vol. 9, No. 4, England, Aug. 1995; pp. 251-257.;;Chamberlain, Jefferey et al., ""Deletion Screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification"", Nucl Acids Res., vol. 16, No. 23, 1998, pp. 11141-11155.;;D'Aquila, Richard T. et al., ""Maximizing sensitivity and specificity of PCR by pre-amplification heating"", Nucleic Acids Research, vol. 19, No. 13, Oxford University Press, Jul. 11, 1991; p. 3749.;;Dolganov, G. , ""A Novel Method of Gene Transcript Profiling in Airway Biopsy Homogenates reveals Increased Expression of Na+-K+-Cl- Cotransporter (NKCC1) in Asthmatic Subjects"", Genome Research, vol. 11, 2001; pp. 1473-1483.;;Edwards, M. C. et al., ""Multiplex PCR: Advantages, Development, and Applications"", PCR Methods and Applications, vol. 3, No. 4, Cold Spring Harbor Laboratory Press, US, Feb. 1994; pp. S65-S75.;;Exner, M. et al., ""Sensitivity of multiplex real-time PCR reactions, using the LightCycler and the ABI PRISM 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase"", Mol. Cell Probes, vol. 16, Oct. 2002; pp. 351-357.;;Gonin, P. et al., ""Performance of a multiplex PCR for the determination of Haemophilub influenzae capsular types in the clinical microbiology laboratory"", Diagnostic Microbiology and Infectious Disease, vol. 37, No. 1, US, May 2000; pp. 1-4.;;Grace, M. et al., ""Degradable dUMP Outer Primers in Merged Tandem (M/T)-Nested PCR: Low- and Single-Copy DNA target Amplification"", vol. 263, Article No. AB982771, 1998, 85-92.;;Graves, L. M., et al., ""Universal Bacterial DNA Isolation Procedure"", Diagnostic Molecular Microbiology: Principles and Application, American Society for Microbiology, Washington, D.C., 1993; pp. 617-621.;;Green, D et al., ""Detection of faecal pollution in water by an Escherichia coll uidA gene probe"", Journal of Microbiological Methods, vol. 13, Issue 3, Jul. 1991; pp. 207-214.;;Heid, et al., ""Real Time Quantitative PCR"", Genome Research, vol. 6, No. 10, Cold Spring Harbor Laboratory Press, Woodbury, NY, Oct. 1996; pp. 986-994.;;Henegariu, et al., ""Multiplex PCR: Critical Parameters and Step-by-Step Protocol"", BioTechniques, vol. 23, No. 3, Sep. 1997; pp. 504-511.;;Jayaraman, et al., ""A PCR-mediated Gene Synthesis strategy involving assamply of oligonucleotides resenting only one of the strands"", BioTechniques, vol. 12, No. 3, 1992; pp. 392-398.;;Kainz, P., et al. ""The PCR plateau phase-towards an understanding of its limitations"", Biochimica et Bio physica Acta, vol. 1494, 2000; pp. 23-27.;;Kaltenboeck, ""Two-step Polymerase Chain Reactions and Restriction Endonuclease Analyses Detect and Differentiate ompA DNA of Chlamydia spp"", Journal of Clinical Microbiology, vol. 30, No. 5, American Society for Microbiology, May 1992; pp. 1098-1104.;;Kato, K., ""Laboratory Manual PCR-Study and Application to Clinical Diagnosis"", First Edition Takara Shuzo Co. Ltd, 1996; pp. 73-81.;;Li, D. et al., ""Multiplex co-amplification of 24 retinoblastoma gene exons after pre-amplification by long-distance PCR"", Nucleic Acids Research, vol. 24, No. 3, 1996; pp. 538-539.;;Lin, Z et al., ""Multiplex Genotype Determination at a Large Number of Gene Loci"", Proceedings of the National Academy of Sciences of the United States, vol. 93, No. 6, Genetics, USA, Mar. 1996: pp. 2582-2587.;;Liu, Q., ""Subcycling-PCR for Multiplex Long-Distance Amplification of Regions with High and Low GC Content: Application to the Inversion Hotspot in the Factor VIII Gene"", BioTechniques, vol. 25, No. 6, Dec. 1998; pp. 1022-1028.;;Longo, M. et al., ""Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions"", Gene, vol. 93, 1990; pp. 125-128.;;Lupo, M et al., ""Gene Controlling L-Glutamic Acid Decarboxylase Synthesis in Escherichia coli K-12"", Journal of Bacteriology, vol. 103, No. 2, American Society for Microbiology, USA, Aug. 1970; pp. 382-386.;;Martell, M et al., ""High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA"", Journal of Clinical Microbiology, vol. 37, No. 2, American Society for Microbiology, Feb. 1999; pp. 327-332.;;Min, J. et al., ""Highly Sensitive and Specific Detection of Viable Escherichia coll in Drinking Water"", Analytical Biochemistry, vol. 303, Issue 2, Elsevier Science, USA, Apr. 15, 2002; pp. 186-193.;;Ohnishi, et al., ""A high-throughput SNP typing system for genome-wide association studies"", J. Hum. Genet., vol. 46, 2001; pp. 471-477.;;Peirson, S. N., ""Experimental validation of novel and conventional approaches to quantitive real-time PCR data analysis"", Nucleic Acids Res., vol. 31, No. 14 e73, 2003; pp. 1-7.;;Picard, C. et al., ""detection and Enumeration of Bacteria in Soil by Direct DNA Extraction and Polymerase Chain Reaction"", Applied and Environmental Microbiology, vol. 58, No. 9, Sep. 1992; pp. 2717-2722.;;Rice, et al., ""Detection of Escherichia coli in Water Using a Colorimetric Gene Probe Assay"", Journal of Environmental Science and Health, vol. 30, Issue 5, 1995; pp. 1059-1067.;;Roche Diagnostics GMBH, ""RealTime ready cDNA Pre-Amp Master"", Roche Applied Science Catalog No. 06 720 455 001, Version 01, Sep. 2012; 16 pages.;;Ruano, G. et al., ""Coupled amplification and sequencing of genomic DNA"", Proceedings of the National Academy of Sciences of the United States, vol. 86, 1991; pp. 2815-2519.;;Ruano, G. et al., ""Biphasic Amplification of Very Dilute DNA Samples Via 'Booster'PCR"", Nucleic Acids Research, vol. 17, No. 13, Oxford University Press, Surrey, GB, Jul. 11, 1989; p. 5047.;;Ruano, G. et al., ""Booster PCR: A Biphasic Paradigm for Amplification of a Few Molecules of Target"", Amplifications: A Forum for PCR Users, Perkin-Elmer Co., Norwalk, CT, US, Sep. 1989; pp. 12-13.;;Rudi, K et al., ""A Novel MUltiplex Quantitive DNA Array Based PCR (MQDAPCR)"", Nucleic Acids Research, 2003, vol. 31, No. 11 e62, Jan. 31, 2008, 1-8.;;Saiki, R.K., ""The Design and Optimization of the PCR"", PCR Technology, Principles and Applications for DNA Amplification, Stockton Press, New York, US, Jan. 1989; pp. 7-16.;;Saulnier, P. et al., ""Detection of Genes in Feces by Booster Polymerase Chain Reaction"", Journal of Clinical Microbiology, vol. 30, No. 8, American Society for Microbiology, Aug. 1992; pp. 2060-2083.;;Sheridan, G. E. et al., ""Detection of mRNA by Reverse Transcription-PCR as an Indicator of Viability in Escherichia coli Cells"", Applied and Environmental Microbiology, vol. 64, No. 4, American Society for Microbiology, Apr. 1998; pp. 1313-1318.;;Shuber, A. et al., ""A Simplified Procedure for Developing Multiplex PCRs"", Genome Research, vol. 5, 1995; pp. 488-493.;;Song, Y. et al., ""Rapid identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA"", FEMS Microbiology Letters, vol 167, No. 2, Federation of European Microbiological Societies, Elsevier Science B.V., Netherlands, 2000; pp. 167-173.;;Tettelin, et al., ""Optimized Multiplex PCR: Efficiently Closing a Whole-Genome Shotgun Sequencing Project"", Genomics, vol. 62, 1999; pp. 500-507.;;Tichopad, A. et al., ""Standardized determination of real-time PCR effieciency from a single reaction set-up"", Nucleic Acids Res., vol. 31 e122, 2003; pp. 1-6.;;User Bulletin #2:, ""ABI Prism 7700 Sequence Detection System. Subject: Relative Quantitation of Gene Expression, Datasheet"", Applied Biosystems, (updated Oct. 2001), 1997.",EXPIRED
31,US,A1,US 2015/0125869 A1,043-452-198-114-334,2015-05-07,2015,US 201514589864 A,2015-01-05,US 201514589864 A;;US 201414302980 A;;US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,METHODS FOR MULTIPLEXING AMPLIFICATION REACTIONS,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLERA CORPORATION (2004-03-31);;APPLIED BIOSYSTEMS INC (2008-06-30);;XTRANA INC (2003-07-31),https://lens.org/043-452-198-114-334,Patent Application,yes,0,5,17,17,100,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12Q1/68;;G01N33/53;;C12N15/09;;C12P19/34;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;G01N33/566,435/6.12,0,0,,,,EXPIRED
32,US,B2,US 9481907 B2,099-839-315-154-203,2016-11-01,2016,US 201414302980 A,2014-06-12,US 201414302980 A;;US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,Methods for multiplexing amplification reactions,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLERA CORPORATION (2004-03-31);;APPLIED BIOSYSTEMS INC (2008-06-30);;XTRANA INC (2003-07-31),https://lens.org/099-839-315-154-203,Granted Patent,yes,80,0,17,17,100,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12P19/34;;G01N33/53;;C12N15/09;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,,99,37,007-782-541-984-959;;045-081-326-747-615;;070-660-701-185-769;;005-540-691-594-134;;079-074-030-459-68X;;113-237-014-874-941;;014-353-991-909-225;;045-377-687-919-809;;078-302-340-811-20X;;051-671-860-596-375;;001-560-891-833-008;;016-383-594-999-909;;014-051-545-273-403;;004-802-768-681-203;;041-417-339-486-865;;055-980-684-558-947;;043-583-305-054-251;;055-501-408-900-258;;042-810-087-283-347;;070-656-465-248-593;;010-045-471-526-650;;091-616-122-117-431;;054-095-134-696-001;;005-093-091-683-529;;012-315-547-510-664;;080-120-399-411-790;;005-098-521-717-817;;017-515-593-292-125;;008-213-359-148-352;;032-597-682-620-712;;030-415-746-440-014;;068-917-929-803-50X;;017-391-717-403-017;;066-697-166-954-718;;003-784-819-011-670;;138-426-789-339-83X;;032-781-980-714-725,2306085;;10.1128/aem.56.2.307-314.1990;;pmc183336;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;2059028;;10.1128/aem.57.4.1013-1017.1991;;pmc182838;;10.1016/0890-8508(90)90026-v;;2280781;;10.1016/s0890-8508(95)90125-6;;7477021;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;pmc328414;;10.1093/nar/19.13.3749;;1852616;;10.1101/gr.191301;;11544191;;10.1101/gr.3.4.s65;;8173510;;10.1006/mcpr.2002.0433;;12477439;;10794932;;10.1016/s0732-8893(00)00116-4;;10.1006/abio.1998.2771;;9750148;;10.1016/0167-7012(91)90046-s;;10.1101/gr.6.10.986;;8908518;;9298224;;10.2144/97233rr01;;1571150;;11072065;;10.1016/s0167-4781(00)00200-1;;1349899;;pmc265232;;10.1128/jcm.30.5.1098-1104.1992;;10.1093/nar/24.3.538;;pmc145645;;8602371;;8637917;;pmc39840;;10.1073/pnas.93.6.2582;;9863056;;10.2144/98256rr01;;2227421;;10.1016/0378-1119(90)90145-h;;pmc248091;;4914564;;10.1128/jb.103.2.382-386.1970;;pmc84298;;10.1128/jcm.37.2.327-332.1999;;9889212;;11950218;;10.1006/abio.2002.5593;;10.1007/s100380170047;;11501945;;pmc167648;;10.1093/nar/gng073;;12853650;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;10.1073/pnas.88.7.2815;;1672768;;pmc51330;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;12771226;;10.1093/nar/gng061;;pmc156739;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;9546166;;10.1128/aem.64.4.1313-1318.1998;;pmc106147;;10.1101/gr.5.5.488;;8808470;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8;;10.1006/geno.1999.6048;;10644449;;10.1093/nar/gng122;;14530455;;pmc219490,"EP14164752.9, Extended European Search Report mailed on Oct. 12, 2015, 12 Pages.;;U.S. Appl. No. 10/441,158; Office Action mailed Mar. 23, 2005.;;U.S. Appl. No. 10/441,158; Response to Mar. 23, 2005 Office Action filed on May 23, 2005.;;U.S. Appl. No. 10/441,158; Office Action mailed Aug. 17, 2005.;;U.S. Appl. No. 10/441,158; Response to Aug. 17, 2005 Office Action filed on Sep. 14, 2005.;;U.S. Appl. No. 10/441,158; Notice of Allowance mailed Dec. 13, 2005.;;U.S. Appl. No. 10/723,520; Office Action mailed Oct. 30, 2006.;;U.S. Appl. No. 10/723,520; Response to Oct. 30, 2006 Office Action filed on Nov. 29, 2006.;;U.S. Appl. No. 10/723,520; Office Action mailed Jan. 19, 2007.;;U.S. Appl. No. 10/723,520; Response to Jan. 19, 2007 Office Action filed on Jul. 19, 2007.;;U.S. Appl. No. 10/723,520; Office Action mailed Aug. 1, 2007.;;U.S. Appl. No. 10/723,520; Response to Aug. 1, 2007 Office Action filed on Feb. 1, 2008.;;U.S. Appl. No. 10/723,520; Office Action mailed Apr. 29, 2008.;;U.S. Appl. No. 10/723,520; Response to Apr. 29, 2008 Office Action filed on Aug. 29, 2008.;;U.S. Appl. No. 10/723,520; Office Action mailed Nov. 7, 2008.;;U.S. Appl. No. 10/723,520; Response to Nov. 7, 2008 Office Action filed Aug. 7, 2009.;;U.S. Appl. No. 10/723,520; Office Action mailed Oct. 13, 2009.;;U.S. Appl. No. 10/723,520; Response to Oct. 13, 2009 Office Action filed Apr. 13, 2010.;;U.S. Appl. No. 10/723,520; Office Action mailed Jul. 6, 2010.;;U.S. Appl. No. 11/176,795; Office Action mailed Jul. 11, 2007.;;U.S. Appl. No. 11/176,795; Response to Jul. 11, 2007 Office Action filed on Jul. 30, 2007.;;U.S. Appl. No. 11/176,795; Office Action mailed Oct. 12, 2007.;;U.S. Appl. No. 11/176,795; Response to Oct. 12, 2007 Office Action filed on Jan. 14, 2008.;;U.S. Appl. No. 11/176,795; Office Action mailed Apr. 1, 2008.;;U.S. Appl. No. 11/176,795; Response to Apr. 1, 2008 Office Action filed on Jul. 30, 2008.;;U.S. Appl. No. 11/176,795; Office Action mailed Sep. 16, 2008.;;U.S. Appl. No. 11/176,795; Response to Sep. 16, 2008 Office Action filed on Oct. 1, 2008.;;U.S. Appl. No. 11/176,795; Notice of Allowance mailed Dec. 30, 2008.;;CA 2,410,281; Notice of Allowance mailed Aug. 24, 2009.;;EP01939852.8; Office Action mailed Apr. 6, 2006.;;EP01939852.8; Response to Apr. 6, 2006 Office Action filed on Oct. 24, 2006.;;EP01939852.8; Office Action mailed Jun. 2, 2009.;;EP01939852.8; Response to Jun. 2, 2009 Office Action filed on Dec. 14, 2009.;;EP03796461.6; Partial European Search Report mailed Apr. 6, 2006.;;EP03796461.6; Supplementary European Search Report mailed Jun. 30, 2006.;;EP03796461.6; Office Action mailed Oct. 13, 2006.;;EP03796461.6; Response to Oct. 13, 2006 Office Action filed on Feb. 19, 2007.;;EP03796461.6; Office Action mailed Mar. 9, 2007.;;EP03796461.6; Response to Mar. 7, 2007 Office Action filed on Apr. 16, 2007.;;EP03796461.6; Office Action mailed Sep. 9, 2008.;;EP08020322.7; EP search report mailed Jan. 29, 2009.;;EP08020322.7; Office Action mailed Sep. 18, 2009.;;EP08020322.7; Response to Sep. 18, 2009 Office Action filed on Mar. 18, 2010.;;EP09016059.9; Extended European Search Report mailed Apr. 29, 2010.;;EP10182843.2; Extended European Search Report mailed Jun. 20, 2011.;;JP2002-502174; English Translation of Office Action mailed Oct. 9, 2008.;;JP2004-557332 ; Office Action mailed Jun. 4, 2009.;;WO2001/094634; PCT International Search Report mailed Jan. 23, 2003.;;WO2001/094634; PCT International Preliminary Examination Report mailed Mar. 4, 2004.;;WO2004/051218; PCT International Search Report mailed Dec. 10, 2004.;;WO2004/104214; PCT International Search Report mailed Jan. 26, 2006.;;WO2004/104214; PCT Written Opinion mailed Mar. 7, 2006.;;WO2004/104214; PCT International Preliminary Report on Patentability mailed Mar. 13, 2006.;;Assays-By-Design Service[Online], [retrieved on May 13, 2003], .;;Assays-On-Demand, Gene Expression Products [online], [retrieved on May 13, 2003], .;;Assays-On-Demand, SNP Genotyping Products [online], [retrieved on May 13, 2003], .;;Bej, A K. et al., ""Detection of Coliform Bacteria in Water by Polymerase Chain Reaction and Gene Probes"", Applied and Environmental Microbiology, vol. 56, No. 2, Feb. 1990; pp. 307-314.;;Bej, A. K. et al., ""Detection of Coliform Bacteria and Escherichia coli by Multiplex Polymerase Chain Reaction: Comparison With Defined Substrate and Planting Methods for Water Quality Monitoring"", Applied and Environmental Microbiology, vol. 57, No. 8, Aug. 1991; pp. 2429-2432.;;Bej, A. K. et al., ""Detection of Escherichia coli and Shigella spp. In Water by Using the Polymerase Chain Reaction and Gene Probes for uid"" Applied and Environmental Microbiology, vol. 57, No. 4, Apr. 1991; pp. 1013-1017.;;Bej, A. K. et al., ""Multiplex PCR Amplification and Immobilized Capture Probes for Detection of Bacterial Pathogenes and Indicators in Water"", Molecular and Cellular Probes, vol. 4, Issue 5 Academic Press, London, GB, Oct. 1990; pp. 353-365.;;Borg, K. L. et al., ""Detection of cytomegalovirus using 'boosted' nested PCR."", Molecular and Cellular Probes, vol. 9, No. 4, England, Aug. 1995; pp. 251-257.;;Chamberlain, Jeffrey et al., ""Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification"", Nucl. Acids Res., vol. 16, No. 23, 1988 ; pp. 11141-11155.;;D'Aquila, Richard T. et al., ""Maximizing sensitivity and specificity of PCR by pre-amplification heating"", Nucleic Acids Research, vol. 19, No. 13, Oxford University Press, Jul. 1991; p. 3749.;;Dolganov, G. , ""A Novel Method of Gene Transcript Profiling in Airway Biopsy Homogenates Reveals Increased Expression of a Na+ -K+-Cl- Cotransporter (NKCC1) in Asthmatic Subjects"", Genome Research, vol. 11, 2001; pp. 1473-1483.;;Edwards, M. C. et al., ""Multiplex PCR: Advantages, Development, and Applications"" PCR Methods and Applications, vol. 3, No. 4, Cold Spring Harbor Laboratory Press, US, Feb. 1994; pp. S65-S75.;;Exner, M. et al., ""Sensitivity of multiplex real-time PCR reactions, using the LightCycler and the ABI PRISM 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase"", Mol. Cell Probes, vol. 16, Oct. 2002; pp. 351-357.;;Gonin, P. et al., ""Performance of a multiplex PCR for the determination of Haemophilus influenzae capsular types in the clinical microbiology laboratory"", Diagnostic Microbiology and Infectious Disease, vol. 37, No. 1, US May 2000; pp. 1-4.;;Grace, M. et al., ""Degradable dUMP Outer Primers in Merged Tandem (M/T)-Nested PCR: Low- and Sincle-Copy DNA Target Amplification"", vol. 263, Article No. AB982771, 1998, 85-92.;;Graves, L. M. et al., ""Universal Bacterial DNA Isolation Procedure"", Diagnostic Molecular Microbiology; Principles and Applications, Washington, D.C., 1993; pp. 617-621.;;Green, D et al., ""Detection of faecal pollution in water by an Escherichia coli uidA gene probe"", Journal of Microbiological Methods, vol. 13, Issue 3, Jul. 1991; pp. 207-214.;;Heid, et al., ""Real Time Quantitative PCR"", Genome Research, vol. 6, No. 10, Cold Spring Harbor Laboratory Press, Woodbury, NY, Oct. 1996; pp. 986-994.;;Henegariu, et al., ""Multiplex PCR: Critical Parameters and Step-by-Step Protocol"", BioTechniques, vol. 23, No. 3, Sep. 1997; pp. 504-511.;;Jayaraman, et al., ""A PCR-mediated Gene Synthesis strategy involving assamply of oligonucleotides resenting only one of the strands"", BioTechniques, vol. 12, No. 3, 1992; pp. 392-398.;;Kainz, P., et al. ""The PCR plateau phase-towards an understanding of its limitations"", Biochimica et Biophysica Acta, vol. 1494, 2000; pp. 23-27.;;Kaltenboeck, ""Two-Step Polymerase Chain Reactions and Restriction Endonuclease Analyses Detect and Differentiate ompA DNA of Chlamydia spp"", Journal of Clinical Microbiology, vol. 30, No. 5, American Society for Microbiology, May 1992; pp. 1098-1104.;;Kato, K., ""Laboratory Manual PCR-Study and Application to Clinical Diagnosis"", First Edition Takara Shuzo Co. Ltd, 1996; pp. 73-81.;;Li, D. et al., ""Multiplex co-amplification of 24 retinoblastoma gene exons after pre-amplification by long-distance PCR"", Nucleic Acids Research, vol. 24, No. 3, 1996; pp. 538-539.;;Lin, Z et al., ""Multiplex Genotype Determination at a Large Number of Gene Loci"", Proceedings of the National Academy of Sciences of the United States, vol. 93, No. 6, Genetics, USA, Mar. 1996; pp. 2582-2587.;;Liu, Q., ""Subcycling-PCR for Multiplex Long-Distance Amplification of Regions with High and Low GC Content: Application to the Inversion Hotspot in the Factor VIII Gene"", BioTechniques, vol. 25, No. 6, Dec. 1998; pp. 1022-1028.;;Longo, M. et al., ""Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions"", Gene, vol. 93, 1990; 125-128.;;Lupo, M et al., ""Gene Controlling L-Glutamic Acid Decarboxylase Synthesis in Escherichia coliK-12"", Journal of Bacteriology, vol. 103, No. 2, American Society for Microbiology, USA, Aug. 1970; pp. 382-386.;;Martell, M et al., ""High-Throughput Real-Time reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA"", Journal of Clinical Microbiology, vol. 37, No. 2, American Society for microbiology, Feb. 1999; pp. 327-332.;;Min, J. et al., ""Highly Sensitive and Specific Detection of Viable Escherichia coli in Drinking"", Analytical Biochemisrty, vol. 303, Issue 2, Elsevier Science, USA, Apr. 15, 2002; pp. 186-193.;;Ohnishi, et al., ""A high-throughput SNP typing system for genome-wide association studies"", J. Hum. Genet., vol. 46, 2001; pp. 471-477.;;Peirson, S. N., ""Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis"", Nucleic Acids Res., vol. 31, No. 14 e73, 2003; pp. 1-7.;;Picard, C. et al., ""Detection and Enumeration of Bacteria in Soil by Direct DNA Extraction and Polymerase Chain Reaction"", Applied and Environmental Microbiology, vol. 58, No. 9, Sep. 1992; pp. 2717-2722.;;Rice, et al., ""Detection of Escherichia coli in Water Using a Colorimetric Gene Probe Assay"", Journal of Environmental Science and Health, vol. 30, Issue 5, 1995; pp. 1059-1067.;;Roche Giagnostics GMBH, ""RealTime ready cDNA Pre-Amp Master"", Roche Applied Science Catalog No. 06 720 455 001, Version 01 Sep. 2012; 16 pages.;;Ruano, G. et al., ""Coupled amplification and sequencing of genomic DNA"", Proceedings of the National Academy of Sciences of the United States of America, vol. 88, 1991; pp. 2815-2519.;;Ruano, G. et al., ""Biphasic Amplification of Very Dilute DNA Samples Via 'Booster' PCR"", Nucleic Acids Research, vol. 17, No. 13, Oxford University Press, Surrey, GB, Jul. 11, 1989; p. 5407.;;Ruano, G. et al., ""Booster PCR: A Biphasic Paradigm for Amplification of a Few Molecules of Target"", Amplifications: A Forum for PCR Users, Perkin-Elmer Co., Norwalk, CT, US, Sep. 1989; pp. 12-13.;;Rudi, K et al., ""A Novel MUItiplex Quantitative DNA Array Based PCR (MQDAPCR)"", Nucleic Acids Research, 2003, vol. 31, No. 11 e62, Jan. 31, 2008, 1-8.;;Saiki, R.K., ""The Design and Optimization of The PCR"", PCR Technology. Principles and Applications for DNA Amplification, Stockton Press, New York, US, Jan. 1989; pp. 7-16.;;Saulnier, P. et al., ""Detection of Genes in Feces by Booster Polymerase Chain Reaction"", Journal of Clinical Microbiology, vol. 30, No. 8, American Society for Microbiolgy, Aug. 1992; pp. 2080-2083.;;Sheridan, G. E. et al., ""Detection of mRNA by Reverse Transcription-PCR as an Indicator of Viability in Escherichia coliCells"", Applied and Environmental Microbiology, vol. 64, No. 4, American Society for Microbiology, Apr. 1998; pp. 1313-1318.;;Shuber, A. et al., ""A Simplified Procedure for Developing Multiplex PCRs"", Genome Research, vol. 5, 1995; pp. 488-493.;;Song, Y. et al., ""Rapid identification 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA"", FEMS Microbiology Letters, vol. 187, No. 2, Federation of European Microbiological Societies, Elsevier Science B.V., Netherlands, 2000; pp. 167-173.;;Tettelin, et al., ""Optimized Multiplex PCR: Efficiently Closing a Whole-Genome Shotgun Sequencing Project"", Genomics, vol. 62, 1999; pp. 500-507.;;Tichopad, A. et al., ""Standardized determination of real-time PCR efficiency from a single reaction set-up"", Nucleic Acids Res., vol. 31 e122, 2003; pp. 1-6.",EXPIRED
33,US,A1,US 2014/0329247 A1,193-208-240-995-812,2014-11-06,2014,US 201414302980 A,2014-06-12,US 201414302980 A;;US 201213619436 A;;US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,METHODS FOR MULTIPLEXING AMPLIFICATION REACTIONS,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;BEST ELAINE;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLERA CORPORATION (2004-03-31);;APPLIED BIOSYSTEMS INC (2008-06-30);;XTRANA INC (2003-07-31),https://lens.org/193-208-240-995-812,Patent Application,yes,1,0,17,17,100,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12Q1/68;;G01N33/53;;C12N15/09;;C12P19/34;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;G01N33/566,435/6.12,0,0,,,,EXPIRED
34,CA,A1,CA 2458664 A1,171-505-035-520-247,2003-03-13,2003,CA 2458664 A,2002-08-16,US 94460401 A;;US 0226108 W,2001-08-31,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for tightly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrices exhibiting sufficient hydrophilicity a nd electropositivity to tightly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) captu re from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bou nd nucleic acid may be used, for example, in repeated analyses to confirm resul ts or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",XTRANA INC,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A;;IVES JEFFREY T,,https://lens.org/171-505-035-520-247,Patent Application,no,0,0,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,,0,0,,,,DISCONTINUED
35,EP,A4,EP 1432818 A4,029-266-820-797-694,2007-05-30,2007,EP 02757163 A,2002-08-16,US 0226108 W;;US 94460401 A,2001-08-31,NUCLEIC ACID ARCHIVING,,APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLERA CORPORATION (2004-08-25),https://lens.org/029-266-820-797-694,Search Report,no,5,0,12,12,0,C07B2200/11;;C12N15/1006;;C12Q1/6806;;C12Q1/6834;;C12Q1/6837;;C12Q1/6848;;C12Q1/6806;;C12N15/1006;;C12Q1/6834;;C12Q1/6848;;C07B2200/11;;C12Q1/6837,C07H21/02;;C07H21/04;;G01N33/53;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,,1,0,,,See also references of WO 03020981A1,DISCONTINUED
36,EP,A1,EP 1432818 A1,023-506-316-700-648,2004-06-30,2004,EP 02757163 A,2002-08-16,US 0226108 W;;US 94460401 A,2001-08-31,NUCLEIC ACID ARCHIVING,,XTRANA INC,GERDES JOHN C;;MARMARO JEFFREY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLERA CORPORATION (2004-08-25),https://lens.org/023-506-316-700-648,Patent Application,yes,0,35,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,C12N15/10;;G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,,0,0,,,,DISCONTINUED
37,WO,A1,WO 2003/020981 A1,038-320-274-999-133,2003-03-13,2003,US 0226108 W,2002-08-16,US 94460401 A,2001-08-31,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for tightly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrices exhibiting sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",XTRANA INC,GERDES JOHN C;;MARMARO JEFFREY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,,https://lens.org/038-320-274-999-133,Patent Application,yes,2,0,12,12,0,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,,5,4,046-147-446-740-851;;161-984-098-819-367;;060-762-936-275-157;;040-216-302-327-193,8273146;;10.1016/0168-9525(93)90024-c;;3896567;;10.1093/clinchem/31.9.1438;;10.1139/o71-090;;4328119;;10.1016/b978-0-12-372180-8.50019-6,"NEHLS ET AL.: ""S-300 gel matrix irreversibly binds single-stranded nucleic acids"", TRENDS IN GENETICS, vol. 9, no. 10, October 1993 (1993-10-01), pages 336 - 337, XP002959605;;POLSKY-CYNKIN ET AL.: ""Use of DNA immobilized on plastic and agarose supports to detect DNA by sandwich hybridization"", CLINICAL CHEMISTRY, vol. 31, no. 9, 1985, pages 1438 - 1443, XP000574712;;HUDSON J.: ""The fixation and retention of viral and mammalian deoxyribonucleic acids on nitrocellulose filters"", CANADIAN JOURNAL OF BIOCHEMISTRY, vol. 49, 1971, pages 631 - 636, XP002959281;;HELMUTH R.: ""Nonisotropic detection of PCR products. PCR protocols: a guide to methods and applications"", ACADEMIC PRESS, INC., 1990, pages 119 - 128, XP002959282;;See also references of EP 1432818A4",PENDING
38,AU,B2,AU 745126 B2,178-096-488-944-886,2002-03-14,2002,AU 1998/071271 A,1998-04-16,US 4199997 P;;US 9807707 W,1997-04-16,Nucleic acid archiving,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,,https://lens.org/178-096-488-944-886,Granted Patent,no,0,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
39,US,B1,US 6291166 B1,196-531-535-836-893,2001-09-18,2001,US 6175798 A,1998-04-16,US 6175798 A;;US 4199997 P,1997-04-16,Nucleic acid archiving,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",XTRANA INC,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2000-01-31);;IMMUNOLOGICAL ASSOCIATES OF DENVER (1999-03-30),https://lens.org/196-531-535-836-893,Granted Patent,yes,8,110,14,14,10,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;G01N33/50;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,435/6;;435/91.2;;536/23.1;;536/24.3;;935/76;;935/77;;935/78,6,4,046-147-446-740-851;;161-984-098-819-367;;060-762-936-275-157;;062-547-084-865-157,8273146;;10.1016/0168-9525(93)90024-c;;3896567;;10.1093/clinchem/31.9.1438;;10.1139/o71-090;;4328119;;10.1093/nar/18.10.3093;;pmc330877;;2349127,"Nehls et al., Trends oin Genetics 9 (10) : 336-337 (1993).;;Helmuth R., in PCR Protocols: A Guide to Methods and Applications. 1990. Eds. Innis et al., Academic Press, Inc., SanDiego CA. pp. 119-128.*;;Davis et al. (Eds.) Basic Methods in Molecular Biology. 1986. Elsevier Science Publishing Co., Inc. New York, New York, pp. 42-78 and 130-149.*;;Polsky-Cynkin et al., Clincal Chemistry 31(9) : 1438-1443 (1985).*;;Hudson J., Candian Journal of Biochemistry 49 : 631-636(1971).*;;Reed et al., Nucleic Acids Research 18(10) : 3093 (1990).*",EXPIRED
40,US,B2,US 8399396 B2,075-055-937-482-029,2013-03-19,2013,US 31757408 A,2008-12-23,US 31757408 A;;US 1026008 P,2008-01-07,Tiron-containing detergents having acceptable color,"Detergent compositions containing catechols, such as Tiron (1,2-dihydroxybenzene-3,5-disulfonic acid), which do not have or do not develop the reddish color associated with the catechol/ferric iron chelate are disclosed. Methods for reducing the intensity of red color in a Tiron (1,2-dihydroxybenzene-3,5-disulfonic acid) containing detergent composition are also disclosed.",GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON;;PROCTER & GAMBLE,GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,PROCTER & GAMBLE COMPANY THE (2008-01-10),https://lens.org/075-055-937-482-029,Granted Patent,yes,18,4,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D1/12;;C11D3/30,510/498;;510/276;;510/300;;510/345;;510/392;;510/480,1,0,,,"PCT International Search Report, dated Apr. 1, 2009, 15 pages.",INACTIVE
41,CA,A1,CA 2709703 A1,122-397-174-205-869,2009-07-16,2009,CA 2709703 A,2008-12-17,US 1026008 P;;IB 2008055398 W,2008-01-07,DETERGENTS HAVING ACCEPTABLE COLOR,"Detergent compositions containing tiron (1, 2-diydroxybenzene-3, 5- disulfonic acid), which do not have or do not develop the reddish color associated with the tiron/ferric iron chelate are disclosed. Methods for reducing the intensity of red color in a tiron containing detergent composition are also disclosed.",PROCTER & GAMBLE,GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,,https://lens.org/122-397-174-205-869,Patent Application,no,0,0,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D3/34;;C11D3/33;;C11D3/36;;C11D7/32;;C11D7/34;;C11D7/36,,0,0,,,,DISCONTINUED
42,US,A,US 3894963 A,185-499-189-253-559,1975-07-15,1975,US 32410573 A,1973-01-16,US 32410573 A;;US 14200371 A,1971-05-10,High surface area catalyst bodies,"High surface area alumina bodies for use as catalysts, catalyst carriers, and sorbents are made by controlled mixing of fine particle size platy boehmite alumina aggregates with a monobasic acid to produce non-pasty free-flowing particulate mass of aggregates of boehmite. This mass can then be formed by pressure into selected shapes such as rings, saddles, cylinders, solid, or hollow, or pellets, dried and fired to produce bodies of boehmite, gamma alumina, delta alumina, theta alumina or alpha alumina ranging in surface area of from 10 square meters per gram to greater than 300 square meters per gram. Catalytic metal can be included in the bodies by impregnation, before or after firing, or can be incorporated by inclusion in the aqueous acid treating solution.",NORTON CO,GERDES WILLIAM H;;KIOVSKY JOSEPH R;;MEACHAM JEFFREY W,,https://lens.org/185-499-189-253-559,Granted Patent,no,3,37,1,7,0,B01J20/08;;B01J23/72;;B01J23/74;;B01J23/755;;B01J23/86;;B01J37/0009;;C04B35/10;;B01J35/50;;B01J23/755;;B01J23/72;;B01J37/0009;;C04B35/10;;B01J23/74;;B01J23/86;;B01J20/08;;B01J35/50,B01J20/08;;B01J23/72;;B01J23/74;;B01J23/86;;B01J35/02;;B01J37/00;;C04B35/10,252/464,0,0,,,,EXPIRED
43,US,B2,US 8304214 B2,013-046-333-668-048,2012-11-06,2012,US 94416907 A,2007-11-21,US 94416907 A;;US 17679505 A;;US 44115803 A;;US 58956000 A,2000-06-06,Methods for multiplexing amplification reactions,"A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.",GERDES JOHN C;;BEST ELAINE A;;MARMARO JEFFREY M;;APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;BEST ELAINE A;;MARMARO JEFFREY M,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2003-07-31),https://lens.org/013-046-333-668-048,Granted Patent,yes,68,18,17,17,84,C12Q1/686;;C12Q1/686;;C12Q1/6806;;C12Q1/6806;;C12Q1/6827;;C12Q1/6827;;C12Q1/6844;;C12Q1/6844;;C12Q1/689;;C12Q1/689;;C12Q2600/156;;C12Q2600/16;;C12Q2600/16,C12P19/34;;G01N33/53;;C12N15/09;;C12Q/;;C12Q1/06;;C12Q1/10;;C12Q1/48;;C12Q1/68;;G01N33/566,435/91.2;;435/6.1,100,38,008-213-359-148-352;;055-501-408-900-258;;113-237-014-874-941;;045-377-687-919-809;;051-671-860-596-375;;004-802-768-681-203;;042-810-087-283-347;;091-616-122-117-431;;005-093-091-683-529;;080-120-399-411-790;;005-098-521-717-817;;066-697-166-954-718;;032-781-980-714-725;;025-891-722-731-526;;030-836-231-181-354;;050-069-505-989-408;;014-353-991-909-225;;041-417-339-486-865;;070-656-465-248-593;;055-980-684-558-947;;041-417-339-486-865;;010-045-471-526-650;;138-426-789-339-83X;;054-095-134-696-001;;070-660-701-185-769;;014-051-545-273-403;;007-782-541-984-959;;045-081-326-747-615;;012-315-547-510-664;;017-391-717-403-017;;005-540-691-594-134;;078-302-340-811-20X;;001-560-891-833-008;;079-074-030-459-68X;;032-597-682-620-712;;017-515-593-292-125;;068-917-929-803-50X;;003-784-819-011-670,10.1073/pnas.88.7.2815;;1672768;;pmc51330;;1349899;;pmc265232;;10.1128/jcm.30.5.1098-1104.1992;;pmc339001;;10.1093/nar/16.23.11141;;3205741;;10.1101/gr.191301;;11544191;;10.1006/mcpr.2002.0433;;12477439;;10.1101/gr.6.10.986;;8908518;;10.1093/nar/24.3.538;;pmc145645;;8602371;;2227421;;10.1016/0378-1119(90)90145-h;;pmc84298;;10.1128/jcm.37.2.327-332.1999;;9889212;;10.1007/s100380170047;;11501945;;pmc167648;;10.1093/nar/gng073;;12853650;;10.1101/gr.5.5.488;;8808470;;10.1093/nar/gng122;;14530455;;pmc219490;;9582121;;10.1126/science.280.5366.1077;;10.1006/meth.2001.1265;;11846612;;8994665;;10.2144/97221pf02;;pmc328414;;10.1093/nar/19.13.3749;;1852616;;9298224;;10.2144/97233rr01;;8637917;;pmc39840;;10.1073/pnas.93.6.2582;;1571150;;9298224;;10.2144/97233rr01;;9863056;;10.2144/98256rr01;;10.1006/geno.1999.6048;;10644449;;pmc248091;;4914564;;10.1128/jb.103.2.382-386.1970;;2059028;;10.1128/aem.57.4.1013-1017.1991;;pmc182838;;10.1016/0167-7012(91)90046-s;;2306085;;10.1128/aem.56.2.307-314.1990;;pmc183336;;1768116;;pmc183591;;10.1128/aem.57.8.2429-2432.1991;;11950218;;10.1006/abio.2002.5593;;9546166;;10.1128/aem.64.4.1313-1318.1998;;pmc106147;;10.1016/0890-8508(90)90026-v;;2280781;;10.1101/gr.3.4.s65;;8173510;;10794932;;10.1016/s0732-8893(00)00116-4;;10.1016/s0890-8508(95)90125-6;;7477021;;10.1093/nar/17.13.5407;;pmc318146;;2762140;;pmc182998;;1444380;;10.1128/aem.58.9.2717-2722.1992;;1500516;;10.1128/jcm.30.8.2080-2083.1992;;pmc265446;;10.1111/j.1574-6968.2000.tb09155.x;;10856652;;10.1016/s0378-1097(00)00196-8,"Ruano et al. PNAS, vol. 88, pp. 2815-2519, 1991.;;Kaltenboeck ""Two-Step Polymerase Chain Reactions and Restriction Endonuclease Analyses Detect and Differentiate ompA DNA of Chlamydia spp."" Journal of Clinical Microbiology; May 1992; vol. 30, No. 5; pp. 1098-1104; American Society for Microbiology.;;English Translation of JP Official Action; JP Application No. 2002-502174; Oct. 9, 2008.;;U.S. Appl. No. 10/723,520, U.S. Office Action Mailed Jul. 6, 2010.;;U.S. Appl. No. 10/441,158, Response to Mar. 23, 2005 U.S. Office Action, filed May 23, 2005.;;U.S. Appl. No. 10/441,158, Response to Aug. 17, 2005 U.S. Office Action, filed Sep. 14, 2005.;;U.S. Appl. No. 10/441,158, U.S. Notice of Allowance, mailed Dec. 13, 2005.;;U.S. Appl. No. 10/441,158, U.S. Office Action, mailed Mar. 23, 2005.;;U.S. Appl. No. 10/441,158, U.S. Office Action, mailed Aug. 17, 2005.;;U.S. Appl. No. 10/723,520, Response to Jan. 19, 2007 U.S. Office Action, filed Jul. 19, 2007.;;U.S. Appl. No. 10/723,520, Response to Apr. 29, 2008 U.S. Office Action, filed Aug. 29, 2008.;;U.S. Appl. No. 10/723,520, Response to Aug. 1, 2007 U.S. Office Action, filed Feb. 1, 2008.;;U.S. Appl. No. 10/723,520, Response to Oct. 13, 2009 U.S. Office Action, filed Apr. 13, 2010.;;U.S. Appl. No. 10/723,520, Response to Oct. 30, 2006 U.S. Office Action, filed Nov. 29, 2006.;;U.S. Appl. No. 10/723,520, Response to Nov. 7, 2008 U.S. Office Action, filed Aug. 7, 2009.;;U.S. Appl. No. 10/723,520, U.S. Office Action, mailed Jan. 19, 2007.;;U.S. Appl. No. 10/723,520, U.S. Office Action, mailed Apr. 29, 2008.;;U.S. Appl. No. 10/723,520, U.S. Office Action, mailed Aug. 1, 2007.;;U.S. Appl. No. 10/723,520, U.S. Office Action, mailed Oct. 13, 2009.;;U.S. Appl. No. 10/723,520, U.S. Office Action, mailed Oct. 30, 2006.;;U.S. Appl. No. 10/723,520, U.S. Office Action, mailed Nov. 7, 2008.;;U.S. Appl. No. 11/176,795, Response to Apr. 1, 2008 U.S. Office Action, filed Jul. 30, 2008.;;U.S. Appl. No. 11/176,795, Response to Jul. 11, 2007 U.S. Office Action, filed Jul. 30, 2007.;;U.S. Appl. No. 11/176,795, Response to Sep. 16, 2008 U.S. Office Action, filed Oct. 1, 2008.;;U.S. Appl. No. 11/176,795, Response to Oct. 12, 2007 U.S. Office Action, filed Jan. 14, 2008.;;U.S. Appl. No. 11/176,795, U.S. Notice of Allowance, mailed Dec. 30, 2008.;;U.S. Appl. No. 11/176,795, U.S. Office Action, mailed Apr. 1, 2008.;;U.S. Appl. No. 11/176,795, U.S. Office Action, mailed Jul. 11, 2007.;;U.S. Appl. No. 11/176,795, U.S. Office Action, mailed Sep. 16, 2008.;;U.S. Appl. No. 11/176,795, U.S. Office Action, mailed Oct. 12, 2007.;;2,410,281, CA Notice of Allowance, mailed Aug. 24, 2009.;;2004-557332, JP Office Action, mailed Jun. 4, 2009.;;Assays-By-Design Service[Online], [retrieved on May 13, 2003], .;;Assays-On-Demand, Gene Expression Products [online], [retrieved on May 13, 2003], .;;Assays-On-Demand, SNP Genotyping Products [online], [retrieved on May 13, 2003], .;;Chamberlain, Jeffrey et al., ""Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification"", Nucl. Acids Res. vol. 16, No. 23 1988 , 11141-11155.;;Dolganov, G., ""A Novel Method of Gene Transcript Profiling in Airway Biopsy Homogenates Reveals Increased Expression of a Na+ -K+-Cl- Cotransporter (NKCC1) in Asthmatic Subjects"", Genome Research 11 2001 , 1473-1483.;;EP 01939852.8, EP Office Action, mailed Apr. 6, 2006.;;EP 01939852.8, EP Office Action, mailed Jun. 2, 2009.;;EP 01939852.8, Response to Apr. 6, 2006 EP Office Action, filed on Oct. 24, 2006.;;EP 01939852.8, Response to Jun. 2, 2009 EP Office Action, filed on Dec. 14, 2009.;;EP 03796461, Office Action, mailed Mar. 9, 2007.;;EP 03796461, EP Office Action, mailed Sep. 9, 2008.;;EP 03796461, EP Office Action, mailed Oct. 13, 2006.;;EP 03796461, Partial European Search Report, dated Apr. 6, 2006.;;EP 03796461, Response to Mar. 9, 2007 EP Office Action, filed on Apr. 16, 2007.;;EP 03796461, Response to Oct. 13, 2006 EP Office Action, filed on Feb. 19, 2007.;;EP 03796461, Supplementary European Search Report, dated Jun. 30, 2006.;;EP 08020322, EP Office Action, mailed Sep. 18, 2009.;;EP 08020322, EP Search Report, mailed Jan. 29, 2009.;;EP 08020322, Response to Sep. 18, 2009 EP Office Action, filed on Mar. 18, 2010.;;EP 09016059, EP Search Report, mailed Apr. 29, 2010.;;Exner, M. et al., ""Sensitivity of multiplex real-time PCR reactions, using the LightCycler and the ABI PRISM 7700 Sequence Detection System, is dependent on the concentration of the DNA polymerase"", Mol. Cell Probes 16: Oct. 2002 , 351-357.;;Heid, Christian A. et al., ""Real Time Quantitative PCR"", Genome Research vol. 6, Cold Spring Harbor Laboratory Press, Woodbury, NY, US 1996, 986-994.;;Kato, K. , ""Laboratory Manual PCR- Study and Application to Clinical Diagnosis"", First Edition Takara Shuzo Co. Ltd 1996, 73-81.;;Li, D. et al., ""Multiplex co-amplification of 24 retinoblastoma gene exons after pre-amplification by long-distance PCR"", Nucleic Acids Research 24(3) 1996, 538-539.;;Longo, Mary et al., ""Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions"", Gene vol. 93(1) 1990, 125-128.;;Martell, Maria et al., ""High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA"", J. Clin. Microbiol. vol. 37(2) 1999, 327-332.;;Ohnishi, et al., ""A high-throughput SNP typing system for genome-wide association studies"", J. Hum. Genet. 46: 2001 , 471-477.;;PCT/US01/17901, PCT ISR, dated Jan. 23, 2003.;;PCT/US04/15826, PCT ISR, dated Jan. 26, 2006.;;Peirson, S. N. ""Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis"", Nucleic Acids Res. 31(14) 2003 , e73.;;Shuber, A. et al., ""A Simplified Procedure for Developing Multiplex PCRs"", Genome Research 5 1995 , 488-493.;;Tichopad, A et al., ""Standardized determination of real-time PCR efficiency from a single reaction set-up"", Nucleic Acids Res. 31 2003 , e122.;;User Bulletin #2:, ""ABI Prism 7700 Sequence Detection System. Subject: Relative Quantitation of Gene Expression, Datasheet"", Applied Biosystems (updated Oct. 2001) 1997.;;Wang, et al., ""Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome"", Science 280: 1998 , 1077-1082.;;Wittwer, C. et al., ""Real-Time Multiplex PCR Assays"", Methods vol. 25 2001, 430-442.;;Wittwer, C.T. et al., ""The LightCycler(TM): A Microvolume Multisample Fluorimeter with Rapid Temperature Control"", BioTechniques vol. 22 (1) Jan. 1997, 176-181.;;WO 01/094634, PCT IPER, mailed Mar. 4, 2004.;;WO 01/094634, PCT ISR, mailed Jan. 23, 2003.;;WO 04/104214, PCT IPRP, mailed Mar. 13, 2006.;;WO 04/104214, PCT ISR, mailed Jan. 26, 2006.;;WO 04/104214, PCT Written Opinion, mailed Mar. 7, 2006.;;WO 2004/051218, PCT ISR, mailed Dec. 10, 2004.;;D'Aquila, Richard T. et al., ""Maximizing sensitivity and specificity of PCR by pre-amplification amplification heating"", Nucleic Acids Research, vol. 19, No. 13, Oxford University Press,, Jul. 11, 1991, 3749.;;Henegariu, O et al., """"Multiplex PCR: Critical Parameters and Step-By-Step Protocol"""", Biotechniques, vol. 23, No. 3, Eaton Publishing, Natick, US,, Sep. 1997, 504-511.;;Lin, Z et al., ""Multiplex Genotype Determination at a Large Number of Gene Loci"", Proceedings of the National Academy of Sciences of the United States, vol. 93, No. 6, Genetics, USA,, Mar. 1996, 2582-2587.;;Saiki, R. K. , ""The Design and Optimization of the PCR"", PCR Technology. Principles and Applications for DNA Amplification, Stockton Press, New York, US,, Jan. 7-16, 1989.;;Jayaraman, et al.; ""A PCR-Mediated Gene Synthesis Strategy Involving the Assembly of Oligonucleotides Representing Only One of the Strands""; BioTechniques; Mar. 1992; pp. 392-398; vol. 12, No. 3.;;Henegariu, et al; ""Multipelx PCR: Critical Parameters and Step-by-Step Protocol""; BioTechniques; Sep. 1997; pp. 504-511; vol. 23, No. 3.;;Liu, et al. ""Subcycling-PCR for Multiplex Long-Distance Amplification of Regions with High and Low GC Content: Application to the Inversion Hotspot in the Factor VIII Gene""; BioTechniques; Dec. 1998; pp. 1022-1028; vol. 25, No. 6.;;Tettelin, et al. ""Optimized Multiplex PCR: Efficiency Closing a Whole-Genome Shotgun Sequencing Project""; Genomics; 1999; pp. 500-507; vol. 62; Academic Press.;;Lupo, et al. Gene Controlling L-Glutamic Acid Decarboxylase Synthesis in Escherichia coli K-12; 1970; pp. 382-386; vol. 103, No. 2; American Society for Microbiology; US.;;Graves, et al.""Universal Bacterial DNA Isolation Procedure""; Diagnostic Molecular Microbiology Principals and Applications; 1993; pp. 617-621.;;Bej, et al. Detection of Escherichia coil and Shigella spp. In Water by Using the Polymerase Chain Reaction and Gene Probes for uid; Applied and Environmental Microbiology; Apr. 1991; pp. 1013-1017; vol. 57, No. 4; American Society for Microbiology.;;Green, et al. ""Detection of faecal pollution in water by an Escherichia coli uidA gene probe""; Journal of Microbiological Methods; 1991; pp. 207-214; vol. 13; Elsevier Science Publishers.;;Rice, et al. ""Detection of Escherichia coli in Water Using a Colorimetric Gene Probe Assay""; Environ. Sci. Health,; 1995; pp. 1059-1067; vol. A30(5); Marcel Dekker, Inc.;;Bej, et al. ""Detection of Coliform Bacteria in Water by Polymerase Chain Reaction and Gene Probes""; Applied and Environmental Microbiology; Feb. 1990; pp. 307-314; vol. 56, No. 2; American Society for Microbiology.;;Bej, et al.; ""Detection of Coliform Bacteria and Escherichia coli by Multiplex Polymerase Chain Reaction: Comparison with Defined Substrate and Plating Methods for Water Quality Monitoring;"" Applied and Environmental Microbiology; Aug. 1991; pp. 2429-2432; vol. 57, No. 8; American Society for Microbiology.;;Min, et al. ""Highly Sensitive and Specific Detection of Viable Escherichia coli in Drinking Water; ""Analytical Biochemistry; 2002; pp. 186-193; vol. 303; Elsevier Science; US.;;Sheridan, et al. ""Detection of mRNA by Reverse Transcription-PCR as an Indicator of Vialbity in Escherichia coli Cells""; Applied and Environmental Microbiology; Apr. 1998; pp. 1313-1318; vol. 64; American Society for Microbiology.;;Bej, et al. ""Multiplex PCR amplification and immobilized capture probes for detection of bacterial pathogens and indicators in water""; Molecular and Cellular Probes; 1990; pp. 353-365; vol. 4; Academic Press Limited.;;Edwards, et al.; ""Multiplex PCR: Advantages, Development, and Applications""; PCR Methods and Applications; Feb. 1994; pp. 565-575; vol. 3, No. 4; Cold Spring Harbor Laboratory.;;Gonin, et al.; ""Performance of a multiplex PCR for the determination of Haemphilus influenzae capsular types in the clinical microbiology laboratory""; Diagnostic Microbiology and Infectious Disease; May 2000; pp. 1-4,; vol. 37, No. 1; Elsevier.;;Borg, et al. ""Detection of cytomegalovirus using 'boosted' nested PCR""; Molecular and Cellular Probes; 1995; pp. 251-257; vol. 9; Academic Press Limited.;;Ruano, et al. Biphasic amplification of very dilute DNA samples via 'booster' PCR; Nucleic Acids Research; Jul. 1989; p. 5407; vol. 17, No. 13; IRL Press.;;Ruano, et al. ""Booster PCR: A Biphasic Paradigm for Amplification of a Few Molecules of Target""; Amplifications: A Forum for PCR Users; Sep. 1989; pp. 12-13.;;Picard, et al. ""Detection and Enumeration of Bacteria in Soil by Direct DNA Extraction and Polymerase Chain Reaction""; Applied and Environmental Microbiology; Sep. 1992; pp. 2717-2722; vol. 58, No. 9.;;Saulnier, et al. ""Detection of Genes in Feces by Booster Polymerase Chain Reaction""; Journal of Clinical Microbiology; Aug. 1992; pp. 2080-2083; vol. 30, No. 8.;;Song, et al. ""Rapid Identification of 11 human intestinal Lactobacillus species by multiplex PCR assays using group- and species-specific primers derived from the 16S-23S rRNA intergenic spacer region and its flanking 23S rRNA""; FEMS Microbiology Letters; Jun. 2000; pp. 167-173; vol. 187; Elsevier; Netherlands.",EXPIRED
44,DE,T2,DE 69836587 T2,142-992-193-843-120,2007-10-11,2007,DE 69836587 T,1998-04-16,US 4199997 P;;US 9807707 W,1997-04-16,NUKLEINSÄURESAMMLUNG,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,"APPLIED BIOSYSTEMS, LLC (N. D. GES. D. STAATES, US (2009-12-03)",https://lens.org/142-992-193-843-120,Granted Patent,no,0,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,C12Q1/68;;G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
45,DE,A1,DE 2318573 A1,160-624-708-902-681,1973-10-25,1973,DE 2318573 A,1973-04-12,US 24383572 A;;US 32410873 A,1972-04-13,KATALYSATORTRAEGER AUF DER BASIS VON TONERDE,,NORTON CO,KIOVSKY JOSEPH RICHARD;;MEACHAM JEFFREY WILLIAM;;GERDES WILLIAM HERMAN,,https://lens.org/160-624-708-902-681,Patent Application,no,5,0,9,9,0,B01J20/08;;B01J21/04;;B01J37/0009;;C01F7/025;;C01P2006/12;;C01P2006/14;;C01P2006/16;;C01P2006/17;;C01P2006/80;;C04B35/10,C01F7/025;;B01J20/08;;B01J21/04;;B01J37/00;;C04B35/10,,1,0,,,In Betracht gezogene ältere Patente: DE-PS 22 56 012 DE-AS 22 50 892,EXPIRED
46,DE,A1,DE 2223401 A1,091-312-463-939-078,1972-11-30,1972,DE 2223401 A,1972-05-10,US 14200371 A;;US 14200471 A,1971-05-10,Verfahren zur Herstellung von Aluminiumoxid-Koerpern,,NORTON CO,HERMAN GERDES WILLIAM;;RICHARD KIOVSKY JOSEPH;;WILLIAM MEACHAM JEFFREY,,https://lens.org/091-312-463-939-078,Patent Application,no,3,1,5,7,0,B01J21/04;;B01J23/72;;B01J23/74;;B01J23/868;;B01J37/0009;;C04B35/10;;B01J35/50,B01J21/04;;B01J23/72;;B01J23/74;;B01J23/86;;B01J35/02;;B01J37/00;;C04B35/10,,0,0,,,,EXPIRED
47,BR,A2,BR PI0822145 A2,099-679-111-769-767,2015-06-30,2015,BR PI0822145 A,2008-12-17,US 1026008 P;;IB 2008055398 W,2008-01-07,Detergentes com cor aceitável,,PROCTER & GAMBLE,GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,,https://lens.org/099-679-111-769-767,Patent Application,no,0,0,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D3/34;;C11D3/33;;C11D3/36;;C11D7/32;;C11D7/34;;C11D7/36,,0,0,,,,DISCONTINUED
48,AU,A,AU 1998/071271 A,148-333-481-341-087,1998-11-11,1998,AU 1998/071271 A,1998-04-16,US 4199997 P;;US 9807707 W,1997-04-16,Nucleic acid archiving,,APPLIED BIOSYSTEMS LLC,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,,https://lens.org/148-333-481-341-087,Patent Application,no,0,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
49,US,A1,US 2009/0176684 A1,008-095-941-770-388,2009-07-09,2009,US 31757408 A,2008-12-23,US 31757408 A;;US 1026008 P,2008-01-07,Detergents having acceptable color,"Detergent compositions containing catechols, such as tiron (1,2-dihydroxybenzene-3,5-disulfonic acid), which do not have or do not develop the reddish color associated with the catechol/ferric iron chelate are disclosed. Methods for reducing the intensity of red color in a tiron containing detergent composition are also disclosed.",GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,PROCTER & GAMBLE COMPANY THE (2008-01-10),https://lens.org/008-095-941-770-388,Patent Application,yes,15,151,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D3/386;;C11D1/22,510/392;;510/495;;510/480;;510/469,0,0,,,,INACTIVE
50,WO,A1,WO 1998/046797 A1,164-364-108-363-060,1998-10-22,1998,US 9807707 W,1998-04-16,US 4199997 P,1997-04-16,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume: low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,,https://lens.org/164-364-108-363-060,Patent Application,yes,1,65,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,C07H21/02;;C07H21/04;;G01N33/50;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,3,2,029-685-542-836-230;;093-992-351-106-367,1789415;;10.1016/0003-2697(91)90518-x;;1380482;;10.1016/0888-7543(92)90014-j,"RASMUSSEN S.R., LARSEN M.R., RASMUSSEN S.E.: ""COVALENT IMMOBILIZATION OF DNA ONTO POLYSTYRENE MICROWELLS: THE MOLECULES ARE OMLY BOUND AT THE 5' END."", ANALYTICAL BIOCHEMISTRY., ACADEMIC PRESS INC., NEW YORK., vol. 198., no. 01., 1 October 1991 (1991-10-01), NEW YORK., pages 138 - 142., XP002914075, ISSN: 0003-2697, DOI: 10.1016/0003-2697(91)90518-X;;SOUTHERN E.M., MASKOS U., ELDER J.K.: ""ANALYZING AND COMPARING NUCLEIC ACID SEQUNECES BY HYBRIDIZATION TO ARRAYS OF OLIGONUCLEOTIDES: EVALUATION USING EXPERIMENTAL MODELS."", GENOMICS, ACADEMIC PRESS, SAN DIEGO., US, vol. 13., 1 August 1992 (1992-08-01), US, pages 1008 - 1017., XP002914076, ISSN: 0888-7543, DOI: 10.1016/0888-7543(92)90014-J;;BEATTIE K L, ET AL.: ""ADVANCES IN GENOSENSOR RESEARCH"", CLINICAL CHEMISTRY., AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY, WASHINGTON, DC., vol. 41, no. 05, 1 May 1995 (1995-05-01), WASHINGTON, DC., pages 700 - 706, XP002914077, ISSN: 0009-9147",PATENTED
51,WO,A1,WO 2009/087515 A1,064-752-100-863-836,2009-07-16,2009,IB 2008055398 W,2008-12-17,US 1026008 P,2008-01-07,DETERGENTS HAVING ACCEPTABLE COLOR,"Detergent compositions containing tiron (1, 2-diydroxybenzene-3, 5- disulfonic acid), which do not have or do not develop the reddish color associated with the tiron/ferric iron chelate are disclosed. Methods for reducing the intensity of red color in a tiron containing detergent composition are also disclosed.",PROCTER & GAMBLE;;GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,,https://lens.org/064-752-100-863-836,Patent Application,yes,5,1,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D3/34;;C11D3/33;;C11D3/36;;C11D7/32;;C11D7/34;;C11D7/36,,0,0,,,,PENDING
52,DE,D1,DE 69836587 D1,117-130-721-967-093,2007-01-18,2007,DE 69836587 T,1998-04-16,US 4199997 P;;US 9807707 W,1997-04-16,NUKLEINSÄURESAMMLUNG,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,"APPLIED BIOSYSTEMS, LLC (N. D. GES. D. STAATES, US (2009-12-03)",https://lens.org/117-130-721-967-093,Granted Patent,no,0,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,C12Q1/68;;G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
53,EP,A1,EP 2231845 A1,134-444-363-658-490,2010-09-29,2010,EP 08869831 A,2008-12-17,IB 2008055398 W;;US 1026008 P,2008-01-07,DETERGENTS HAVING ACCEPTABLE COLOR,,PROCTER & GAMBLE,GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,,https://lens.org/134-444-363-658-490,Patent Application,yes,0,0,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D3/34;;C11D3/33;;C11D3/36;;C11D7/32;;C11D7/34;;C11D7/36,,0,0,,,,ACTIVE
54,EP,B1,EP 1003908 B1,048-418-618-631-948,2006-12-06,2006,EP 98918325 A,1998-04-16,US 9807707 W;;US 4199997 P,1997-04-16,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,APPLERA CORPORATION (2004-10-06),https://lens.org/048-418-618-631-948,Granted Patent,yes,8,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,C12Q1/68;;G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,3,0,,,"RASMUSSEN et al., ""Covalent Immobilization of DNA onto Polystyrene Microwells: The Molecules are only Bound at the 5' End"", ANALYTICAL BIOCHEMISTRY, October 1991, Vol. 198, No. 1, pages 138-142, XP002914075;;SOUTHERN et al., ""Analyzing and Comparing Nucleic Acid Sequences by Hybridization to Arrays of Oligonucleotides: Evaluation Using Experimental Models"", GENOMICS, August 1992, Vol. 13, pages 1008-1017, XP002914076;;BEATTIE et al., ""Advances in Genosensor Research"", CLINICAL CHEMISTRY, May 1995, Vol. 41, No. 5, pages 700-706, XP002914077",EXPIRED
55,EP,A4,EP 1003908 A4,196-267-884-390-578,2004-05-12,2004,EP 98918325 A,1998-04-16,US 9807707 W;;US 4199997 P,1997-04-16,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,APPLERA CORPORATION (2004-10-06),https://lens.org/196-267-884-390-578,Search Report,no,7,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
56,ZA,B,ZA 201004598 B,099-989-277-767-351,2011-12-28,2011,ZA 201004598 A,2010-06-30,US 1026008 P;;IB 2008055398 W,2008-01-07,DETERGENTS HAVING ACCEPTABLE COLOR,,PROCTER & GAMBLE,GARDENER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,,https://lens.org/099-989-277-767-351,Granted Patent,no,0,0,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D/,,0,0,,,,ACTIVE
57,EP,B1,EP 2231845 B1,125-594-055-350-897,2015-11-11,2015,EP 08869831 A,2008-12-17,IB 2008055398 W;;US 1026008 P,2008-01-07,DETERGENTS HAVING ACCEPTABLE COLOR,,PROCTER & GAMBLE,GARDNER ROBB RICHARD;;GERDES ALLISON LYNN;;SEELEY JEFFREY ANDERSON,,https://lens.org/125-594-055-350-897,Granted Patent,yes,5,0,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D3/34;;C11D3/33;;C11D3/36;;C11D7/32;;C11D7/34;;C11D7/36,,0,0,,,,ACTIVE
58,CN,A,CN 101910389 A,182-350-233-360-702,2010-12-08,2010,CN 200880123955 A,2008-12-17,IB 2008055398 W;;US 1026008 P,2008-01-07,Detergents having acceptable color,"Detergent compositions containing tiron (1, 2-diydroxybenzene-3, 5- disulfonic acid), which do not have or do not develop the reddish color associated with the tiron/ferric iron chelate are disclosed. Methods for reducing the intensity of red color in a tiron containing detergent composition are also disclosed.",PROCTER & GAMBLE,RICHARD GARDNER ROBB;;LYNN GERDES ALLISON;;ANDERSON SEELEY JEFFREY,,https://lens.org/182-350-233-360-702,Patent Application,no,0,1,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,C11D3/34;;C11D3/33;;C11D3/36;;C11D7/32;;C11D7/34;;C11D7/36,,0,0,,,,DISCONTINUED
59,AT,T1,AT E347615 T1,122-866-460-517-07X,2006-12-15,2006,AT 98918325 T,1998-04-16,US 4199997 P,1997-04-16,NUKLEINSÄURESAMMLUNG,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,,https://lens.org/122-866-460-517-07X,Granted Patent,no,0,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
60,CA,A1,CA 2286573 A1,063-374-707-796-834,1998-10-22,1998,CA 2286573 A,1998-04-16,US 4199997 P;;US 9807707 W,1997-04-16,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume: low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",IMMUNOLOGICAL ASSOCIATES OF DE,ROEHL CHRISTOPHER A;;MARMARO JEFFREY M;;GERDES JOHN C,,https://lens.org/063-374-707-796-834,Patent Application,no,0,0,14,14,9,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
61,AR,A1,AR 070108 A1,118-898-425-255-643,2010-03-17,2010,AR P090100024 A,2009-01-06,US 1026008 P,2008-01-07,DETERGENTES QUE TIENEN COLOR ACEPTABLE,"Se exponen las composiciones detergentes que consisten de catecoles, tales como tiron (ácido 1,2-dihidroxibenceno-3,5-disulfonico), que no tienen o no desarrollan el color rojizo asociado con el quelato de catecol/hierro férrico. Además, se exponen los métodos para reducir la intensidad del color rojo en una composicion detergente que contiene tiron.",PROCTER & GAMBLE,SEELEY JEFFREY ANDERSON;;GERDES ALLISON LYNN;;GARDNER ROBB RICHARD,,https://lens.org/118-898-425-255-643,Patent Application,no,0,0,12,12,0,C11D3/33;;C11D3/34;;C11D3/364;;C11D7/3245;;C11D7/34;;C11D7/36;;C11D3/364;;C11D3/34;;C11D7/34;;C11D7/3245;;C11D3/33;;C11D7/36,,,0,0,,,,PENDING
62,EP,A1,EP 1003908 A1,141-233-126-598-985,2000-05-31,2000,EP 98918325 A,1998-04-16,US 9807707 W;;US 4199997 P,1997-04-16,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;MARMARO JEFFREY M;;ROEHL CHRISTOPHER A,APPLERA CORPORATION (2004-10-06),https://lens.org/141-233-126-598-985,Patent Application,yes,0,0,14,14,0,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
63,CA,C,CA 2286573 C,177-371-811-479-900,2004-10-26,2004,CA 2286573 A,1998-04-16,US 4199997 P;;US 9807707 W,1997-04-16,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for irreversibly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrixes exhibiting sufficient hydrophilicity and electropositivity to irreversibly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume:low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. T he invention, solid phase irreversibly bound nucleic acid, may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for vir us extraction, purification, and solid phase amplification from large volume plasma specimens.",IMMUNOLOGICAL ASSOCIATES OF DE,GERDES JOHN C;;ROEHL CHRISTOPHER A;;MARMARO JEFFREY M,,https://lens.org/177-371-811-479-900,Granted Patent,no,0,0,14,14,9,C12Q1/68;;C12Q1/6806;;C12Q1/6834;;C12Q1/6806;;C12Q1/68;;C12Q1/6834,G01N33/50;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12P19/34;;C12Q1/68;;C12Q1/6806;;C12Q1/6834;;G01N33/53;;G01N33/566,,0,0,,,,EXPIRED
64,DE,B2,DE 2318573 B2,088-583-448-359-549,1980-06-04,1980,DE 2318573 A,1973-04-12,US 24383572 A;;US 32410873 A,1972-04-13,DE 2318573 B2,,"NORTON CO., WORCESTER, MASS. (V.ST.A.)","KIOVSKY, JOSEPH RICHARD;;MEACHAM, JEFFREY WILLIAM;;GERDES, WILLIAM HERMAN, HUDSON",,https://lens.org/088-583-448-359-549,Patent Application,no,0,0,9,9,0,B01J20/08;;B01J21/04;;B01J37/0009;;C01F7/025;;C01P2006/12;;C01P2006/14;;C01P2006/16;;C01P2006/17;;C01P2006/80;;C04B35/10,C01F7/025;;B01J20/08;;B01J21/04;;B01J37/00;;C04B35/10,,0,0,,,,EXPIRED
65,US,A1,US 2004/0091925 A1,056-902-462-961-872,2004-05-13,2004,US 69035903 A,2003-10-21,US 69035903 A;;US 94460401 A;;US 6175798 A;;US 4199997 P,1997-04-16,Nucleic acid archiving,"
   This invention provides a kit comprising a substrate having a surface coated with a solid phase matrix for nucleic acid manipulation. The solid phase matrix exhibits sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids in a sample. The manipulations include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method for virus extraction, purification, and solid phase amplification from large volume plasma specimens is described. 
",GERDES JOHN C.;;MARMARO JEFFERY M.;;IVES JEFFREY T.;;ROEHL CHRISTOPHER A.,GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2001-11-19),https://lens.org/056-902-462-961-872,Patent Application,yes,11,5,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,435/6;;435/91.2;;435/287.2,0,0,,,,EXPIRED
66,US,B2,US 6872527 B2,141-547-843-975-095,2005-03-29,2005,US 94460401 A,2001-08-31,US 94460401 A;;US 6175798 A;;US 4199997 P,1997-04-16,Nucleic acid archiving,"This invention is directed to a process for tightly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrices exhibiting sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",XTRANA INC,GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC. A DELAWARE CORPORATION (2001-11-14),https://lens.org/141-547-843-975-095,Granted Patent,yes,17,31,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,435/6;;536/23.1;;536/24.3,6,4,161-984-098-819-367;;060-762-936-275-157;;062-547-084-865-157;;046-147-446-740-851,3896567;;10.1093/clinchem/31.9.1438;;10.1139/o71-090;;4328119;;10.1093/nar/18.10.3093;;pmc330877;;2349127;;8273146;;10.1016/0168-9525(93)90024-c,"Helmuth R., in PCR Protocols: A Guide to Methods and Applications .1990. Eds. Innis et al. , Academic Press, Inc., SanDiego CA. pp. 119-128.*;;Davis et al. (Eds.) Basic Methods in Molecular Biology. 1986. Elsevier Science Publishing Co., Inc. New York, New York, pp. 42-78 and 130-149.*;;Polsky-Cynkin et al., Clinical Chemistry 31(9) : 1438-1443 (1985).*;;Hudson J., Canadian Journal of Biochemistry 49 : 631-636 (1971).*;;Reed et al., Nucleic Acids Research 18(10) : 3093 (1990).*;;Nehls et al., Trends oin Genetics 9 (10) : 336-337 (1993).",EXPIRED
67,US,B2,US 7087387 B2,007-501-272-870-860,2006-08-08,2006,US 69035903 A,2003-10-21,US 69035903 A;;US 94460401 A;;US 6175798 A;;US 4199997 P,1997-04-16,Nucleic acid archiving,"This invention provides a kit comprising a substrate having a surface coated with a solid phase matrix for nucleic acid manipulation. The solid phase matrix exhibits sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids in a sample. The manipulations include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method for virus extraction, purification, and solid phase amplification from large volume plasma specimens is described.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2001-11-19),https://lens.org/007-501-272-870-860,Granted Patent,yes,11,128,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,C12Q1/68;;G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;G01N33/543;;G01N37/00,435/6;;536/23.1;;536/24.3,5,3,046-147-446-740-851;;161-984-098-819-367;;060-762-936-275-157,8273146;;10.1016/0168-9525(93)90024-c;;3896567;;10.1093/clinchem/31.9.1438;;10.1139/o71-090;;4328119,"The Stratagene Catalog, p. 39 (1988).;;Vehis et al., Trends in Genetics (1993) 9(10): 336-337.;;R. Polsky-Cynkin, et al., Clin. Chem. (1985) 31(9): 1438-1443.;;J.B. Hudson, Canadian J. Biochem. (1971) 49:631-636.;;M. Innis, et al., PCR Protocols (1990) pp. 119-128.",EXPIRED
68,US,A1,US 2002/0132242 A1,084-069-368-968-259,2002-09-19,2002,US 94460401 A,2001-08-31,US 94460401 A;;US 6175798 A;;US 4199997 P,1997-04-16,Nucleic acid archiving,"
   This invention is directed to a process for tightly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrices exhibiting sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens. 
",GERDES JOHN C.;;MARMARO JEFFERY M.;;IVES JEFFREY T.;;ROEHL CHRISTOPHER A.,GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC. A DELAWARE CORPORATION (2001-11-14),https://lens.org/084-069-368-968-259,Patent Application,yes,0,19,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,435/6;;435/287.2;;536/23.1,0,0,,,,EXPIRED
69,US,A1,US 2009/0082225 A1,020-438-293-468-354,2009-03-26,2009,US 10690808 A,2008-04-21,US 10690808 A;;US 43691906 A;;US 69035903 A;;US 94460401 A;;US 6175798 A;;US 4199997 P,1997-04-16,NUCLEIC ACID ARCHIVING,"This invention is directed to a process for tightly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrices exhibiting sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,,https://lens.org/020-438-293-468-354,Patent Application,yes,3,7,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,C40B50/06;;G01N33/53;;C07H1/00;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;C12Q1/68;;G01N33/543;;G01N37/00,506/26;;536/25.4,0,0,,,,DISCONTINUED
70,US,B2,US 7361471 B2,082-178-244-211-406,2008-04-22,2008,US 43691906 A,2006-05-18,US 43691906 A;;US 69035903 A;;US 94460401 A;;US 6175798 A;;US 4199997 P,1997-04-16,Nucleic acid archiving,"This invention is directed to a process for tightly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrices exhibiting sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",APPLERA CORP,GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2001-11-19),https://lens.org/082-178-244-211-406,Granted Patent,yes,20,33,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,C12Q1/68;;G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;G01N33/543;;G01N37/00,435/6;;435/91.2;;536/23.1;;536/24.3,7,5,012-957-981-858-385;;161-984-098-819-367;;060-762-936-275-157;;046-147-446-740-851;;062-547-084-865-157,10.1016/b978-0-12-372180-8.50037-8;;3896567;;10.1093/clinchem/31.9.1438;;10.1139/o71-090;;4328119;;8273146;;10.1016/0168-9525(93)90024-c;;10.1093/nar/18.10.3093;;pmc330877;;2349127,"Chamberlain et al. Multiplex PCR for the Diagnosis of Duchenne Muscular Dystrophy. Chapter 33 PCR Protocols : A Guide to Methods and Applications pp. 272-281 (1990).;;Polsky-Cynkin, et al. ""Use of DNA Immobilized on Plastic and Agarose Supports to Detect DNA by Sandwich Hybridization""; Clinical Chemistry; 1985; pp. 1438-1443; vol. 31, No. 9.;;Hudson ""The Fixation and Retention of Viral and Mammalian Deoxyribonucleic Acids on Nitrocellulose Filters""; Canadian Journal of Biochemistry; 1971; pp. 631-638; vol. 49.;;Innis, et al. ""PCR Protocols A Guide to Methods and Applications""; 1990; pp. 119-128; Academic Press, Inc. San Diego, CA, US.;;Vehls, et al. ""Trends in Genetics""; TIG, Technical Tips; Oct. 1993; pp. 336-337; vol. 9, No. 10.;;Reed, et al. ""Rapid preparation of DNA dot blots from tissue samples, using hot alkaline lysis and filtration onto charge-modified nylon membrane""; Nucleic Acids Research; 1990; pp. 3093; vol. 18, No. 10; Oxford University Press.;;David, et al. (Eds.) ""Basic Methods in Molecular Biology""; Elsevier Science Publishing Co.; 1986; pp. 42-78 and 130-149; New York, NY.",EXPIRED
71,US,A1,US 2006/0211034 A1,190-317-008-451-11X,2006-09-21,2006,US 43691906 A,2006-05-18,US 43691906 A;;US 69035903 A;;US 94460401 A;;US 6175798 A;;US 4199997 P,1997-04-16,Nucleic acid archiving,"This invention is directed to a process for tightly binding nucleic acid to solid phase and corresponding processes for the utilization thereof. Nucleic acid is bound to solid phase matrices exhibiting sufficient hydrophilicity and electropositivity to tightly bind the nucleic acids from a sample. These processes include nucleic acid (double or single stranded DNA and RNA) capture from high volume and/or low concentration specimens, buffer changes, washes, and volume reductions, and enable the interface of solid phase bound nucleic acid with enzyme, hybridization or amplification strategies. The tightly bound nucleic acid may be used, for example, in repeated analyses to confirm results or test additional genes in both research and commercial applications. Further, a method is described for virus extraction, purification, and solid phase amplification from large volume plasma specimens.",GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,GERDES JOHN C;;MARMARO JEFFERY M;;IVES JEFFREY T;;ROEHL CHRISTOPHER A,APPLIED BIOSYSTEMS LLC (2008-11-21);;APPLIED BIOSYSTEMS INC (2008-07-01);;XTRANA INC (2001-11-19),https://lens.org/190-317-008-451-11X,Patent Application,yes,20,0,12,12,10,C12Q1/6806;;C12Q1/6806;;C07B2200/11;;C07B2200/11;;C12N15/1006;;C12N15/1006;;C12Q1/6834;;C12Q1/6834;;C12Q1/6837;;C12Q1/6837;;C12Q1/6848;;C12Q1/6848,C12Q1/68;;G01N33/53;;C07H21/02;;C07H21/04;;C12M1/34;;C12N15/00;;C12N15/09;;C12N15/10;;C12P19/34;;G01N33/543;;G01N37/00,435/6;;435/91.2,0,0,,,,EXPIRED
72,WO,A1,WO 2003/008010 A1,068-256-630-937-532,2003-01-30,2003,EP 0207568 W,2002-07-08,DE 10135315 A,2001-07-19,STENTS WITH VITRONECTIN RECEPTOR ANTAGONISTS AGAINST RESTENOSIS,The invention relates to stents containing vitronectin receptor antagonists and to the production and use thereof.,BAYER AG;;URBAHNS KLAUS;;GERDES CHRISTOPH;;ZULEGER SUSANNE;;GELFERT-PEUKERT SABINE;;LOW JEFFREY;;KALBE JOCHEN,URBAHNS KLAUS;;GERDES CHRISTOPH;;ZULEGER SUSANNE;;GELFERT-PEUKERT SABINE;;LOW JEFFREY;;KALBE JOCHEN,,https://lens.org/068-256-630-937-532,Patent Application,yes,7,0,6,6,0,A61L31/16;;A61L2300/416;;A61L2300/436;;A61P9/10;;A61L31/16;;A61L2300/436;;A61L2300/416,A61F2/06;;A61F2/82;;A61L31/00;;A61K45/00;;A61L31/16;;A61P9/10,,0,0,,,,PENDING
73,CA,A1,CA 2453977 A1,081-999-122-606-444,2003-01-30,2003,CA 2453977 A,2002-07-08,DE 10135315 A;;EP 0207568 W,2001-07-19,STENTS WITH VITRONECTIN RECEPTOR ANTAGONISTS AGAINST RESTENOSIS,The invention relates to stents containing vitronectin receptor antagonists and to the production and use thereof.,BAYER HEALTHCARE AG,URBAHNS KLAUS;;GERDES CHRISTOPH;;ZULEGER SUSANNE;;KALBE JOCHEN;;LOW JEFFREY;;GELFERT-PEUKERT SABINE,,https://lens.org/081-999-122-606-444,Patent Application,no,0,0,6,6,0,A61L31/16;;A61L2300/416;;A61L2300/436;;A61P9/10;;A61L31/16;;A61L2300/436;;A61L2300/416,A61L31/00;;A61F2/06;;A61F2/82;;A61K45/00;;A61L31/16;;A61P9/10,,0,0,,,,DISCONTINUED
74,US,B1,US 11600429 B1,120-190-416-774-765,2023-03-07,2023,US 202016751830 A,2020-01-24,US 202016751830 A,2020-01-24,Geometrically configurable planar wafers,"A system of modular components each include pin ports that may be connected in different configurations to enact alternative planar designs. Each modular component has asymmetries that are utilized to facilitate alternative wiring. Such asymmetries could include protrusions in the wafer to align edge connections. Alternatively, or in addition, the asymmetries include differences in copper disposition to certain edge connections. Each modular component has a non-conductive coating on each side of the wafer to insulate the underlaying copper layer.",ROCKWELL COLLINS INC,GERDES JOSHUA;;DELOY JEFFREY J;;MAYFIELD JAMES B;;KENDALL TRISTAN J;;STOWE STEVEN,ROCKWELL COLLINS INC (2020-01-20),https://lens.org/120-190-416-774-765,Granted Patent,yes,10,0,1,1,0,H01F27/2804;;H01F2027/2819;;H01F2027/2809;;H01F27/29;;H01F27/2804;;H01F27/324;;H01F2027/2819;;H01F27/29,H01F27/28;;H01F27/29;;H01F27/32,,2,0,,,"Planar Transformer Prototyping Kit Designer's Kit C356, Coilcraft, https://www.coilcraft.com/pdfs/PlanarKitManual.pdf, Revised Nov. 15, 2012, 16 pages.;;Versatile Planar Transformer, Vishay, https://datasheet.octopart.com/PLAC100S100-Vishay-datasheet-13712928.pdf, Revised Jun. 18, 2009, 7 pages.",ACTIVE
75,DE,A1,DE 10135315 A1,184-238-871-486-695,2003-01-30,2003,DE 10135315 A,2001-07-19,DE 10135315 A,2001-07-19,Stents,The invention relates to stents containing vitronectin receptor antagonists and to the production and use thereof.,BAYER AG,URBAHNS KLAUS;;GERDES CHRISTOPH;;ZULEGER SUSANNE;;GELFERT-PEUKERT SABINE;;LOW JEFFREY;;KALBE JOCHEN,"BAYER HEALTHCARE AG, 51373 LEVERKUSEN, DE (2004-05-27)",https://lens.org/184-238-871-486-695,Patent Application,no,0,0,6,6,0,A61L31/16;;A61L2300/416;;A61L2300/436;;A61P9/10;;A61L31/16;;A61L2300/436;;A61L2300/416,A61L31/00;;A61F2/06;;A61F2/82;;A61K45/00;;A61L31/16;;A61P9/10,,0,0,,,,DISCONTINUED
76,EP,A1,EP 1411998 A1,028-803-034-256-027,2004-04-28,2004,EP 02762331 A,2002-07-08,DE 10135315 A;;EP 0207568 W,2001-07-19,STENTS WITH VITRONECTIN RECEPTOR ANTAGONISTS AGAINST RESTENOSIS,,BAYER HEALTHCARE AG,URBAHNS KLAUS;;GERDES CHRISTOPH;;ZULEGER SUSANNE;;GELFERT-PEUKERT SABINE;;LOW JEFFREY;;KALBE JOCHEN,,https://lens.org/028-803-034-256-027,Patent Application,yes,0,0,6,6,0,A61L31/16;;A61L2300/416;;A61L2300/436;;A61P9/10;;A61L31/16;;A61L2300/436;;A61L2300/416,A61L31/00;;A61F2/06;;A61F2/82;;A61K45/00;;A61L31/16;;A61P9/10,,0,0,,,,DISCONTINUED
77,US,A1,US 2004/0236413 A1,088-859-747-155-938,2004-11-25,2004,US 48441404 A,2004-06-28,DE 10135315 A;;EP 0207568 W,2001-07-19,Stents with vitronectin receptor antagonists against restenosis,"
   The application relates to vitronectin receptor antagonist-containing stents and to their production and use. 
",URBAHNS KLAUS;;GERDES CHRISTOPH;;ZULEGER SUSANNE;;GELFERT-PEUKERT SABINE;;LOW JEFFREY;;KALBE JOCHEN,URBAHNS KLAUS;;GERDES CHRISTOPH;;ZULEGER SUSANNE;;GELFERT-PEUKERT SABINE;;LOW JEFFREY;;KALBE JOCHEN,BAYER HEALTHCARE AG (2004-01-09),https://lens.org/088-859-747-155-938,Patent Application,yes,13,0,6,6,0,A61L31/16;;A61L2300/416;;A61L2300/436;;A61P9/10;;A61L31/16;;A61L2300/436;;A61L2300/416,A61F2/06;;A61L31/00;;A61F2/82;;A61K45/00;;A61L31/16;;A61P9/10,623/1.42;;623/1.46,0,0,,,,DISCONTINUED
78,DE,C3,DE 2318573 C3,108-693-415-245-271,1981-04-02,1981,DE 2318573 A,1973-04-12,US 24383572 A;;US 32410873 A,1972-04-13,DE 2318573 C3,,"NORTON CO., WORCESTER, MASS., US","KIOVSKY, JOSEPH RICHARD;;MEACHAM, JEFFREY WILLIAM, KENT, OHIO, US;;GERDES, WILLIAM HERMAN, HUDSON, OHIO, US",,https://lens.org/108-693-415-245-271,Granted Patent,no,0,0,9,9,0,B01J20/08;;B01J21/04;;B01J37/0009;;C01F7/025;;C01P2006/12;;C01P2006/14;;C01P2006/16;;C01P2006/17;;C01P2006/80;;C04B35/10,C01F7/025;;B01J20/08;;B01J21/04;;B01J37/00;;C04B35/10,,0,0,,,,EXPIRED
79,DE,B2,DE 2223401 B2,020-937-263-774-795,1981-04-30,1981,DE 2223401 A,1972-05-10,US 14200371 A;;US 14200471 A,1971-05-10,DE 2223401 B2,,"NORTON CO., WORCESTER, MASS., US","GERDES, WILLIAM HERMAN, HUDSON, OHIO, US;;KIOVSKY, JOSEPH RICHARD;;MEACHAM, JEFFREY WILLIAM, KENT, OHIO, US",,https://lens.org/020-937-263-774-795,Patent Application,no,0,0,5,7,0,B01J21/04;;B01J23/72;;B01J23/74;;B01J23/868;;B01J37/0009;;C04B35/10;;B01J35/50,B01J21/04;;B01J23/72;;B01J23/74;;B01J23/86;;B01J35/02;;B01J37/00;;C04B35/10,,0,0,,,,EXPIRED
80,WO,A1,WO 2018/034949 A1,032-658-359-715-355,2018-02-22,2018,US 2017/0046399 W,2017-08-11,US 201662377285 P,2016-08-19,"SOUND-ABSORBING PANELS COMPRISING A CORE CONSISTING OF CONNECTED CELLS, WHEREIN SOME OF THE CELL WALLS HAVE OPENINGS","Panels comprising first and second layers and a core disposed there between, wherein the core has a plurality of walls providing a series of connected cells, wherein some of the cell walls have openings providing fluid communication between a series of at least 3 cells, and wherein the opening in a cell wall has an area that is at least 50 percent of the area of a side of that cell wall. Exemplary embodiments of panels described herein can be formed articles such as panels, walls, or other parts with curved surfaces. In one exemplary method, panels are shaped via thermoforming. In another exemplary method, panels are shaped via insert molding to provide the article. In another exemplary method, panels are shaped via compression molding to provide the article. The panels are useful for absorbing sound in a designed frequency range.",3M INNOVATIVE PROPERTIES CO,JONZA JAMES M;;GERDES RONALD W;;HERDTLE THOMAS;;KALISH JEFFREY P;;MCNULTY JASON D;;KNECHT HAROLD C III,,https://lens.org/032-658-359-715-355,Patent Application,yes,3,17,6,6,0,B32B3/12;;B32B3/266;;B60R13/08;;E04B1/86;;G10K11/172;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2307/102;;B32B2307/546;;B32B2605/003;;B32B2607/00;;E04B2001/8428;;B32B3/12;;B60R13/08;;B32B2307/102;;B32B2307/546;;B32B2605/003;;E04B2001/8428;;B32B3/266;;E04B1/86;;G10K11/172;;B32B2250/05;;B32B2250/03;;B32B2607/00;;B32B2250/04;;B60N3/044;;B60R13/0815;;B60R13/0838;;B60R13/0861;;E04B1/8409;;G10K11/168,B32B3/12;;B32B3/26;;B60R13/08;;E04B1/84;;E04B1/86;;G10K11/16;;G10K11/168;;G10K11/172,,4,2,098-926-221-399-786;;098-926-221-399-786,10.4271/2017-01-1813;;10.4271/2017-01-1813,"JAMES M. JONZA ET AL: ""Acoustically Absorbing Lightweight Thermoplastic Honeycomb Panels"", SAE INTERNATIONAL JOURNAL OF VEHICLE DYNAMICS, STABILITY, AND NVH, vol. 1, no. 2, 15 January 2017 (2017-01-15), pages 445 - 454, XP055417551, ISSN: 2380-2170, DOI: 10.4271/2017-01-1813;;JONZA, J.; HERDTLE, T.; KALISH, J.; GERDES, R. ET AL.: ""Acoustically Absorbing Lightweight Thermoplastic Honeycomb Panels"", SAE INT. J. VEH. DYN., STAB., AND NVH, vol. 1, no. 2, 2017;;AKLONIS ET AL.: ""Introduction to Polymer Viscoelasticity"", 1972, JOHN WILEY & SONS, INC.;;ROBERT NICHOLLS: ""Composite Construction Materials Handbook"", 1976, PRENTICE-HALL",PENDING
81,EP,A1,EP 3500427 A1,020-396-047-045-417,2019-06-26,2019,EP 17757974 A,2017-08-11,US 201662377285 P;;US 2017/0046399 W,2016-08-19,"SOUND-ABSORBING PANELS COMPRISING A CORE CONSISTING OF CONNECTED CELLS, WHEREIN SOME OF THE CELL WALLS HAVE OPENINGS",,3M INNOVATIVE PROPERTIES CO,JONZA JAMES M;;GERDES RONALD W;;HERDTLE THOMAS;;KALISH JEFFREY P;;MCNULTY JASON D;;KNECHT HAROLD C III;;YOO TAEWOOK,,https://lens.org/020-396-047-045-417,Patent Application,yes,0,2,6,6,0,B32B3/12;;B32B3/266;;B60R13/08;;E04B1/86;;G10K11/172;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2307/102;;B32B2307/546;;B32B2605/003;;B32B2607/00;;E04B2001/8428;;B32B3/12;;B60R13/08;;B32B2307/102;;B32B2307/546;;B32B2605/003;;E04B2001/8428;;B32B3/266;;E04B1/86;;G10K11/172;;B32B2250/05;;B32B2250/03;;B32B2607/00;;B32B2250/04;;B60N3/044;;B60R13/0815;;B60R13/0838;;B60R13/0861;;E04B1/8409;;G10K11/168,B32B3/26;;B32B3/12;;B60R13/08;;E04B1/84;;E04B1/86;;G10K11/16;;G10K11/168;;G10K11/172,,0,0,,,,ACTIVE
82,US,A1,US 2019/0213990 A1,031-565-553-130-749,2019-07-11,2019,US 201716325464 A,2017-08-11,US 201716325464 A;;US 201662377285 P;;US 2017/0046399 W,2016-08-19,"SOUND-ABSORBING PANELS COMPRISING A CORE CONSISTING OF CONNECTED CELLS, WHEREIN SOME OF THE CELL WALLS HAVE OPENINGS","Panels comprising first and second layers and a core disposed there between, wherein the core has a plurality of walls providing a series of connected cells, wherein some of the cell walls have openings providing fluid communication between a series of at least 3 cells, and wherein the opening in a cell wall has an area that is at least 50 percent of the area of a side of that cell wall. Exemplary embodiments of panels described herein can be formed articles such as panels, walls, or other parts with curved surfaces. In one exemplary method, panels are shaped via thermoforming. In another exemplary method, panels are shaped via insert molding to provide the article. In another exemplary method, panels are shaped via compression molding to provide the article. The panels are useful for absorbing sound in a designed frequency range.",3M INNOVATIVE PROPERTIES CO,JONZA JAMES M;;GERDES RONALD W;;HERDTLE THOMAS;;KALISH JEFFREY P;;MCNULTY JASON D;;KNECHT III HAROLD C;;YOO TAEWOOK,3M INNOVATIVE PROPERTIES COMPANY (2018-08-17),https://lens.org/031-565-553-130-749,Patent Application,yes,0,8,6,6,0,B32B3/12;;B32B3/266;;B60R13/08;;E04B1/86;;G10K11/172;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2307/102;;B32B2307/546;;B32B2605/003;;B32B2607/00;;E04B2001/8428;;B32B3/12;;B60R13/08;;B32B2307/102;;B32B2307/546;;B32B2605/003;;E04B2001/8428;;B32B3/266;;E04B1/86;;G10K11/172;;B32B2250/05;;B32B2250/03;;B32B2607/00;;B32B2250/04;;B60N3/044;;B60R13/0815;;B60R13/0838;;B60R13/0861;;E04B1/8409;;G10K11/168,B32B3/12;;G10K11/168,,0,0,,,,DISCONTINUED
83,EP,B1,EP 3500427 B1,048-375-174-183-234,2021-02-03,2021,EP 17757974 A,2017-08-11,US 201662377285 P;;US 2017/0046399 W,2016-08-19,"SOUND-ABSORBING PANELS COMPRISING A CORE CONSISTING OF CONNECTED CELLS, WHEREIN SOME OF THE CELL WALLS HAVE OPENINGS",,3M INNOVATIVE PROPERTIES CO,KALISH JEFFREY P;;MCNULTY JASON D;;KNECHT HAROLD C III;;YOO TAEWOOK;;JONZA JAMES M;;GERDES RONALD W;;HERDTLE THOMAS,,https://lens.org/048-375-174-183-234,Granted Patent,yes,3,0,6,6,0,B32B3/12;;B32B3/266;;B60R13/08;;E04B1/86;;G10K11/172;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2307/102;;B32B2307/546;;B32B2605/003;;B32B2607/00;;E04B2001/8428;;B32B3/12;;B60R13/08;;B32B2307/102;;B32B2307/546;;B32B2605/003;;E04B2001/8428;;B32B3/266;;E04B1/86;;G10K11/172;;B32B2250/05;;B32B2250/03;;B32B2607/00;;B32B2250/04;;B60N3/044;;B60R13/0815;;B60R13/0838;;B60R13/0861;;E04B1/8409;;G10K11/168,B32B3/12;;B32B3/26;;B60R13/08;;E04B1/84;;E04B1/86;;G10K11/16;;G10K11/168;;G10K11/172,,1,0,,,"JAMES M. JONZA ET AL: ""Acoustically Absorbing Lightweight Thermoplastic Honeycomb Panels"", SAE INTERNATIONAL JOURNAL OF VEHICLE DYNAMICS, STABILITY, AND NVH, vol. 1, no. 2, 15 January 2017 (2017-01-15), pages 445-454, XP055417551, ISSN: 2380-2170, DOI: 10.4271/2017-01-1813",ACTIVE
84,EP,A1,EP 2260283 A1,044-067-427-053-033,2010-12-15,2010,EP 09726485 A,2009-04-01,US 2009/0039052 W;;US 6104408 A,2008-04-02,ITERATIVE STAINING OF BIOLOGICAL SAMPLES,,GEN ELECTRIC,XIE JUN;;GINTY FIONA;;FILKINS ROBERT JOHN;;MONTALTO MICHAEL CHRISTOPHER;;SOOD ANUP;;FORTIN JEFFREY BERNARD;;TIAN WEI-CHENG;;GERDES MICHAEL J,,https://lens.org/044-067-427-053-033,Patent Application,yes,0,0,7,7,0,G01N1/312;;G01N1/312,G01N1/10;;B01L99/00,,1,0,,,See references of WO 2009124099A1,DISCONTINUED
85,US,A1,US 2009/0253163 A1,039-978-948-480-651,2009-10-08,2009,US 6104408 A,2008-04-02,US 6104408 A,2008-04-02,ITERATIVE STAINING OF BIOLOGICAL SAMPLES,"Automated methods and devices that facilitate iterative staining of biological samples from imaging applications are provided. The methods include the steps of providing a small volume flow cell containing a biological sample, applying a stain to the biological sample, combining at least two precursor reagents to form an activated destaining agent and wherein the activated destaining agent decomposition rate is greater than or similar to the destaining reaction rate, and flowing the destaining agent over the biological sample at a flow rate that is greater than the decomposition rate of the activated destaining agent. The process of staining, combining and flowing may be iteratively repeated. Also disclosed herein are devices for iterative staining of biological samples comprising a flow cell, in fluid communication with a premixer, wherein the volume capacity of the premixer is smaller than about five times the volume capacity of the flow cell.",GEN ELECTRIC,XIE JUN;;GINTY FIONA;;FILKINS ROBERT JOHN;;MONTALTO MICHAEL CHRISTOPHER;;SOOD ANUP;;FORTIN JEFFREY BERNARD;;TIAN WEI-CHENG;;GERDES MICHAEL JOHN,GENERAL ELECTRIC COMPANY (2008-03-18),https://lens.org/039-978-948-480-651,Patent Application,yes,16,52,7,7,0,G01N1/312;;G01N1/312,G01N1/30;;B01L99/00;;C12M1/34;;C12M1/36,435/40.5;;435/287.1;;435/288.7;;435/286.5,0,0,,,,DISCONTINUED
86,CN,A,CN 109641416 A,055-209-034-869-912,2019-04-16,2019,CN 201780050905 A,2017-08-11,US 201662377285 P;;US 2017/0046399 W,2016-08-19,"SOUND-ABSORBING PANELS COMPRISING A CORE CONSISTING OF CONNECTED CELLS, WHEREIN SOME OF THE CELL WALLS HAVE OPENINGS","Panels comprising first and second layers and a core disposed there between, wherein the core has a plurality of walls providing a series of connected cells, wherein some of the cell walls have openings providing fluid communication between a series of at least 3 cells, and wherein the opening in a cell wall has an area that is at least 50 percent of the area of a side of that cell wall. Exemplaryembodiments of panels described herein can be formed articles such as panels, walls, or other parts with curved surfaces. In one exemplary method, panels are shaped via thermoforming. In another exemplary method, panels are shaped via insert molding to provide the article. In another exemplary method, panels are shaped via compression molding to provide the article. The panels are useful for absorbing sound in a designed frequency range.",3M INNOVATIVE PROPERTIES CO,JONZA JAMES M;;GERDES RONALD W;;HERDTLE THOMAS;;KALISH JEFFREY P;;MCNULTY JASON D;;KNECHT HAROLD C III;;KYU TAE-OOK,,https://lens.org/055-209-034-869-912,Patent Application,no,4,0,6,6,0,B32B3/12;;B32B3/266;;B60R13/08;;E04B1/86;;G10K11/172;;B32B2250/03;;B32B2250/04;;B32B2250/05;;B32B2307/102;;B32B2307/546;;B32B2605/003;;B32B2607/00;;E04B2001/8428;;B32B3/12;;B60R13/08;;B32B2307/102;;B32B2307/546;;B32B2605/003;;E04B2001/8428;;B32B3/266;;E04B1/86;;G10K11/172;;B32B2250/05;;B32B2250/03;;B32B2607/00;;B32B2250/04;;B60N3/044;;B60R13/0815;;B60R13/0838;;B60R13/0861;;E04B1/8409;;G10K11/168,B32B3/12;;B32B3/26;;B60R13/08;;E04B1/84;;E04B1/86;;G10K11/16;;G10K11/168;;G10K11/172,,0,0,,,,DISCONTINUED
87,CN,A,CN 101983327 A,034-659-111-418-282,2011-03-02,2011,CN 200980112550 A,2009-04-01,US 2009/0039052 W;;US 6104408 A,2008-04-02,Iterative staining of biological samples,"Automated methods and devices that facilitate iterative staining of biological samples from imaging applications are provided. The methods include the steps of providing a small volume flow cell containing a biological sample, applying a stain to the biological sample, combining at least two precursor reagents to form an activated destaining agent and wherein the activated destaining agent decomposition rate is greater than or similar to the destaining reaction rate, and flowing the destaining agent over the biological sample at a flow rate that is greater than the decomposition rate of the activated destaining agent. The process of staining, combining and flowing may be iteratively repeated. Also disclosed herein are devices for iterative staining of biological samples comprising a flow cell, in fluid communication with a premixer, wherein the volume capacity of the premixer is smaller than about five times the volume capacity of the flow cell.",GEN ELECTRIC,XIE JUN;;FIONA GINTY;;JOHN FILKINS ROBERT;;CHRISTOPHER MONTALTO MICHAEL;;ANUP SOOD;;BERNARD FORTIN JEFFREY;;WEI-CHENG TIAN;;GERDES MICHAEL J,,https://lens.org/034-659-111-418-282,Patent Application,no,0,3,7,7,0,G01N1/312;;G01N1/312,G01N1/10;;B01L99/00,,0,0,,,,DISCONTINUED
88,WO,A1,WO 2009/124099 A1,184-386-065-256-451,2009-10-08,2009,US 2009/0039052 W,2009-04-01,US 6104408 A,2008-04-02,ITERATIVE STAINING OF BIOLOGICAL SAMPLES,"Automated methods and devices that facilitate iterative staining of biological samples from imaging applications are provided. The methods include the steps of providing a small volume flow cell containing a biological sample, applying a stain to the biological sample, combining at least two precursor reagents to form an activated destaining agent and wherein the activated destaining agent decomposition rate is greater than or similar to the destaining reaction rate, and flowing the destaining agent over the biological sample at a flow rate that is greater than the decomposition rate of the activated destaining agent. The process of staining, combining and flowing may be iteratively repeated. Also disclosed herein are devices for iterative staining of biological samples comprising a flow cell, in fluid communication with a premixer, wherein the volume capacity of the premixer is smaller than about five times the volume capacity of the flow cell.",GEN ELECTRIC;;XIE JUN;;GINTY FIONA;;FILKINS ROBERT JOHN;;MONTALTO MICHAEL CHRISTOPHER;;SOOD ANUP;;FORTIN JEFFREY BERNARD;;TIAN WEI-CHENG;;GERDES MICHAEL J,XIE JUN;;GINTY FIONA;;FILKINS ROBERT JOHN;;MONTALTO MICHAEL CHRISTOPHER;;SOOD ANUP;;FORTIN JEFFREY BERNARD;;TIAN WEI-CHENG;;GERDES MICHAEL J,,https://lens.org/184-386-065-256-451,Patent Application,yes,9,2,7,7,0,G01N1/312;;G01N1/312,G01N1/10;;B01L99/00,,0,0,,,,PENDING
89,US,A1,US 2012/0135449 A1,117-601-989-669-394,2012-05-31,2012,US 201213365525 A,2012-02-03,US 201213365525 A;;US 6104408 A,2008-04-02,ITERATIVE STAINING OF BIOLOGICAL SAMPLES,"Automated methods and devices that facilitate iterative staining of biological samples from imaging applications are provided. The methods include the steps of providing a small volume flow cell containing a biological sample, applying a stain to the biological sample, combining at least two precursor reagents to form an activated destaining agent and wherein the activated destaining agent decomposition rate is greater than or similar to the destaining reaction rate, flowing the destaining agent over the biological sample at a flow rate that is greater than the decomposition rate of the activated destaining agent, and releasing the sample from the flow cell wherein the integrity of the sample is intact. The process of staining, combining and flowing may be iteratively repeated. Also disclosed herein are devices for iterative staining of biological samples comprising a flow cell, in fluid communication with a premixer, wherein the volume capacity of the premixer is smaller than about five times the volume capacity of the flow cell.",XIE JUN;;FILKINS ROBERT JOHN;;GINTY FIONA MARY;;MONTALTO MICHAEL CHRISTOPHER;;SOOD ANUP;;FORTIN JEFFREY BERNARD;;TIAN WEI-CHENG;;GERDES MICHAEL JOHN;;GEN ELECTRIC,XIE JUN;;FILKINS ROBERT JOHN;;GINTY FIONA MARY;;MONTALTO MICHAEL CHRISTOPHER;;SOOD ANUP;;FORTIN JEFFREY BERNARD;;TIAN WEI-CHENG;;GERDES MICHAEL JOHN,GENERAL ELECTRIC COMPANY (2012-01-23),https://lens.org/117-601-989-669-394,Patent Application,yes,4,4,7,7,0,G01N1/312;;G01N1/312,G01N21/75;;B01L99/00;;C12M1/34,435/29;;435/288.7,1,1,063-661-957-046-122,1893571;;10.1093/clinchem/37.9.1472,"Kricka (Clin. Chem., vol. 37(9), pages 1472-1481, 1991)",DISCONTINUED
90,CN,A,CN 107406892 A,105-224-783-500-079,2017-11-28,2017,CN 201680019880 A,2016-03-30,US 201514672358 A;;EP 2016056854 W,2015-03-30,METHODS OF CAPTURING SPERM NUCLEIC ACIDS,"A method is provided herein, wherein the method of capturing a sperm deoxyribonucleic acid (DNA) in a sample, comprises contacting a lysis solution to the sample comprising at least a sperm cell or a sperm cell lysate to lyse the sperm cell. The sperm cell or sperm cell lysate comprises a protamine-DNA complex. The method further comprises applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody- protamine- DNA complex. The antibody binding is followed by capturing the antibody-protamine-DNA complex; and isolating and detecting the sperm DNA from the captured antibody-protamine-DNA complex.",GEN ELECTRIC,GERDES MICHAEL JOHN;;HORTON JEFFREY KENNETH;;TATNELL PETER JAMES;;NELSON JOHN RICHARD;;KIEL SUZANA;;SPOONER PATRICK MCCOY;;LENIGK RALF;;SCHENK ALEXANDER;;SUN WEI,,https://lens.org/105-224-783-500-079,Patent Application,no,6,0,9,12,0,C12N15/1003;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12N15/1003;;C12Q1/6804,C12Q1/68;;C12N15/10,,6,0,,,"赵兴春等: ""“精子细胞定向捕获与分离技术初步研究”"", 《刑事技术》;;李鑫等: ""“混合斑中精子细胞分离及其DNA 制备方法”"", 《法医学杂志》;;吴明章等: ""《生殖疾病诊断学》"", 30 November 2006, 上海科学出版社;;于源华等: ""《生物工程与技术专业实验教程》"", 30 September 2009, 兵器工业出版社;;ROD BALHORN等: ""“The protamine family of sperm nuclear proteins”"", 《GENOME BIOL》;;FRANCESCO DATI等: ""《蛋白质实验室检测项目临床应用指南》"", 31 October 2008, 上海科学技术出版社",ACTIVE
91,WO,A1,WO 2016/156353 A1,171-278-165-600-360,2016-10-06,2016,EP 2016056854 W,2016-03-30,US 201514672358 A,2015-03-30,METHODS OF CAPTURING SPERM NUCLEIC ACIDS,"A method is provided herein, wherein the method of capturing a sperm deoxyribonucleic acid (DNA) in a sample, comprises contacting a lysis solution to the sample comprising at least a sperm cell or a sperm cell lysate to lyse the sperm cell. The sperm cell or sperm cell lysate comprises a protamine-DNA complex. The method further comprises applying at least a protamine-specific antibody to the lysed sperm cell, wherein the protamine-specific antibody binds to the protamine-DNA complex of the lysed sperm cell to form an antibody- protamine- DNA complex. The antibody binding is followed by capturing the antibody-protamine-DNA complex; and isolating and detecting the sperm DNA from the captured antibody-protamine-DNA complex.",GEN ELECTRIC;;GE HEALTHCARE LTD,GERDES MICHAEL JOHN;;HORTON JEFFREY KENNETH;;TATNELL PETER JAMES;;NELSON JOHN RICHARD;;KIEL SUZANA;;SPOONER PATRICK MCCOY;;LENIGK RALF;;SCHENK ALEXANDER;;SUN WEI,,https://lens.org/171-278-165-600-360,Patent Application,yes,2,5,9,12,0,C12N15/1003;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12N15/1003;;C12Q1/6804,G01N33/569;;C12Q1/68,,3,3,004-144-391-185-362;;089-002-342-612-428;;000-086-460-105-111,10.1007/s00120-010-2359-8;;10.1016/s0927-7765(02)00128-5;;11476542;;10.1006/abio.2001.5164,"""Abstracts des 62. Kongresses der Deutschen Gesellschaft für Urologie"", DER UROLOGE, AUSGABE A ; ZEITSCHRIFT FÜR KLINISCHE UND PRAKTISCHE UROLOGIE ORGAN DER DEUTSCHEN GESELLSCHAFT FÜR UROLOGIE, SPRINGER, BERLIN, DE, vol. 49, no. 1, 3 September 2010 (2010-09-03), pages 9 - 146, XP019836001, ISSN: 1433-0563;;S.Z BATHAIE; A.A MOOSAVI-MOVAHEDI; B RANJBAR; A.A SABOURY: ""A mechanistic study of the histone Hl-DNA complex dissociation by sodium dodecyl sulfate"", COLLOIDS AND SURFACES B: BIOINTERFACES, vol. 28, no. 1, 1 April 2003 (2003-04-01), pages 17 - 25;;FILIPPO RUSCONI; ÉDOUARD VALTON; REGIS NGUYEN; ERICK DUFOURC: ""Quantification of Sodium Dodecyl Sulfate in Microliter-Volume Biochemical Samples by Visible Light Spectroscopy"", ANALYTICAL BIOCHEMISTRY, vol. 295, no. 1, 1 August 2001 (2001-08-01), pages 31 - 37",PENDING
92,EP,A1,EP 3277834 A1,120-478-606-710-204,2018-02-07,2018,EP 16712051 A,2016-03-30,US 201514672358 A;;EP 2016056854 W,2015-03-30,METHODS OF CAPTURING SPERM NUCLEIC ACIDS,,GEN ELECTRIC,GERDES MICHAEL JOHN;;HORTON JEFFREY KENNETH;;TATNELL PETER JAMES;;NELSON JOHN RICHARD;;KIEL SUZANA;;SPOONER PATRICK MCCOY;;LENIGK RALF;;SCHENK ALEXANDER;;SUN WEI,QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS LIMITED (2020-03-18);;QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS GMBH (2021-01-06),https://lens.org/120-478-606-710-204,Patent Application,yes,0,0,9,12,0,C12N15/1003;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12N15/1003;;C12Q1/6804,C12Q1/68;;G01N33/569,,0,0,,,,ACTIVE
93,US,A1,US 2016/0289666 A1,055-308-408-697-240,2016-10-06,2016,US 201615150806 A,2016-05-10,US 201615150806 A;;EP 2016056854 W;;US 201514672358 A,2015-03-30,METHODS AND KITS FOR CAPTURING SPERM NUCLEIC ACIDS,"The invention generally relates to methods and kits for capturing sperm nucleic acids from or in a biological sample. In one embodiment the method the method comprises, contacting the sample with a lysis solution, having a protamine-DNA complex, to lyse the cell and applying a protamine-specific antibody. This results in the protamine-specific antibody binding to the protamine-DNA to form a complex which may be captured, purified, or detected. Also provided are kits for carrying out the disclosed methods.",GEN ELECTRIC,SPOONER PATRICK MCCOY;;TATNELL PETER JAMES;;HORTON JEFFREY KENNETH;;NELSON JOHN RICHARD;;GERDES MICHAEL JOHN;;KIEL SUZANA;;LENIGK RALF;;SCHENK ALEXANDER;;SUN WEI,QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS LIMTIED (2019-06-12);;GENERAL ELECTRIC COMPANY (2016-05-05);;QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS GMBH (2020-08-31),https://lens.org/055-308-408-697-240,Patent Application,yes,4,0,2,12,0,G01N33/689;;C12Q1/6888;;C12Q2600/124;;G01N33/5308;;C12Q1/6804;;C12N15/1013;;G01N33/5308;;C12N15/101;;C12Q1/6804;;G01N27/44747;;G01N27/44743;;G01N33/689;;C12Q1/6888;;C12Q2600/124,C12N15/10;;C12Q1/68;;G01N27/447;;G01N33/53,,2,1,066-686-791-507-979,17903313;;10.1186/gb-2007-8-9-227;;pmc2375014,"Balhorn (Genome Biology, 2007, Vol.8, No.9, pages 227.1-227.8);;Taylor (National Institute of Justice, 3/3/11).",ACTIVE
94,US,B2,US 10030241 B2,126-235-656-053-996,2018-07-24,2018,US 201615150806 A,2016-05-10,US 201615150806 A;;EP 2016056854 W;;US 201514672358 A,2015-03-30,Methods and kits for capturing sperm nucleic acids,"The invention generally relates to methods and kits for capturing sperm nucleic acids from or in a biological sample. In one embodiment the method the method includes, contacting the sample with a lysis solution, having a protamine-DNA complex, to lyse the cell and applying a protamine-specific antibody. This results in the protamine-specific antibody binding to the protamine-DNA to form a complex which may be captured, purified, or detected. Also provided are kits for carrying out the disclosed methods.",GEN ELECTRIC,SPOONER PATRICK MCCOY;;TATNELL PETER JAMES;;HORTON JEFFREY KENNETH;;NELSON JOHN RICHARD;;GERDES MICHAEL JOHN;;KIEL SUZANA;;LENIGK RALF;;SCHENK ALEXANDER;;SUN WEI,QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS LIMTIED (2019-06-12);;GENERAL ELECTRIC COMPANY (2016-05-05);;QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS GMBH (2020-08-31),https://lens.org/126-235-656-053-996,Granted Patent,yes,33,0,2,12,0,G01N33/689;;C12Q1/6888;;C12Q2600/124;;G01N33/5308;;C12Q1/6804;;C12N15/1013;;G01N33/5308;;C12N15/101;;C12Q1/6804;;G01N27/44747;;G01N27/44743;;G01N33/689;;C12Q1/6888;;C12Q2600/124,C12N15/10;;C12Q1/6804;;C12Q1/6888;;G01N27/447;;G01N33/53;;G01N33/68,,10,7,066-686-791-507-979;;000-086-460-105-111;;089-002-342-612-428;;039-134-637-286-392;;025-877-986-708-695;;027-474-942-267-521;;065-952-260-264-958,17903313;;10.1186/gb-2007-8-9-227;;pmc2375014;;11476542;;10.1006/abio.2001.5164;;10.1016/s0927-7765(02)00128-5;;10.1186/2041-2223-2-11;;21542912;;pmc3119174;;18696055;;10.1007/s00216-008-2287-2;;pmc1904290;;17478499;;10.1093/nar/gkm269;;19591449;;10.1021/ac900439b,"Balhorn (Genome Biology, 2007, vol. 8, No. 9, pp. 227.1-227.8).;;Taylor (National Institute of Justice, Mar. 3, 2011).;;Rusconi et al., “Quantification of Sodium Dodecyl Sulfate in Microliter-Volume Biochemical Samples by Visible Light Spectroscopy”, Analytical Biochemistry, vol. No. 295, pp. 31-37, 2001.;;Bathaie et al., “A Mechanistic Study of the Histone H1-DNA Complex Dissociation by Sodium Dodecyl Sulfate”, Colloids and Surfaces B: Biointerfaces, vol. No. 28, pp. 17-25, 2003.;;Paradowska et al., “Binding of Histone H4k12ac Is Depleted in Promoters of Developmen-Tally Important Genes in Sperm of Subfertile Patients”, Springer-Verlag, vol. No. 49, Issue No. 1, pp. 121-122, Sep. 3, 2010.;;Vuichard et al., “Differential DNA Extraction of Challenging Simulated Sexual-Assault Samples: A Swiss Collaborative Study”, Investigative Genetics, pp. 1-7, 2011.;;PCT Search Report and Written Opinion issued in connection with related Application No. PCT/EP2016/056854 dated Jun. 23, 2016.;;Posthuma-Trumpie, G.A., et al, Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and threats. A literature survey, Anal. Bioanal. Chem. 2009, vol. 393, pp. 569-582.;;Carter et al, Lateral flow microarrays: a novel platform for nucleic acid detection based on miniaturized lateral flow chromatography, Nucleic Acids Research, 2007, vol. 35, No. 10 (e74), pp. 1-11.;;Norris et al, Acoustic Differential Extraction for Forensic Analysis of Sexual Assault Evidence, Anal. Chem., 2009, vol. 81, No. 15, pp. 6089-6095.",ACTIVE
95,EP,B1,EP 3277834 B1,057-570-707-079-14X,2021-02-17,2021,EP 16712051 A,2016-03-30,US 201514672358 A;;EP 2016056854 W,2015-03-30,METHODS OF CAPTURING SPERM NUCLEIC ACIDS,,QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS GMBH,SCHENK ALEXANDER;;SUN WEI;;GERDES MICHAEL JOHN;;HORTON JEFFREY KENNETH;;TATNELL PETER JAMES;;NELSON JOHN RICHARD;;KIEL SUZANA;;SPOONER PATRICK MCCOY;;LENIGK RALF,QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS LIMITED (2020-03-18);;QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS GMBH (2021-01-06),https://lens.org/057-570-707-079-14X,Granted Patent,yes,2,0,9,12,0,C12N15/1003;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12Q1/6804;;C12Q2522/101;;G01N33/689;;C12N15/1003;;C12Q1/6804,C12Q1/6804;;G01N33/68,,1,0,,,"""Abstracts des 62. Kongresses der Deutschen Gesellschaft fÃ 1/4 r Urologie"", DER UROLOGE, AUSGABE A ; ZEITSCHRIFT FÜR KLINISCHE UND PRAKTISCHE UROLOGIE ORGAN DER DEUTSCHEN GESELLSCHAFT FÜR UROLOGIE, SPRINGER, BERLIN, DE, vol. 49, no. 1, 3 September 2010 (2010-09-03), pages 9-146, XP019836001, ISSN: 1433-0563",ACTIVE
96,US,A1,US 2018/0327811 A1,161-786-240-069-855,2018-11-15,2018,US 201816042320 A,2018-07-23,US 201816042320 A;;EP 2016056854 W;;US 201615150806 A;;US 201514672358 A,2015-03-30,METHODS AND KITS FOR CAPTURING SPERM NUCLEIC ACIDS,"The invention generally relates to methods and kits for capturing sperm nucleic acids from or in a biological sample. In one embodiment the method the method comprises, contacting the sample with a lysis solution, having a protamine-DNA complex, to lyse the cell and applying a protamine-specific binding element. This results in the protamine-specific binding element binding to the protamine-DNA to form a complex which may be captured, purified, or detected. Also provided are kits for carrying out the disclosed methods.",GEN ELECTRIC,SPOONER PATRICK MCCOY;;TATNELL PETER JAMES;;HORTON JEFFREY KENNETH;;NELSON JOHN RICHARD;;GERDES MICHAEL JOHN;;KIEL SUZANA;;LENIGK RALF;;SCHENK ALEXANDER;;SUN WEI;;HANSEN THOMAS,QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS LIMTIED (2019-06-12);;GENERAL ELECTRIC COMPANY (2019-06-13);;QIAGEN HEALTHCARE BIOTECHNOLOGIES SYSTEMS GMBH (2020-08-31),https://lens.org/161-786-240-069-855,Patent Application,yes,0,0,1,12,0,C12Q1/6806;;C12Q1/6804;;C12Q1/6869;;C12Q1/6876;;C12N2310/16;;C12N15/11;;C12Q2522/101;;C07K16/44;;C12Q1/6806,C12Q1/6804;;C07K16/44;;C12N15/11;;C12Q1/6869;;C12Q1/6876,,0,0,,,,DISCONTINUED
97,WO,A1,WO 2021/044272 A1,076-586-661-936-198,2021-03-11,2021,IB 2020058055 W,2020-08-28,US 201962895317 P,2019-09-03,ASSEMBLY INCLUDING ACOUSTIC BAFFLES,"An assembly includes an enclosure including first and second regions spaced apart along a first direction, and a plurality of spaced apart acoustic baffles arranged along a second direction different from the first direction and disposed in the enclosure between the first and second regions. The plurality of spaced apart acoustic baffles includes adjacent first and second acoustic baffles. Each of the first and second acoustic baffles include an acoustically absorptive layer disposed on a sheet having a specific airflow resistance greater than 200 MKS Rayl. The first and second acoustic baffles define a channel therebetween. At least a portion of the channel extends along a longitudinal direction making an oblique angle with the first direction.",3M INNOVATIVE PROPERTIES CO,GERDES RONALD W;;LEATHERDALE CATHERINE A;;HERDTLE THOMAS;;NIELSEN PAUL A;;ROWELL TIMOTHY J;;REN LIYUN;;ZILLIG DANIEL J;;TALWAR SACHIN;;PYUN EUMI;;CHAMBERS JEFFREY A;;WU PINGFAN,,https://lens.org/076-586-661-936-198,Patent Application,yes,3,1,4,4,0,G10K11/168;;G10K11/168,G10K11/16;;G10K11/168,,0,0,,,,PENDING
98,US,A1,US 2022/0366887 A1,027-289-745-833-470,2022-11-17,2022,US 202017633851 A,2020-08-28,US 202017633851 A;;US 201962895317 P;;IB 2020058055 W,2019-09-03,ASSEMBLY INCLUDING ACOUSTIC BAFFLES,"An assembly includes an enclosure including first and second regions spaced apart along a first direction, and a plurality of spaced apart acoustic baffles arranged along a second direction different from the first direction and disposed in the enclosure between the first and second regions. The plurality of spaced apart acoustic baffles includes adjacent first and second acoustic baffles. Each of the first and second acoustic baffles include an acoustically absorptive layer disposed on a sheet having a specific airflow resistance greater than 200 MKS Rayl. The first and second acoustic baffles define a channel therebetween. At least a portion of the channel extends along a longitudinal direction making an oblique angle with the first direction.",3M INNOVATIVE PROPERTIES COMPANY,NIELSEN PAUL A;;GERDES RONALD W;;LEATHERDALE CATHERINE A;;HERDTLE THOMAS;;ROWELL TIMOTHY J;;REN LIYUN;;ZILLIG DANIEL J;;TALWAR SACHIN;;PYUN EUMI;;CHAMBERS JEFFREY A;;WU PINGFAN,,https://lens.org/027-289-745-833-470,Patent Application,yes,27,0,4,4,0,G10K11/168;;G10K11/168,G10K11/168,,0,0,,,,PENDING
99,CN,A,CN 114341973 A,114-397-978-945-205,2022-04-12,2022,CN 202080062252 A,2020-08-28,US 201962895317 P;;IB 2020058055 W,2019-09-03,Assembly comprising sound barrier,The present invention proposes an assembly comprising: a package comprising a first region and a second region spaced apart in a first direction; and a plurality of spaced apart sound baffles arranged in a second direction different from the first direction and disposed between the first region and the second region in the package. The plurality of spaced apart sound baffles includes a first sound baffle and a second sound baffle adjacent to each other. Each of the first acoustic baffle and the second acoustic baffle includes an acoustic absorbing layer disposed on a sheet having a specific airflow resistance greater than 200 MKS Rayl. A channel is defined between the first acoustic baffle and the second acoustic baffle. At least a portion of the channel extends in the longitudinal direction so as to form an oblique angle with the first direction.,3M INNOVATION CO LTD,GERDES RONALD W;;LEATHERDALE CATHERINE A;;HERDTLE THOMAS;;NIELSEN PAUL A;;ROWELL TIMOTHY J;;REN LIYUN;;ZILLIG DANIEL J;;TALWAR SACHIN;;PYUN EUMI;;CHAMBERS JEFFREY A;;WU PINGFAN,,https://lens.org/114-397-978-945-205,Patent Application,no,0,0,4,4,0,G10K11/168;;G10K11/168,G10K11/16;;G10K11/162,,0,0,,,,PENDING
100,TW,A,TW 202121396 A,141-061-243-933-713,2021-06-01,2021,TW 109129990 A,2020-09-02,US 201962895317 P,2019-09-03,Assembly including acoustic baffles,"An assembly includes an enclosure including first and second regions spaced apart along a first direction, and a plurality of spaced apart acoustic baffles arranged along a second direction different from the first direction and disposed in the enclosure between the first and second regions. The plurality of spaced apart acoustic baffles includes adjacent first and second acoustic baffles. Each of the first and second acoustic baffles include an acoustically absorptive layer disposed on a sheet having a specific airflow resistance greater than 200 MKS Rayl. The first and second acoustic baffles define a channel therebetween. At least a portion of the channel extends along a longitudinal direction making an oblique angle with the first direction.",3M INNOVATIVE PROPERTIES CO,GERDES RONALD WAYNE;;LEATHERDALE CATHERINE ANNE;;HERDTLE THOMAS;;NIELSEN PAUL ANDERS;;ROWELL TIMOTHY JOHN;;REN LI-YUN;;ZILLIG DANIEL JOSEPH;;TALWAR SACHIN WAYNE;;PYUN EUMI WAYNE;;CHAMBERS JEFFREY ADAM;;WU PINGFAN,,https://lens.org/141-061-243-933-713,Patent of Addition,no,0,0,4,4,0,G10K11/168;;G10K11/168,G10K11/175;;G10K11/162;;H05K5/02,,0,0,,,,PENDING
